Endocrinology and Metabolism

Original Article

GYG1 as a Dual Biomarker of Glucagon-Like Peptide-1 Receptor Agonist Weight-Loss Response: Findings from an Integrative Multi-Omics Substudy of a Phase II Trial: Lijun Li, Mengyu Hou, Qiannan Gao, Ruihua Dong; Received September 3, 2025 Accepted October 22, 2025 Published online February 4, 2026; DOI: https://doi.org/10.3803/EnM.2025.2641 [Epub ahead of print]

616 View
29 Download

Abstract PDF Supplementary Material PubReader ePub: Background
The global obesity crisis requires precision biomarkers to overcome treatment resistance. We investigated circulating multi-omics signatures for predicting and monitoring glucagon-like peptide-1 receptor agonist (GLP-1RA) (GZR18) response, addressing gaps in personalized obesity therapy.
Methods
We conducted longitudinal multi-omics profiling (proteomics, metabolomics, and lipidomics) of 221 plasma samples from 25 participants (n=25) treated with GZR18 at nine time points over 30 weeks. High-resolution mass spectrometry quantified molecular features alongside clinical body mass index (BMI) trajectories. Theil-Sen regression modeled baseline predictors (BMI slope Z), while linear regression analysis identified longitudinal biomarkers (%BMI change). Significant candidates (P<0.05) underwent gene set enrichment analysis (GSEA; Kyoto Encyclopedia of Genes and Genomes [KEGG] pathways) and STRING network integration, with dual-response biomarkers validated through correlation and trajectory analyses.
Results
GZR18-treated obese patients exhibited a dose-dependent reduction in BMI, with 48 mg biweekly producing the steepest declines (Z<–0.4 vs. placebo: Z=–0.22, P<0.001). We identified glycogenin 1 (GYG1) as a dual-function biomarker (coefficient= 2.0 for prediction, P<0.05 for monitoring) and as a central network hub. Lipidomic (phosphatidylinositol 18:2–18:2) and metabolomic (oxoglutaric acid) markers predicted baseline response, while proteomic (insulin like growth factor binding protein 2 [IGFBP2]) and lipidomic (phosphatidylcholine 18:0–20:3) profiles tracked longitudinal efficacy (P<0.05). Adipocytokine signaling governed the initial response (normalized enrichment score >1.8), while starch/sucrose metabolism modulated ongoing efficacy through integrated molecular networks.
Conclusion
This study establishes GYG1 as a clinically actionable, dual-function biomarker for GLP-1RA therapy in obesity, linking baseline prediction and real-time monitoring of treatment response through integrated multi-omics profiling. Our findings highlight convergent metabolic pathways driving therapeutic efficacy and provide a precision-medicine framework for optimizing obesity pharmacotherapy through blood-based molecular signatures.

Brief Report

Diabetes, obesity and metabolism
Early Dose Escalation of Tirzepatide after Switching from Semaglutide in Type 2 Diabetes Mellitus: Noboru Kurinami, Masafumi Takada, Seigo Sugiyama, Akira Yoshida, Kunio Hieshima, Tomoko Suzuki, Fumio Miyamoto, Keizo Kajiwara, Katsunori Jinnouchi, Kenji Ashida, Masatoshi Nomura, Hideaki Jinnouchi; Endocrinol Metab. 2025;40(6):1012-1015. Published online October 15, 2025; DOI: https://doi.org/10.3803/EnM.2025.2420

2,044 View
151 Download

Abstract PDF PubReader ePub: Tirzepatide has demonstrated greater efficacy than semaglutide in improving glycemic control and reducing body weight in patients with type 2 diabetes mellitus (T2DM). However, the optimal tirzepatide dose following a switch from 1.0 mg of semaglutide remains unclear. This retrospective study included 15 T2DM patients who switched to tirzepatide due to inadequate weight loss. All patients started tirzepatide at 2.5 mg, with escalation to either 7.5 mg (n=10) or 10 mg (n=5). Changes in glycated hemoglobin (HbA1c) and body weight were assessed over a 3-month period. The 10 mg group experienced a significant reduction in HbA1c (−0.7%±0.3%, P<0.01) and a non-significant trend toward weight loss (−6.6±5.4 kg, P=0.07). In contrast, no significant changes were observed in the 7.5 mg group. There were no statistically significant differences between groups. Since 10 mg of tirzepatide significantly improved glycemic control after switching from 1.0 mg of semaglutide, early escalation to 10 mg may be beneficial for patients who respond inadequately to semaglutide.

Original Articles

Thyroid
High TRAb Titer at Diagnosis Predicts Persistent Positivity and Relapse in Graves’ Disease after Prolonged Antithyroid Therapy: Zimiao Chen, Jinglu Xu, Wenrui Kang, Yang Zhang, Rujun Chen, Xiaohua Gong; Endocrinol Metab. 2025;40(6):950-960. Published online September 16, 2025; DOI: https://doi.org/10.3803/EnM.2025.2405

3,252 View
99 Download
1 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
The association between high thyrotropin receptor antibody (TRAb) titers at diagnosis and long-term outcomes following prolonged antithyroid drug (ATD) therapy in Graves’ disease (GD) remains unclear. This study examined TRAb dynamics and outcomes in high-titer patients receiving prolonged ATD.
Methods
In this retrospective cohort (2018–2021), 1,148 of 3,052 newly diagnosed GD patients met inclusion criteria (≥18-month ATD course, TRAb negativity before withdrawal, and ≥12-month follow-up). Initial TRAb levels were defined as low-titer (<5.25 IU/L, 3×upper normal limit [UNL]), intermediate-titer (5.25–10.5 IU/L), and high-titer (>10.5 IU/L, 6×UNL). Outcomes included TRAb dynamics, treatment duration, and relapse.
Results
High-titer patients required longer therapy (50 months vs. 30 months vs. 22 months, P<0.001) and slower thyroid-stimulating hormone normalization (6 months vs. 4 months vs. 2 months, both P<0.001). TRAb negativity at 24/48 months occurred in 91.85%/99.26% (low-titer), 52.38%/75.24% (intermediate-titer), and 12.70%/52.68% (high-titer) (P<0.001). High-titer patients showed fluctuant (46.20%) or smoldering (28.89%) trends. Remission rates declined with higher TRAb titer (60.45% vs. 42.70% vs. 30.47%, P<0.001). High-titer patients showed increased risk of persistent TRAb positivity (2.17-fold; 95% confidence interval [CI], 1.55 to 3.05) and relapse (1.66-fold; 95% CI, 1.45 to 3.22). Thresholds of 10.90 IU/L and 16.01 IU/L predicted positivity and relapse, respectively. Definitive therapy post-relapse was more common in high-titer patients (38.29% vs. 16.98% in low-titer, P<0.001).
Conclusion
High TRAb titers strongly predict persistent TRAb positivity and relapse after ATD withdrawal. Cut-off at 10.90 and 16.01 IU/L may guide prognosis and treatment.

Citations

Citations to this article as recorded by

Peripartum Management of Refractory Graves’ Thyrotoxicosis
Sonam Tshering, Ashutosh Kapoor, Sophie Buckley, Fareeha Rizvi
Cureus.2026;[Epub] CrossRef

Diabetes, obesity and metabolism
Comparison of Population Attributable Fractions of Cancer Incidence and Mortality Linked to Excess Body Weight in Korea from 2015 to 2030: Youjin Hong, Jihye An, Jeehi Jung, Hyeon Sook Lee, Soseul Sung, Sungji Moon, Inah Kim, Jung Eun Lee, Aesun Shin, Sun Ha Jee, Sun-Seog Kweon, Min-Ho Shin, Sangmin Park, Seung-Ho Ryu, Sun Young Yang, Seung Ho Choi, Jeongseon Kim, Sang-Wook Yi, Yoon-Jung Choi, Sangjun Lee, Woojin Lim, Kyungsik Kim, Sohee Park, Jeong-Soo Im, Hong Gwan Seo, Kwang-Pil Ko, Sue K. Park; Endocrinol Metab. 2024;39(6):921-931. Published online November 28, 2024; DOI: https://doi.org/10.3803/EnM.2024.2071

4,240 View
105 Download
3 Web of Science
4 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
The increasing rate of excess body weight (EBW) in the global population has led to growing health concerns, including cancer-related EBW. We aimed to estimate the population attributable fraction (PAF) of cancer incidence and deaths linked to EBW in Korean individuals from 2015 to 2030 and to compare its value with various body mass index cutoffs.
Methods
Levin’s formula was used to calculate the PAF; the prevalence rates were computed using the Korean National Health and Nutrition Examination Survey data, while the relative risks of specific cancers related to EBW were estimated based on the results of Korean cohort studies. To account for the 15-year latency period when estimating the PAF in 2020, the prevalence rates from 2015 and attributable cases or deaths from 2020 were used.
Results
The PAF attributed to EBW was similar for both cancer incidence and deaths using either the World Health Organization (WHO) Asian-Pacific region standard or a modified Asian standard, with the WHO standard yielding the lowest values. In the Korean population, the PAFs of EBW for cancer incidence were 2.96% in men and 3.61% in women, while those for cancer deaths were 0.67% in men and 3.06% in women in 2020. Additionally, PAFs showed a gradual increase in both sexes until 2030.
Conclusion
The EBW continues to have a significant impact on cancer incidence and deaths in Korea. Effective prevention strategies targeting the reduction of this modifiable risk factor can substantially decrease the cancer burden.

Citations

Citations to this article as recorded by

Over one‐third of cancer cases and two‐fifths of cancer deaths in southern China are preventable: Insights from the latest representative population‐based cancer registry data and risk factor survey
Xiaolan Wen, Yu Liao, Jiayue Li, Qian Zhu, Xinmei Lin, Bingfeng Han, Li Li, Ru Chen, Ruilin Meng, Ni Xiao, Xueyan Zheng, Xiaojun Xu, Dejian Zhao, Yue Gao, Liming Pu, Ye Wang, Wenqiang Wei, Shaoming Wang
International Journal of Cancer.2026; 158(4): 909. CrossRef
Cancer attributable to excess body weight in Korea: a focus on primary prevention
Yoon-Jung Choi
Journal of the Korean Medical Association.2025; 68(2): 100. CrossRef
Population attributable fraction as a key measure of primary cancer prevention strategy
Sohee Park, Yoon-Jung Choi, Sue Kyung Park, Hong Gwan Seo
Journal of the Korean Medical Association.2025; 68(2): 82. CrossRef
Fraction of cancer incidence and mortality attributable to dietary factors in Korea from 2015 to 2030
Hyun Jeong Cho, Jin Young Yoo, Ga-Eun Yie, An Na Kim, Soseul Sung, Sungji Moon, Youjin Hong, Sangjun Lee, Inah Kim, Kwang-Pil Ko, Sun-Seog Kweon, Jung Eun Lee, Sue K. Park
Epidemiology and Health.2025; 47: e2025065. CrossRef

Review Article

Diabetes, obesity and metabolism
The Road towards Triple Agonists: Glucagon-Like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide and Glucagon Receptor - An Update: Agnieszka Jakubowska, Carel W. le Roux, Adie Viljoen; Endocrinol Metab. 2024;39(1):12-22. Published online February 14, 2024; DOI: https://doi.org/10.3803/EnM.2024.1942

35,294 View
963 Download
23 Web of Science
31 Crossref

Abstract PDF PubReader ePub

Obesity is the fifth leading risk factor for global deaths with numbers continuing to increase worldwide. In the last 20 years, the emergence of pharmacological treatments for obesity based on gastrointestinal hormones has transformed the therapeutic landscape. The successful development of glucagon-like peptide-1 (GLP-1) receptor agonists, followed by the synergistic combined effect of glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists achieved remarkable weight loss and glycemic control in those with the diseases of obesity and type 2 diabetes. The multiple cardiometabolic benefits include improving glycemic control, lipid profiles, blood pressure, inflammation, and hepatic steatosis. The 2023 phase 2 double-blind, randomized controlled trial evaluating a GLP-1/GIP/glucagon receptor triagonist (retatrutide) in patients with the disease of obesity reported 24.2% weight loss at 48 weeks with 12 mg retatrutide. This review evaluates the current available evidence for GLP-1 receptor agonists, dual GLP-1/GIP receptor co-agonists with a focus on GLP-1/GIP/glucagon receptor triagonists and discusses the potential future benefits and research directions.

Citations

Citations to this article as recorded by

A narrative review on tirzepatide’s therapeutic potential in glycemic control and cardioprotection
Mrudula Thiriveedi, Francis Sto. Domingo, Hannah Yates, Sujatha Baddam, Rafik El Beblawy, Bala Nimmana, Siddharth Patel
Annals of Medicine & Surgery.2026; 88(1): 371. CrossRef
Gastrointestinal safety of semaglutide and tirzepatide vs. placebo in obese individuals without diabetes: a systematic review and meta analysis
Moaz Safwan, Mariam Safwan Bourgleh, Shahad Abdullah Alotaibi, Eman Alotaibi, Abdulsalam Al-Ruqi, Fathiya El Raeya
Annals of Saudi Medicine.2025; 45(2): 129. CrossRef
Glucose-dependent insulinotropic peptide and beyond: co-agonist innovations in the treatment of metabolic diseases
Chenxu Zhou, Binbin Gong, Xiyu Liu, Guoqiang Hu, Lidan Sun
European Journal of Pharmacology.2025; 999: 177681. CrossRef
Advancing Cardiovascular, Kidney, and Metabolic Medicine: A Narrative Review of Insights and Innovations for the Future
Kevin Fernando, Derek Connolly, Eimear Darcy, Marc Evans, William Hinchliffe, Patrick Holmes, W. David Strain
Diabetes Therapy.2025; 16(6): 1155. CrossRef
Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD
Maryam Zafer, Federica Tavaglione, Manuel Romero‐Gómez, Rohit Loomba
Alimentary Pharmacology & Therapeutics.2025; 61(12): 1872. CrossRef
Retatrutide—A Game Changer in Obesity Pharmacotherapy
Vasiliki Katsi, Georgios Koutsopoulos, Christos Fragoulis, Kyriakos Dimitriadis, Konstantinos Tsioufis
Biomolecules.2025; 15(6): 796. CrossRef
The role of broad bean albumin 1b on GIP and GLP-1 mediated alterations to glucose metabolism in diabetic mice
Feifei Han, Lu Jin, Lulu Zhou, Qi Liu, MengLu Ding, Weilin Liu, Jianzhong Han
npj Science of Food.2025;[Epub] CrossRef
Next generation dual GLP-1/GIP, GLP-1/glucagon, and triple GLP-1/GIP/glucagon agonists: a literature review
Jimmy Wen, Denise Nadora, Alina Truong, Ethan Bernstein, Christiane How-Volkman, Adam Razick, Daniel Razick, Muhammad Karabala, Eldo Frezza
Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(12): 104213. CrossRef
Retatrutide: A novel approach in the treatment of obesity, diabetes mellitus, and MASLD (metabolic dysfunction-associated steatotic liver disease)
Robert Prosecký, Klaudia Hálová Karoliová
Klinická farmakologie a farmacie.2025; 39(2): 122. CrossRef
Triple Agonist Therapy: A New Frontier in Treating Type 2 Diabetes and Obesity
Heather P. Whitley
Clinical Diabetes.2025; 43(3): 439. CrossRef
Current and Future Implications of Weight Loss Drugs on Liver Disease
Arvind Bussetty, Nishali Shah, Toni Marie Chandler, Meghana Ghattu, Keerthana Kesavarapu
Clinics in Liver Disease.2025; 29(4): 743. CrossRef
Are GLP-1 receptor agonists and diabetic retinopathy foes or friends?
Kai Liu, Shu Liu, Dong Wang, Hong Qiao
Diabetes & Metabolism.2025; 51(6): 101696. CrossRef
Semaglutide and the skin: A brief review of dermatologic implications
Arisha Salam, Mohammed Salman Hyder
Cosmoderma.2025; 5: 84. CrossRef
Chronic kidney disease in metabolic syndrome
S. V. Villevalde, N. E. Zvartau
Russian Journal of Cardiology.2025; 30(1S): 6537. CrossRef
Novel Dual and Triple Agonists Targeting GLP-1, GIP, Glucagon, and GDF15 for Type 2 Diabetes and Obesity Management
Jiudan Zhang, Shriya Sanan, Marta Csanalosi, Chao Zheng, Andreas F H Pfeiffer
Endocrinology.2025;[Epub] CrossRef
MASLD Pharmacotherapy: Current Standards, Emerging Treatments, and Practical Guidance for Indian Physicians
Ashish Kumar
Journal of The Association of Physicians of India.2025; 73(7): e45. CrossRef
Effect of GLP-1 receptor agonists on body composition
Akhila Bhandarkar, Sowrabha Bhat, Nitin Kapoor
Current Opinion in Endocrinology, Diabetes & Obesity.2025; 32(6): 279. CrossRef
Innovative Therapeutic Approaches Targeting Obesity: Can Flavonoids Improve the Efficacy of Anti-Obesogenic Drugs?
Emanuele-Salvatore Scarpa, Stefano Amatori, Giovanni Caprioli, Filippo Maggi, Gianluca Moroncini, Giancarlo Balercia, Gilberta Giacchetti
International Journal of Molecular Sciences.2025; 26(20): 10142. CrossRef
Antidiabetic Agents as Antioxidant and Anti-Inflammatory Therapies in Neurological and Cardiovascular Diseases
Snehal Raut, Luca Cucullo
Antioxidants.2025; 14(12): 1490. CrossRef
New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review
Jorge E. Jalil, Luigi Gabrielli, María Paz Ocaranza, Paul MacNab, Rodrigo Fernández, Bruno Grassi, Paulina Jofré, Hugo Verdejo, Monica Acevedo, Samuel Cordova, Luis Sanhueza, Douglas Greig
International Journal of Molecular Sciences.2024; 25(8): 4407. CrossRef
New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
Kyriazoula Chatzianagnostou, Melania Gaggini, Adrian Suman Florentin, Ludovica Simonini, Cristina Vassalle
International Journal of Molecular Sciences.2024; 25(11): 6218. CrossRef
Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors, anti-diabetic drugs in heart failure and cognitive impairment: potential mechanisms of the protective effects
Maria Antonietta Riemma, Elena Mele, Maria Donniacuo, Marialucia Telesca, Gabriella Bellocchio, Giuseppe Castaldo, Francesco Rossi, Antonella De Angelis, Donato Cappetta, Konrad Urbanek, Liberato Berrino
Frontiers in Pharmacology.2024;[Epub] CrossRef
Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
Se Hee Min
The Journal of Korean Diabetes.2024; 25(2): 82. CrossRef
Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide
Wenzhuo Li, Qingtong Zhou, Zhaotong Cong, Qingning Yuan, Wenxin Li, Fenghui Zhao, H. Eric Xu, Li-Hua Zhao, Dehua Yang, Ming-Wei Wang
Cell Discovery.2024;[Epub] CrossRef
Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy
Michał Nicze, Adrianna Dec, Maciej Borówka, Damian Krzyżak, Aleksandra Bołdys, Łukasz Bułdak, Bogusław Okopień
International Journal of Molecular Sciences.2024; 25(15): 8202. CrossRef
Semaglutide “Ozempic” Face and Implications in Cosmetic Dermatology
Karen Montecinos, Barbara Kania, David J. Goldberg
Dermatological Reviews.2024;[Epub] CrossRef
GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes: Pleiotropic Cardiometabolic Effects and Add-on Value of a Combined Therapy
André J. Scheen
Drugs.2024; 84(11): 1347. CrossRef
Retatrutide
Nathan Ramsbacher
Clinical Diabetes.2024; 42(4): 579. CrossRef
The power of three: Retatrutide's role in modern obesity and diabetes therapy
Toufik Abdul-Rahman, Poulami Roy, Fatma Kamal Ahmed, Jann Ludwig Mueller-Gomez, Sarmistha Sarkar, Neil Garg, Victor Oluwafemi Femi-Lawal, Andrew Awuah Wireko, Hala Ibrahim Thaalibi, Muhammad Usman Hashmi, Andrew Sefenu Dzebu, Sewar Basheer Banimusa, Aayus
European Journal of Pharmacology.2024; 985: 177095. CrossRef
Old and new anti-obesity drugs
Salimeh Dodangeh, Shirin Hasani-Ranjbar
Journal of Diabetes & Metabolic Disorders.2024;[Epub] CrossRef
Innovative approaches to the treatment of obesity: from pharmacotherapy to nanomedicine
T. I. Romantsova
Obesity and metabolism.2024; 21(4): 389. CrossRef

Brief Report

Diabetes, obesity and metabolism
Partial Deletion of Perk Improved High-Fat Diet-Induced Glucose Intolerance in Mice: Jooyeop Lee, Min Joo Kim, Seoil Moon, Ji Yoon Lim, Kyong Soo Park, Hye Seung Jung; Endocrinol Metab. 2023;38(6):782-787. Published online November 13, 2023; DOI: https://doi.org/10.3803/EnM.2023.1738

4,086 View
78 Download
1 Web of Science
2 Crossref

Abstract PDF Supplementary Material PubReader ePub

Although pancreatic endoplasmic reticulum kinase (PERK) is indispensable to beta cells, low-dose PERK inhibitor improved glucose- stimulated insulin secretion (GSIS) and hyperglycemia in diabetic mice. Current study examined if partial deletion of Perk (Perk^+/-) recapitulated the effects of PERK inhibitor, on the contrary to the complete deletion. Perk^+/- mice and wild-type controls were fed with a high-fat diet (HFD) for 23 weeks. Glucose tolerance was evaluated along with serum insulin levels and islet morphology. Perk^+/- mice on normal chow were comparable to wild-type mice in various metabolic features. HFD-induced obesity was not influenced by Perk reduction; however, HFD-induced glucose intolerance was significantly improved since 15-week HFD. HFD-induced compromises in GSIS were relieved by Perk reduction, accompanied by reductions in phosphorylated PERK and activating transcription factor 4 (ATF4) in the islets. Meanwhile, HFD-induced islet expansion was not significantly affected. In summary, partial deletion of Perk improved glucose tolerance and GSIS impaired by diet-induced obesity, without changes in body weights or islet mass.

Citations

Citations to this article as recorded by

The UPR-oxidative stress nexus in diabetes and obesity: Exploring innovative therapeutic approaches for metabolic control
Clinton Ayodeji Akanbi, Oluwafemi Adeleke Ojo
Obesity Medicine.2025; 57: 100634. CrossRef
Oral Indole-3-acetate Supplementation Increases the Abundance of Bifidobacterium pseudolongum and Akkermansia muciniphila in the Intestine of Mice on a High-Fat Diet
O. P. Shatova, A. A. Zabolotneva, S. A. Rumyantsev, A. V. Shestopalov
Russian Journal of Bioorganic Chemistry.2025; 51(5): 2041. CrossRef

Original Articles

Mineral, Bone & Muscle
Age-Dependent Association of Height Loss with Incident Fracture Risk in Postmenopausal Korean Women: Chaewon Lee, Hye-Sun Park, Yumie Rhee, Namki Hong; Endocrinol Metab. 2023;38(6):669-678. Published online September 1, 2023; DOI: https://doi.org/10.3803/EnM.2023.1734

6,311 View
119 Download
2 Web of Science
3 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Height loss is a simple clinical measure associated with increased fracture risk. However, limited data exists on the association between height loss and fracture risk in postmenopausal Korean women. It is unknown whether this association varies with age.
Methods
Data on height loss over a 6-year period were collected from a community-based longitudinal follow-up cohort (Ansung cohort of the Korean Genome and Epidemiology Study). Incident fractures were defined based on self-reported fractures after excluding those due to severe trauma or toes/fingers. The association between incident fractures and height loss was investigated using a Cox proportional hazards model.
Results
During a median follow-up of 10 years after the second visit, 259/1,806 participants (median age, 64 years) experienced incident fractures. Overall, a 1 standard deviation (SD) decrease in height (1.6 cm/median 5.8 years) was associated with 9% increased risk of fracture (hazard ratio [HR], 1.09; P=0.037), which lost statistical significance after adjustment for covariates. When stratified into age groups (50–59, 60–69, 70 years or older), a 1 SD decrease in height remained a robust predictor of fracture in the 50 to 59 years age group after adjusting for covariates (adjusted hazard ratio [aHR], 1.52; P=0.003), whereas height loss was not an independent predictor of fracture in the 60 to 69 (aHR, 1.06; P=0.333) or the 70 years or older age groups (aHR, 1.05; P=0.700; P for interaction <0.05, for all).
Conclusion
Height loss during the previous 6 years was associated with an increased 10-year fracture risk in postmenopausal women in their 50s.

Citations

Citations to this article as recorded by

Evolving trends of hand injuries in Korea (2010-2023): a comprehensive analysis and implications for hand surgeons
Daihun Kang
Archives of Hand and Microsurgery.2025; 30(1): 15. CrossRef
Spine age estimation using deep learning in lateral spine radiographs and DXA VFA to predict incident fracture and mortality
Sang Wouk Cho, Namki Hong, Kyoung Min Kim, Young Han Lee, Chang Oh Kim, Hyeon Chang Kim, Yumie Rhee, Brian H. Chen, William D. Leslie, Steven R. Cummings
npj Aging.2025;[Epub] CrossRef
A Bone Health Optimization Framework for Malaysia: a position paper by the Malaysian Bone Health Optimization Network (MyBONe)
Joon-Kiong Lee, Juzaily Fekry Leong, Fu-Yuen Thong, Mohd Ariff Sharifudin, Azlina Amir Abbas, Nur Azree Ferdaus Kamudin, Sanjiv Rampal, Nor Faissal Yasin, Kwong-Weng Loh, Chee-Ken Chan, Paul James Mitchell
Archives of Osteoporosis.2024;[Epub] CrossRef

Diabetes, Obesity and Metabolism Big Data Articles (National Health Insurance Service Database)
Association of High-Density Lipoprotein Cholesterol Phenotypes with the Risk of Cardiovascular Diseases and Mortality: A Cohort Study in Korea: Ga Eun Nam, Youn Huh, Jin-Hyung Jung, Kyungdo Han, Seon Mee Kim, on Behalf of the Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity; Endocrinol Metab. 2022;37(2):261-271. Published online April 25, 2022; DOI: https://doi.org/10.3803/EnM.2021.1259

7,271 View
166 Download
8 Web of Science
8 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
We investigated whether low high-density lipoprotein cholesterol (HDL-C) and isolated and non-isolated low HDL-C levels are associated with the risk of cardiovascular diseases and all-cause mortality among Korean adults.
Methods
We included 8,665,841 individuals aged ≥20 years who had undergone a health examination provided by the Korean National Health Insurance Service (NHIS) in 2009 and were followed up until the end of 2018. The hazard ratios (HRs) and 95% confidence intervals (CIs) for study outcomes were calculated using multivariable Cox proportional hazard regression analysis.
Results
During the 8.2 years of mean follow-up, myocardial infarction (MI), stroke, and all-cause mortality occurred in 81,431, 110,996, and 244,309 individuals, respectively. After adjusting for confounding variables (model 3), individuals with low HDL-C and lower HDL quartiles were associated with significantly increased risks of all three outcomes, compared to those with normal HDL-C and highest HDL-C quartile (all P<0.001), respectively. HRs for incident MI (1.28; 95% CI, 1.26 to 1.30), stroke (1.13; 95% CI, 1.11 to 1.15), and all-cause mortality (1.07; 95% CI, 1.05 to 1.08) increased in the non-isolated low HDL-C group compared to the normal HDL-C group. Isolated low HDL-C also showed an increase in the HRs of incident stroke (1.06; 95% CI, 1.04 to 1.08) and all-cause mortality (1.30; 95% CI, 1.28 to 1.32).
Conclusion
Low HDL-C and non-isolated low HDL-C were associated with increased risk of MI, stroke, and all-cause mortality, and isolated low HDL-C was associated with incident stroke and all-cause mortality risk.

Citations

Citations to this article as recorded by

Development and Validation of a Risk-Prediction Nomogram for Nutritional Risk in Non-Dialysis Chronic Renal Failure Patients
Chenxin Yu, Fei Xu, Qin Lin, Ling Li
Risk Management and Healthcare Policy.2026; Volume 19: 1. CrossRef
Cardiovascular Complications, Kidney Failure, and Mortality in Young-Onset Type 1 and Type 2 Diabetes: Data From the Korean National Health Insurance Service
Sung Eun Kim, Kyungdo Han, Won Kyoung Cho, Byung-Kyu Suh
Diabetes Care.2025; 48(3): 422. CrossRef
Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
Mingjing Lu, Yingshan Zhang, Qian Yang, Jinfa Huang, Kaixian Deng
International Journal of Women's Health.2025; Volume 17: 1631. CrossRef
Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
Li He, Sisi Chen, Xuan Zhu, Fang He
Frontiers in Cardiovascular Medicine.2025;[Epub] CrossRef
Association Between Platelet to High‐Density Lipoprotein Cholesterol Ratio and Cardiometabolic Multimorbidity in Middle‐Aged and Elderly Chinese Hypertensive Patients
Yang Zheng, Yubing Huang, Haitao Li
The Journal of Clinical Hypertension.2025;[Epub] CrossRef
Association between HDL levels and stroke outcomes in the Arab population
Aizaz Ali, Omar Obaid, Naveed Akhtar, Rahul Rao, Syed Haroon Tora, Ashfaq Shuaib
Scientific Reports.2024;[Epub] CrossRef
Association of adiposity and fitness with triglyceride-to-high-density lipoprotein cholesterol ratio in youth
Danladi Ibrahim Musa, Abel Lamina Toriola, Nurudeen O Abubakar, Sunday Omachi, Victor B Olowoleni, Kolade B Ayodele
Annals of Pediatric Cardiology.2023; 16(3): 194. CrossRef
Association between cholesterol levels and dementia risk according to the presence of diabetes and statin use: a nationwide cohort study
You-Bin Lee, Min Young Kim, Kyungdo Han, Bongsung Kim, Jiyun Park, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
Scientific Reports.2022;[Epub] CrossRef

Brief Report

Diabetes, Obesity and Metabolism
Growth in Children with HLA-Conferred Susceptibility to Type 1 Diabetes: Liisa Saare, Aleksandr Peet, Vallo Tillmann; Endocrinol Metab. 2022;37(1):175-179. Published online February 28, 2022; DOI: https://doi.org/10.3803/EnM.2021.1262

5,046 View
105 Download

Abstract PDF PubReader ePub: The incidence of type 1 diabetes (T1D) is increasing throughout the world. This trend may be explained by the accelerator hypothesis. Our study investigated growth, its biochemical markers, and their associations with the development of diabetes-associated autoantibodies (DAAB) in 219 children with genetic risk for T1D. Subjects were divided into risk groups based on their human leukocyte antigen genotype. Children in the moderate- to high-risk group were significantly taller when corrected to mid-parental height and had a lower insulin-like growth factor 1 (IGF-1)/IGF-1 binding protein (IGFBP-3) molar ratio than those in the low-risk group (corrected height standard deviation score 0.22±0.93 vs. –0.04±0.84, P<0.05; molar ratio 0.199±0.035 vs. 0.211+0.039, P<0.05). Children with DAAB tended to be taller and to have a higher body mass index than those with no DAAB. Our results suggest that the accelerator hypothesis explaining the increasing incidence of T1D may not solely be dependent on environmental factors, but could be partially genetically determined.

Original Article

Diabetes, Obesity and Metabolism
Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability: Inha Jung, Dae-Jeong Koo, Mi Yeon Lee, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee; Endocrinol Metab. 2021;36(4):845-854. Published online August 27, 2021; DOI: https://doi.org/10.3803/EnM.2021.1098

9,793 View
160 Download
12 Web of Science
13 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Weight loss through lifestyle modification is recommended for patients with nonalcoholic fatty liver disease (NAFLD). Recent studies have suggested that repeated loss and gain of weight is associated with worse health outcomes. This study aimed to examine the association between weight variability and the risk of NAFLD in patients without diabetes.
Methods
We examined the health-checkup data of 30,708 participants who had undergone serial examinations between 2010 and 2014. Weight variability was assessed using coefficient of variation and the average successive variability of weight (ASVW), which was defined as the sum of absolute weight changes between successive years over the 5-year period divided by 4. The participants were classified according to the baseline body mass index and weight difference over 4 years.
Results
On dividing the participants into four groups according to ASVW quartile groups, those in the highest quartile showed a significantly increased risk of NAFLD compared to those in the lowest quartile (odds ratio [OR], 1.89; 95% confidence interval [CI], 1.63 to 2.19). Among participants without obesity at baseline, individuals with high ASVW showed increased risk of NAFLD (OR, 1.80; 95% CI, 1.61 to 2.01). Participants with increased weight over 4 years and high ASVW demonstrated higher risk of NAFLD compared to those with stable weight and low ASVW (OR, 4.87; 95% CI, 4.29 to 5.53).
Conclusion
Regardless of participant baseline obesity status, high weight variability was associated with an increased risk of developing NAFLD. Our results suggest that further effort is required to minimize weight fluctuations after achieving a desirable body weight.

Citations

Citations to this article as recorded by

Impact of Change, Fluctuation, or Variability in Weight on the Risk of Nonalcoholic Fatty Liver Disease in General Population: A Systematic Review and Meta‐Analysis
Dorsa Alijanzadeh, Masoud Noroozi, Negin Rostami, Narges Norouzkhani, Mahdie ShojaeiBaghini, Saeed Zivari Lashkajani, Ali Mirzaei, Maryam Dianati, Maryam Salimi, Hamidreza Sadeghsalehi, Faezeh Jadidian, Sajjad Ghane Ezabadi, Mohammad Sadegh Fallahi, Mobin
Health Science Reports.2025;[Epub] CrossRef
Changes in Macronutrients during Dieting Lead to Weight Cycling and Metabolic Complications in Mouse Model
Anouk Charlot, Anthony Bringolf, Léa Debrut, Joris Mallard, Anne-Laure Charles, Emilie Crouchet, Delphine Duteil, Bernard Geny, Joffrey Zoll
Nutrients.2024; 16(5): 646. CrossRef
Body weight variability and the risk of liver‐related outcomes in type 2 diabetes and steatotic liver disease: a cohort study
Nathalie C. Leite, Claudia R. L. Cardoso, Cristiane A. Villela‐Nogueira, Gil F. Salles
Obesity.2024; 32(6): 1210. CrossRef
Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
Inha Jung, Dae-Jeong Koo, Won-Young Lee
Diabetes & Metabolism Journal.2024; 48(3): 327. CrossRef
A machine-learned model for predicting weight loss success using weight change features early in treatment
Farzad Shahabi, Samuel L. Battalio, Angela Fidler Pfammatter, Donald Hedeker, Bonnie Spring, Nabil Alshurafa
npj Digital Medicine.2024;[Epub] CrossRef
Long-Term Yo-Yo Dieting Exaggerates Liver Steatosis and Lesions but Preserves Muscle Performance in Male Zebrafish
Tzu-Chieh Hsu, Chun-Hsien Chiang, I-Hsuan Liu, Chih-Yun Wang, Ching-Yi Chen
International Journal of Molecular Sciences.2024; 25(23): 13225. CrossRef
Weight variability, physical functioning and incident disability in older adults
Katie J. McMenamin, Tamara B. Harris, Joshua F. Baker
Journal of Cachexia, Sarcopenia and Muscle.2023; 14(4): 1648. CrossRef
Dulaglutide Ameliorates Palmitic Acid-Induced Hepatic Steatosis by Activating FAM3A Signaling Pathway
Jinmi Lee, Seok-Woo Hong, Min-Jeong Kim, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
Endocrinology and Metabolism.2022; 37(1): 74. CrossRef
Triglyceride and glucose index is a simple and easy‐to‐calculate marker associated with nonalcoholic fatty liver disease
Kyung‐Soo Kim, Sangmo Hong, Hong‐Yup Ahn, Cheol‐Young Park
Obesity.2022; 30(6): 1279. CrossRef
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
Mohammed Eslam, Hashem B. El-Serag, Sven Francque, Shiv K. Sarin, Lai Wei, Elisabetta Bugianesi, Jacob George
Nature Reviews Gastroenterology & Hepatology.2022; 19(10): 638. CrossRef
Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
Ángel Arturo López-González, Bárbara Altisench Jané, Luis Masmiquel Comas, Sebastiana Arroyo Bote, Hilda María González San Miguel, José Ignacio Ramírez Manent
Nutrients.2022; 14(14): 2795. CrossRef
Higher Weight Variability Could Bring You a Fatty Liver
Yeoree Yang, Jae-Hyoung Cho
Endocrinology and Metabolism.2021; 36(4): 766. CrossRef
Autonomic Imbalance Increases the Risk for Non-alcoholic Fatty Liver Disease
Inha Jung, Da Young Lee, Mi Yeon Lee, Hyemi Kwon, Eun-Jung Rhee, Cheol-Young Park, Ki-Won Oh, Won-Young Lee, Sung-Woo Park, Se Eun Park
Frontiers in Endocrinology.2021;[Epub] CrossRef

Brief Report

Obesity and Metabolism
Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study: Wonjun Ji, Rugyeom Lee, Kyungmin Huh, Minsun Kang, In Cheol Hwang, Munkhzul Radnaabaatar, Dae Ho Lee, Jaehun Jung; Endocrinol Metab. 2021;36(1):196-200. Published online February 24, 2021; DOI: https://doi.org/10.3803/EnM.2020.856

8,706 View
237 Download
8 Web of Science
10 Crossref

Abstract PDF Supplementary Material PubReader ePub

Although obesity is a risk factor for infection, whether it has the same effect on coronavirus disease 2019 (COVID-19) need confirming. We conducted a retrospective propensity score matched case-control study to examine the association between obesity and COVID-19. This study included data from the Nationwide COVID-19 Registry and the Biennial Health Checkup database, until May 30, 2020. We identified 2,231 patients with confirmed COVID-19 and 10-fold-matched negative test controls. Overweight (body mass index [BMI] 23 to 24.9 kg/m²; adjusted odds ratio [aOR], 1.16; 95% confidence interval [CI], 1.1.03 to 1.30) and class 1 obesity (BMI 25 to 29.9 kg/m²; aOR, 1.27; 95% CI, 1.14 to 1.42) had significantly increased COVID-19 risk, while classes 2 and 3 obesity (BMI ≥30 kg/m²) showed similar but non-significant trend. Females and those <50 years had more robust association pattern. Overweight and obesity are possible risk factors of COVID-19.

Citations

Citations to this article as recorded by

The association between excess weight and COVID‐19 outcomes: An umbrella review
Jamie Matu, Alex Griffiths, Oliver M. Shannon, Andrew Jones, Rhiannon Day, Duncan Radley, Alison Feeley, Lisa Mabbs, Jamie Blackshaw, Naveed Sattar, Louisa Ells
Obesity Reviews.2024;[Epub] CrossRef
Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
Endocrinology and Metabolism.2023; 38(2): 245. CrossRef
Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments
Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, Vana Spoulou, Gkikas Magiorkinis, Ioannis Trontzas, Panagiotis Trontzas, Garyphallia Poulakou, Konstantinos Syrigos, Giorgos Bamias
Alimentary Pharmacology & Therapeutics.2022; 55(2): 154. CrossRef
Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study
Kuat Oshakbayev, Zulfiya Zhankalova, Meruyert Gazaliyeva, Khalit Mustafin, Gulnara Bedelbayeva, Bibazhar Dukenbayeva, Nurzhan Otarbayev, Attila Tordai
Journal of Infection and Public Health.2022; 15(2): 255. CrossRef
Association between being underweight and excess body weight before SARS coronavirus type 2 infection and clinical outcomes of coronavirus disease 2019: Multicenter study
João Araújo Barros-Neto, Carolina Santos Mello, Sandra Mary Lima Vasconcelos, Gabriel Soares Bádue, Raphaela Costa Ferreira, Maria Izabel Siqueira de Andrade, Carlos Queiroz do Nascimento, Mateus de Lima Macena, José Adailton da Silva, Heleni Aires Clemen
Nutrition.2022; 101: 111677. CrossRef
Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
Ángel Arturo López-González, Bárbara Altisench Jané, Luis Masmiquel Comas, Sebastiana Arroyo Bote, Hilda María González San Miguel, José Ignacio Ramírez Manent
Nutrients.2022; 14(14): 2795. CrossRef
Trends of overweight and obesity prevalence in school-aged children among Henan Province from 2000 to 2019
Yuhao Zhang, Hao Lou, Ye Huang, Ruijuan Wang, Xiao Wen, Cuiping Wu, Changfu Hao, Ran Li, Genli Gao, Xiaomin Lou, Xian Wang
Frontiers in Public Health.2022;[Epub] CrossRef
The effects of 105 biological, socioeconomic, behavioral, and environmental factors on the risk of SARS-CoV-2 infection and a severe course of COVID-19: a prospective, explorative cohort study
Jaroslav Flegr, Pavel Flegr, Lenka Příplatová
Biology Methods and Protocols.2022;[Epub] CrossRef
Current status of health promotion in Korea
Soo Young Kim
Journal of the Korean Medical Association.2022; 65(12): 776. CrossRef
Obesity and Coronavirus Disease 2019
Min-Ji Kim, Jae-Han Jeon
Journal of Metabolic and Bariatric Surgery.2021; 10(1): 1. CrossRef

Original Articles

Clinical Study Big Data Articles (National Health Insurance Service Database)
Variabilities in Weight and Waist Circumference and Risk of Myocardial Infarction, Stroke, and Mortality: A Nationwide Cohort Study: Da Hye Kim, Ga Eun Nam, Kyungdo Han, Yang-Hyun Kim, Kye-Yeung Park, Hwan-Sik Hwang, Byoungduck Han, Sung Jung Cho, Seung Jin Jung, Yeo-Joon Yoon, Yong Kyun Roh, Kyung Hwan Cho, Yong Gyu Park; Endocrinol Metab. 2020;35(4):933-942. Published online December 23, 2020; DOI: https://doi.org/10.3803/EnM.2020.871

9,597 View
134 Download
18 Web of Science
21 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Evidence regarding the association between variabilities in obesity measures and health outcomes is limited. We aimed to examine the association between variabilities in obesity measures and cardiovascular outcomes and all-cause mortality.
Methods
We identified 4,244,460 individuals who underwent health examination conducted by the Korean National Health Insurance Service during 2012, with ≥3 anthropometric measurements between 2009 and 2012. Variabilities in body weight (BW) and waist circumference (WC) were assessed using four indices including variability independent of the mean (VIM). We performed multivariable Cox proportional hazards regression analyses.
Results
During follow-up of 4.4 years, 16,095, 18,957, and 30,200 cases of myocardial infarction (MI), stroke, and all-cause mortality were recorded. Compared to individuals with the lowest quartiles, incrementally higher risks of study outcomes and those of stroke and all-cause mortality were observed among individuals in higher quartiles of VIM for BW and VIM for WC, respectively. The multivariable adjusted hazard ratios and 95% confidence intervals comparing the highest versus lowest quartile groups of VIM for BW were 1.17 (1.12 to 1.22) for MI, 1.20 (1.16 to 1.25) for stroke, and 1.66 (1.60 to 1.71) for all-cause mortality; 1.07 (1.03 to 1.12) for stroke and 1.29 (1.25 to 1.33) for all-cause mortality regarding VIM for WC. These associations were similar with respect to the other indices for variability.
Conclusion
This study revealed positive associations between variabilities in BW and WC and cardiovascular outcomes and allcause mortality. Our findings suggest that variabilities in obesity measures are associated with adverse health outcomes in the general population.

Citations

Citations to this article as recorded by

Associations of metabolic variabilities and cardiovascular outcomes according to estimated glomerular filtration rate in chronic kidney disease: a nationwide observational cohort study
Jeong Min Cho, Kyungdo Han, Kwon Wook Joo, Soojin Lee, Yaerim Kim, Semin Cho, Hyuk Huh, Seong Geun Kim, Minsang Kim, Eunjeong Kang, Dong Ki Kim, Sehoon Park
Kidney Research and Clinical Practice.2025; 44(2): 265. CrossRef
Metabolic predictors of ischemic stroke in young adults
Maria S. Ponomareva, Larisa A. Shchepankevich, Ksenya V. Rerikh, Andrey V. Zatynko, Ksenia V. Antonova, Marine М. Tanashyan
Annals of Clinical and Experimental Neurology.2025; 19(1): 21. CrossRef
Severity and stroke type according to waist-Hip ratio, body mass index and waist circumference
M. Tirić-Čampara, E. Đozić, I. Tahirović, E. Čampara, S. Kunić, Z. Lepara, A. Skopljak, E. Toromanović
Journal of Neural Transmission.2025; 132(10): 1539. CrossRef
Gender differences in midlife to later-life cumulative burden and variability of obesity measures and risk of all-cause and cause-specific mortality
Karim Kohansal, Siamak Afaghi, Davood Khalili, Danial Molavizadeh, Farzad Hadaegh
International Journal of Obesity.2024; 48(4): 495. CrossRef
Association of body mass index and blood pressure variability with 10-year mortality and renal disease progression in type 2 diabetes
Stephen Fava, Sascha Reiff
Acta Diabetologica.2024; 61(6): 747. CrossRef
Anthropometric indices, a predictive marker for stroke and other metabolic disorders
Clinton David Orupabo, Solomon David Owualah, Iberedem Clinton David
International Journal of Medicine and Medical Research.2024; 10(1): 23. CrossRef
Sex-differential effect of waist circumference on new-onset cerebral infarction: a nationwide cohort study
Sang Min Lee, Minha Hong, Jae-Hong Ryoo
Frontiers in Neurology.2024;[Epub] CrossRef
Weight variability and cardiovascular outcomes: a systematic review and meta-analysis
Robert J. Massey, Moneeza K. Siddiqui, Ewan R. Pearson, Adem Y. Dawed
Cardiovascular Diabetology.2023;[Epub] CrossRef
Family history, waist circumference and risk of ischemic stroke: A prospective cohort study among Chinese adults
Lei Liu, Xiaojia Xue, Hua Zhang, Xiaocao Tian, Yunhui Chen, Yu Guo, Pei Pei, Shaojie Wang, Haiping Duan, Ruqin Gao, Zengchang Pang, Zhengming Chen, Liming Li
Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(4): 758. CrossRef
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
Endocrinology and Metabolism.2023; 38(1): 10. CrossRef
Weight variability and diabetes complications
Francesco Prattichizzo, Chiara Frigé, Rosalba La Grotta, Antonio Ceriello
Diabetes Research and Clinical Practice.2023; 199: 110646. CrossRef
Research on obesity using the National Health Information Database: recent trends
Eun-Jung Rhee
Cardiovascular Prevention and Pharmacotherapy.2023; 5(2): 35. CrossRef
Weight cycling and risk of clinical adverse events in patients with heart failure with preserved ejection fraction: a post-hoc analysis of TOPCAT
Yi Tan, Hang Guo, Ning Zhang, Keyang Zheng, Guifang Liu
Frontiers in Endocrinology.2023;[Epub] CrossRef
Weight variability, physical functioning and incident disability in older adults
Katie J. McMenamin, Tamara B. Harris, Joshua F. Baker
Journal of Cachexia, Sarcopenia and Muscle.2023; 14(4): 1648. CrossRef
Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes
Min Jeong Park, Kyung Mook Choi
Diabetes & Metabolism Journal.2022; 46(1): 49. CrossRef
Effects of exercise initiation and smoking cessation after new-onset type 2 diabetes mellitus on risk of mortality and cardiovascular outcomes
Mee Kyoung Kim, Kyungdo Han, Bongsung Kim, Jinyoung Kim, Hyuk-Sang Kwon
Scientific Reports.2022;[Epub] CrossRef
Lipid cutoffs for increased cardiovascular disease risk in non-diabetic young people
Mee Kyoung Kim, Kyungdo Han, Hun-Sung Kim, Kun-Ho Yoon, Seung-Hwan Lee
European Journal of Preventive Cardiology.2022; 29(14): 1866. CrossRef
Body Mass Index Is Independently Associated with the Presence of Ischemia in Myocardial Perfusion Imaging
Chrissa Sioka, Paraskevi Zotou, Michail I. Papafaklis, Aris Bechlioulis, Konstantinos Sakellariou, Aidonis Rammos, Evangelia Gkika, Lampros Lakkas, Sotiria Alexiou, Pavlos Kekiopoulos, Katerina K. Naka, Christos Katsouras
Medicina.2022; 58(8): 987. CrossRef
Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Post Hoc Analysis of ACCORD Trial
Daniel Nyarko Hukportie, Fu-Rong Li, Rui Zhou, Jia-Zhen Zheng, Xiao-Xiang Wu, Xian-Bo Wu
Diabetes & Metabolism Journal.2022; 46(5): 767. CrossRef
Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
Sang Youn You, Kyungdo Han, Seung-Hawn Lee, Mee Kyoung Kim
Diabetology & Metabolic Syndrome.2021;[Epub] CrossRef
Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
Inha Jung, Dae-Jeong Koo, Mi Yeon Lee, Sun Joon Moon, Hyemi Kwon, Se Eun Park, Eun-Jung Rhee, Won-Young Lee
Endocrinology and Metabolism.2021; 36(4): 845. CrossRef

Clinical Study
Genetic Analysis and Clinical Characteristics of Hereditary Pheochromocytoma and Paraganglioma Syndrome in Korean Population: Heewon Choi, Kyoung Jin Kim, Namki Hong, Saeam Shin, Jong-Rak Choi, Sang Wook Kang, Seung Tae Lee, Yumie Rhee; Endocrinol Metab. 2020;35(4):858-872. Published online December 23, 2020; DOI: https://doi.org/10.3803/EnM.2020.683

9,766 View
227 Download
15 Web of Science
16 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Pheochromocytoma and paragangliomas (PPGL) are hereditary in approximately 30% to 40% cases. With the advancement of genetic analysis techniques, including next-generation sequencing (NGS), there were attempts to classify PPGL into molecular clusters. With NGS being applied to clinical settings recently, we aimed to review the results of genetic analysis, including NGS, and investigate the association with clinical characteristics in Korean PPGL patients.
Methods
We reviewed the medical records of PPGL patients who visited Severance hospital from 2006 to 2019. We documented the clinical phenotype of those who underwent targeted NGS or had known germline mutations of related genes.
Results
Among 57 PPGL patients, we found 28 pathogenic germline mutations of susceptibility genes. Before the targeted NGS was implemented, only obvious syndromic feature lead to the Sanger sequencing for the specific genes. Therefore, for the exact prevalence, only patients after the year 2017, when targeted NGS was added, were included (n=43). The positive germline mutations were found in 14 patients; thus, the incidence rate is 32.6%. Patients with germline mutations had a higher likelihood of family history. There were significant differences in the type of PPGLs, percentage of family history, metastasis rate, presence of other tumors, and biochemical profile among three molecular clusters: pseudohypoxic tricarboxylic acid cycle-related, pseudohypoxic von Hippel-Lindau (VHL)/endothelial PAS domain-containing protein 1-related, and kinase-signaling group. Germline mutations were identified in seven PPGL-related genes (SDHB, RET, VHL, NF1, MAX, SDHA, and SDHD).
Conclusion
We report the expected prevalence of germline mutations in Korean PPGL patients. NGS is a useful and accessible tool for genetic analysis in patients with PPGLs, and further research on molecular classification is needed for precise management.

Citations

Citations to this article as recorded by

Clinical and Genetic Characteristics of Pheochromocytoma and Paraganglioma: A Single-Center Experience Including a Rare VHL Variant
Merve Korkmaz Yilmaz, Ozlem Kandemir Alibakan, Aydeniz Aydin Gumus, Alper Gezdirici, Huseyin Karatay, Serkan Sari, Tugba Matlim Ozel, Mutlu Niyazoglu, Esra Hatipoglu
Journal of Clinical Medicine.2026; 15(2): 712. CrossRef
Carotid body tumors—epidemiology and surgical resection
Kiyoto Shiga, Katsunori Katagiri, Aya Ikeda, Daisuke Saito, Shin-ichi Oikawa, Kodai Tshuchida, Jun Miyaguchi, Takahiro Kusaka, Akio Tamura
Japanese Journal of Clinical Oncology.2025; 55(8): 852. CrossRef
A Family case of von Hippel-Lindau syndrome
R. A. Atanesyan, L. Y. Klimov, T. M. Vdovina, G. A. Saneeva, E. I. Andreeva, I. K. Gasparian
Problems of Endocrinology.2025; 71(5): 68. CrossRef
Patient Sex and Origin Influence Distribution of Driver Genes and Clinical Presentation of Paraganglioma
Susan Richter, Nicole Bechmann
Journal of the Endocrine Society.2024;[Epub] CrossRef
Main mechanisms and clinical implications of alterations in energy expenditure state among patients with pheochromocytoma and paraganglioma: A review
Yuqi Yang, Tong Zhou, Xue Zhao, Yunjia Cai, Yao Xu, Xiaokun Gang, Guixia Wang
Medicine.2024; 103(17): e37916. CrossRef
Validation and Evaluation of 5 Scoring Systems for Predicting Metastatic Risk in Pheochromocytoma and Paraganglioma
Qin Li, Zhigang Lan, Yong Jiang, Rui Wang, Ziyao Li, Xiaolin Jiang
American Journal of Surgical Pathology.2024; 48(7): 855. CrossRef
Differences between Patients with Sporadic and Familial Pheochromocytoma—Is It Possible to Avoid Genetic Testing in Certain Patients?
María Consuelo Muñoz, Beatriz Febrero, Miriam Abellán, Antonio Miguel Hernández, José Manuel Rodríguez
Biomedicines.2024; 12(6): 1352. CrossRef
Germline Mutations and Phenotypic Associations in Korean Patients With Pheochromocytoma and Paraganglioma: A Multicenter Study and Literature Review
Kwan Hoon Jo, Jaewoong Lee, Jaeeun Yoo, Hoon Seok Kim, Eun Sook Kim, Je Ho Han, Yi Sun Jang, Jae-Seung Yun, Jang Won Son, Soon Jib Yoo, Seung Hwan Lee, Dong Jun Lim, Hyuk-Sang Kwon, Seungok Lee, Sungdae Moon, Myungshin Kim
Annals of Laboratory Medicine.2024; 44(6): 591. CrossRef
Genotype and clinical phenotype characteristics of MAX germline mutation–associated pheochromocytoma/paraganglioma syndrome
Bijun Lian, Jun Lu, Xudong Fang, Yiming Zhang, Wei Wang, Yi He, Hongyuan Yu, Feiping Li, Junwei Wang, Weiying Chen, Xiaoping Qi
Frontiers in Endocrinology.2024;[Epub] CrossRef
Novel and recurrent genetic variants of VHL, SDHB, and RET genes in Chinese pheochromocytoma and paraganglioma patients
Chong Li, Jingyi Li, Chao Han, Ting Wang, Lixia Zhang, Zhifang Wang, Tingting Wang, Lijun Xu, Guangzhao Qi, Guijun Qin, Xialian Li, Lili Zheng
Frontiers in Genetics.2023;[Epub] CrossRef
Genetic Study in Pheochromocytoma: Is It Possible to Stratify the Risk of Hereditary Pheochromocytoma?
Marta Araujo-Castro, César Mínguez Ojeda, Iñigo García Sanz, Maria Calatayud, Felicia Hanzu, Mireia Mora, Almudena Vicente, Concepción Blanco Carrera, Paz de Miguel Novoa, María del Carmen López García, Cristina Lamas, Laura Manjón-Miguélez, María del Cas
Neuroendocrinology.2023; 113(6): 657. CrossRef
The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis
Petra Hudler, Mojca Urbancic
Genes.2022; 13(2): 362. CrossRef
Bilateral Pheochromocytoma with Germline MAX Variant without Family History
Shinnosuke Hata, Mai Asano, Hiroyuki Tominaga, Masahide Hamaguchi, Fumiya Hongo, Takeshi Usui, Eiichi Konishi, Michiaki Fukui
Clinics and Practice.2022; 12(3): 299. CrossRef
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, Mi Kyung Kim, Chang Ho Ahn, Kyung Ae Lee, Seung Hun Lee, You-Bin Lee, Kyeong Hye Park, Yun Mi Choi, Namki Hong, A Ram Hong, Sang-Wook Kang, Byung Kwan Park, Moon-Woo Seong, Myungshin Kim, Kyeong Cheon Jung, Chan
Endocrinology and Metabolism.2021; 36(2): 322. CrossRef
Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
Masato Yonamine, Koichiro Wasano, Yuichi Aita, Takehito Sugasawa, Katsutoshi Takahashi, Yasushi Kawakami, Hitoshi Shimano, Hiroyuki Nishiyama, Hisato Hara, Mitsuhide Naruse, Takahiro Okamoto, Tadashi Matsuda, Shinji Kosugi, Kazuhiko Horiguchi, Akiyo Tanab
Cancers.2021; 13(16): 4014. CrossRef
Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
Yinjie Gao, Chao Ling, Xiaosen Ma, Huiping Wang, Yunying Cui, Min Nie, Anli Tong, Dario De Biase
International Journal of Endocrinology.2021; 2021: 1. CrossRef

Review Article

Obesity and Metabolism
Metabolically Healthy and Unhealthy Normal Weight and Obesity: Norbert Stefan; Endocrinol Metab. 2020;35(3):487-493. Published online August 20, 2020; DOI: https://doi.org/10.3803/EnM.2020.301

17,058 View
563 Download
61 Web of Science
64 Crossref

Abstract PDF PubReader ePub

Increased fat mass is an established risk factor for the cardiometabolic diseases type 2 diabetes and cardiovascular disease (CVD) and is associated with increased risk of all-cause and CVD mortality. However, also very low fat mass associates with such an increased risk. Whether impaired metabolic health, characterized by hypertension, dyslipidemia, hyperglycemia, insulin resistance, and subclinical inflammation, may explain part of the elevated risk of cardiometabolic diseases that is found in many subjects with very low fat mass, as it does in many obese subjects, is unknown. An important pathomechanism of impaired metabolic health is disproportionate fat distribution. In this article the risk of cardiometabolic diseases and mortality in subjects with metabolically healthy and unhealthy normal weight and obesity is summarized. Furthermore, the change of metabolic health during a longer period of follow-up and its impact on cardiometabolic diseases is being discussed. Finally, the implementation of the concept of metabolic health in daily clinical practice is being highlighted.

Citations

Citations to this article as recorded by

Metabolic reprogramming in cardiometabolic syndrome: mechanisms, biomarkers, and therapeutic approaches
Milan Obradovic, Jelena Radovanovic, Julijana Stanimirovic, Bozidarka Zaric, Esma R. Isenovic
Acta Biochimica et Biophysica Sinica.2026;[Epub] CrossRef
Maternal Fine Particulate Matter Exposure Impairs Inguinal White Adipose Tissue Plasticity in Middle-Aged Male Mouse Offspring
Renjie Hu, Ran Li, Limin Wang, Sanduo Li, Hanshu Chu, Lu Zhang, Li Qin, Qinghua Sun, Cuiqing Liu
ACS Nano.2026; 20(6): 5054. CrossRef
Thoughts on dietary interventions for metabolic syndrome (MetS) in an era of metabolic heterogeneity
Wei Tang
BioScience Trends.2026;[Epub] CrossRef
National trends of metabolically healthy and unhealthy obesity before and during the COVID-19 pandemic, 2007 to 2021: A representative serial study in South Korea
Ji Ho Kim, Yesol Yim, Hyunyi Yoo, Hyunjeong Kim, Selin Woo, Yerin Hwang, Dong Keon Yon
Medicine.2026; 105(9): e47797. CrossRef
Polyphenols from Edible Brown Seaweeds Against Adiposopathy-Associated Metabolic Ailments
Senthil Arun Kumar, Surabhi Dinesh Sharma, Vaani Katyal R, Chaudhary Yasmeen Gulzar Ahmed
Food Reviews International.2025; 41(6): 1653. CrossRef
Relationship between dietary intake and atherogenic index of plasma in cardiometabolic phenotypes: a cross-sectional study from the Azar cohort population
Shirin Soheilifard, Elnaz Faramarzi, Reza Mahdavi
Journal of Health, Population and Nutrition.2025;[Epub] CrossRef
Uncoupling Proteins Variants Are Linked to Hypercholesterolemia and Abdominal Obesity in Metabolically Unhealthy Women
Erika Sierra-Ruelas, Nathaly Torres-Castillo, Barbara Vizmanos, Wendy Campos Pérez, Erika Martínez-López
Lifestyle Genomics.2025; 18(1): 27. CrossRef
Beyond Body Mass Index: New Criteria for a Holistic Approach to Clinical Obesity
Kyunghun Sung, Seung-Hwan Lee, Soo Lim
Diabetes & Metabolism Journal.2025; 49(2): 165. CrossRef
Is Measuring BMI and Waist Circumference as Good in Assessing Insulin Resistance as Using Bioelectrical Impedance to Measure Total Body Fat and Visceral Fat?
María Gordito Soler, Pedro Juan Tárraga López, Ángel Arturo López-González, Hernán Paublini, Emilio Martínez-Almoyna Rifá, María Teófila Vicente-Herrero, José Ignacio Ramírez-Manent
Diabetology.2025; 6(4): 32. CrossRef
Exploring obesity phenotypes: a longitudinal perspective
Ricardo Rosero-Revelo, Mateo Tamayo, Ricardo Correa, Kevin M. Pantalone, David Creel, Bartolome Burguera, Marcio L. Griebeler
Reviews in Endocrine and Metabolic Disorders.2025; 26(6): 889. CrossRef
Differences in fat distribution between metabolically unhealthy people with normal weight versus obesity, NHANES 2011–2018
Seerat Anand, Tejasvi Pasupneti, Youngju Pak, Sreevastav Teja Kalangi, Rajesh Garg
BMJ Open Diabetes Research & Care.2025; 13(3): e005118. CrossRef
“I Don’t Approve of a Fat Person…”: A Cross-Sectional Survey Exploring the Perceptions of Health, Weight and Obesity
Jordan D. Beaumont, Tina Reimann, Rosie Wyld, Beverley O’Hara
Obesities.2025; 5(3): 49. CrossRef
The Interplay of Cardiometabolic Syndrome Phenotypes and Cardiovascular Risk Indices in Patients Diagnosed with Diabetes Mellitus
Daniela Denisa Mitroi Sakizlian, Lidia Boldeanu, Adina Mitrea, Diana Clenciu, Ionela Mihaela Vladu, Alina Elena Ciobanu Plasiciuc, Andra Veronica Șarla, Isabela Siloși, Mihail Virgil Boldeanu, Mohamed-Zakaria Assani, Daniela Ciobanu
International Journal of Molecular Sciences.2025; 26(13): 6227. CrossRef
Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression
Chrysi Koliaki, Maria Dalamaga, Konstantinos Kakounis, Stavros Liatis
Current Obesity Reports.2025;[Epub] CrossRef
From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their Implications
Sangmo Hong, Cheol-Young Park
Endocrinology and Metabolism.2025; 40(4): 517. CrossRef
Cardiovascular risk factors associated with BMI and metabolic health phenotypes based on measures of coagulation factors
María M. Valle, Ariadna Robledo, Sean O’Leary, Lourdes Basurto, Elba Reyes-Maldonado, Jennyfer Gaspar, Erika Rosales, Sara Vega-Garcia, Carlos Martínez-Murillo
International Journal of Obesity.2025; 49(12): 2530. CrossRef
Understanding overweight and obesity: contemporary evidence-based approaches to delivering person-centred nursing care
Beverley O’Hara, Lucie Nield, Jordan Beaumont
Nursing Standard.2025; 40(12): 59. CrossRef
Inverse Association Between METS-IR and Lung Cancer Risk: The Role of BMI in a Nationwide Korean Cohort
Bo-Kyung Shine, In Hwa Jeong, Minkook Son, Bongjo Kim, Sang Yi Moon, Jong Yoon Lee, Hye Ryeon Kim, Seok Jae Huh
Cancers.2025; 17(23): 3727. CrossRef
Relationship Between Monocyte-to-High-Density Lipoprotein Cholesterol Ratio and Visceral Obesity in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study
Ye Hu, Jia Zheng, Yubo Xing, Yingxiang Song, Xiaohong Wu
Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4755. CrossRef
Phenotyping obesity: A focus on metabolically healthy obesity and metabolically unhealthy normal weight
Rachel Agius, Nikolai P. Pace, Stephen Fava
Diabetes/Metabolism Research and Reviews.2024;[Epub] CrossRef
Comparing verum and sham acupoint catgut embedding for adults with obesity: A systematic review and meta-analysis of randomized clinical trials
Jin-huan Yue, Xiao-ling Li, Yu-ying Zhang, Guan-hu Yang, Jeffrey Zhong-xue Mah, Ang Li, Wei-wei Zhao, Yu-lin Wang, Qin-hong Zhang, Jia-qi Huang
Medicine.2024; 103(4): e36653. CrossRef
Association between Weight Change and Incidence of Dyslipidemia in Young Adults: A Retrospective Cohort Study of Korean Male Soldiers
Joon-Young Yoon, Won Ju Park, Hee Kyung Kim, Ho-Cheol Kang, Cheol-Kyu Park, Wonsuk Choi
Journal of Obesity & Metabolic Syndrome.2024; 33(1): 36. CrossRef
Dietary intake of methyl donor nutrients in relation to metabolic health status, serum levels of brain-derived neurotrophic factor and adropin
Donya Poursalehi, Keyhan Lotfi, Farnaz Shahdadian, Zahra Hajhashemy, Parisa Rouhani, Parvane Saneei
Clinical Nutrition.2024; 43(6): 1353. CrossRef
Hyperleptinemia as a Marker of Various Phenotypes of Obesity and Overweight in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
L.V. Kondratyeva, Yu. N. Gorbunova, T. A. Panafidina, T. V. Popkova
Doklady Biochemistry and Biophysics.2024; 517(1): 182. CrossRef
Digital Biometry as an Obesity Diagnosis Tool: A Review of Current Applications and Future Directions
Florence Porterfield, Vladyslav Shapoval, Jérémie Langlet, Hanen Samouda, Fatima Cody Stanford
Life.2024; 14(8): 947. CrossRef
Ling-gui-zhu-gan granules reduces obesity and ameliorates metabolic disorders by inducing white adipose tissue browning in obese mice
Yuxiu Li, Zimengwei Ye, Yi Zhao, Bingrui Xu, Wanying Xue, Zhufeng Wang, Ran An, Fan Wang, Rui Wu
Frontiers in Physiology.2024;[Epub] CrossRef
Correlation between tooth decay and insulin resistance in normal weight males prompts a role for myo-inositol as a regenerative factor in dentistry and oral surgery: a feasibility study
Fulvio Barbaro, Giusy Di Conza, Francesca Pia Quartulli, Enrico Quarantini, Marco Quarantini, Nicoletta Zini, Celine Fabbri, Salvatore Mosca, Silvio Caravelli, Massimiliano Mosca, Paolo Vescovi, Simone Sprio, Anna Tampieri, Roberto Toni
Frontiers in Bioengineering and Biotechnology.2024;[Epub] CrossRef
Prevalence and factors associated with unhealthy metabolic status according to body mass index: analysis of a national nutritional survey
Víctor Juan Vera-Ponce, Fiorella E. Zuzunaga-Montoya, Luisa Erika Milagros Vásquez-Romero, Joan A. Loayza-Castro, Cori Raquel Iturregui Paucar, Enrique Vigil-Ventura, Carmen Inés Gutiérrez De Carrillo
Diabetology & Metabolic Syndrome.2024;[Epub] CrossRef
When Being Lean Is Not Enough: The Metabolically Unhealthy Normal Weight Phenotype and Cardiometabolic Disease
Dahyun Park, Min-Jeong Shin, Faidon Magkos
CardioMetabolic Syndrome Journal.2024; 4(2): 57. CrossRef
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction
Stefano Ciardullo, Gianluca Perseghin
Metabolism and Target Organ Damage.2024;[Epub] CrossRef
Insights into optimal BMI from the GlasVEGAS study
Chun-Kwan O, Juliana C. N. Chan
Nature Metabolism.2024; 6(8): 1435. CrossRef
The Significance of Comprehensive Metabolic Phenotypes in Cancer Risk: A Japan Multi-Institutional Collaborative Cohort Study
Takeshi Watanabe, Tien Van Nguyen, Sakurako Katsuura-Kamano, Kokichi Arisawa, Masashi Ishizu, Taichi Unohara, Keitaro Tanaka, Chisato Shimanoe, Mako Nagayoshi, Takashi Tamura, Yuko Kubo, Yasufumi Kato, Isao Oze, Hidemi Ito, Nobuaki Michihata, Yohko Nakamu
Cancer Research Communications.2024; 4(11): 2986. CrossRef
The Relationship of Waist Circumference with the Morbidity of Cardiovascular Diseases and All-Cause Mortality in Metabolically Healthy Individuals: A Population-Based Cohort Study
Yue Su, Jinyu Sun, Ying Zhou, Wei Sun
Reviews in Cardiovascular Medicine.2024;[Epub] CrossRef
Comparison of Health Behavior Factors According to the Presence of Obesity and Metabolic Syndrome in Middle-Aged Men: Based on the Korea National Health and Nutrition Examination Survey (2016-2018)
Junya Kang, In-Kyung Jung
Journal of Korean Association of Physical Education and Sport for Girls and Women.2024; 38(4): 201. CrossRef
Niveles de adiposidad corporal en el fenotipo delgado metabólicamente obeso: Análisis transversal de pobladores peruanos
Jamee Guerra Valencia, Kiomi Yabiku-Soto, Juan Carlos Roque, Noël C. Barengo, Lorena Saavedra-Garcia
Revista Española de Nutrición Humana y Dietética.2024; 28(1): 54. CrossRef
Metabolically Healthy Obesity
Purushothaman Padmanabhan, Nagendram Dinakaran, Somnath Verma, S. Keerthana
Gastroenterology, Hepatology and Endoscopy Practice.2023; 3(1): 1. CrossRef
Effect of metabolic health and obesity on all-cause death and CVD incidence in Korean adults: a retrospective cohort study
Ye-Seul Kim, Sang-Jun Shin, Yonghwan Kim, Joungyoun Kim, Hee-Taik Kang
Scientific Reports.2023;[Epub] CrossRef
Coffee and metabolic phenotypes: A cross-sectional analysis of the Japan multi-institutional collaborative cohort (J-MICC) study
Takeshi Watanabe, Kokichi Arisawa, Tien Van Nguyen, Masashi Ishizu, Sakurako Katsuura-Kamano, Asahi Hishida, Takashi Tamura, Yasufumi Kato, Rieko Okada, Rie Ibusuki, Chihaya Koriyama, Sadao Suzuki, Takahiro Otani, Teruhide Koyama, Satomi Tomida, Kiyonori
Nutrition, Metabolism and Cardiovascular Diseases.2023; 33(3): 620. CrossRef
Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity?
Myong-Won Seo, Joon Young Kim
Obesity Research & Clinical Practice.2023; 17(2): 116. CrossRef
Association between metabolic obesity phenotypes and multiple myeloma hospitalization burden: A national retrospective study
Yue Zhang, Xiude Fan, Chunhui Zhao, Zinuo Yuan, Yiping Cheng, Yafei Wu, Junming Han, Zhongshang Yuan, Yuanfei Zhao, Keke Lu
Frontiers in Oncology.2023;[Epub] CrossRef
Metabolically healthy obesity: Misleading phrase or healthy phenotype?
Cem Tanriover, Sidar Copur, Abduzhappar Gaipov, Batu Ozlusen, Rustu E. Akcan, Masanari Kuwabara, Mads Hornum, Daniel H. Van Raalte, Mehmet Kanbay
European Journal of Internal Medicine.2023; 111: 5. CrossRef
Prevalence of combined metabolic health and weight status by various diagnosis criteria and association with cardiometabolic disease in Korean adults
Myong-Won Seo, Jung-Min Lee, Hyun Chul Jung
Obesity Research & Clinical Practice.2023; 17(2): 137. CrossRef
Precision medicine in complex diseases—Molecular subgrouping for improved prediction and treatment stratification
Åsa Johansson, Ole A. Andreassen, Søren Brunak, Paul W. Franks, Harald Hedman, Ruth J. F. Loos, Benjamin Meder, Erik Melén, Craig E. Wheelock, Bo Jacobsson
Journal of Internal Medicine.2023; 294(4): 378. CrossRef
Lipid droplet biogenesis and functions in health and disease
Armella Zadoorian, Ximing Du, Hongyuan Yang
Nature Reviews Endocrinology.2023; 19(8): 443. CrossRef
Molecular Mechanisms for the Vicious Cycle between Insulin Resistance and the Inflammatory Response in Obesity
Dariusz Szukiewicz
International Journal of Molecular Sciences.2023; 24(12): 9818. CrossRef
Insulin Resistance Is the Main Characteristic of Metabolically Unhealthy Obesity (MUO) Associated with NASH in Patients Undergoing Bariatric Surgery
Sophia M. Schmitz, Sebastian Storms, Alexander Koch, Christine Stier, Andreas Kroh, Karl P. Rheinwalt, Sandra Schipper, Karim Hamesch, Tom F. Ulmer, Ulf P. Neumann, Patrick H. Alizai
Biomedicines.2023; 11(6): 1595. CrossRef
Hyperleptinemia as a marker of various phenotypes of obesity and overweight in women with rheumatoid arthritis and systemic lupus erythematosus
L. V. Kondrateva, Yu. N. Gorbunova, T. A. Panafidina, T. V. Popkova
Rheumatology Science and Practice.2023; 61(3): 339. CrossRef
Predictable Representation of Metabolic Synthesis Pathways of Vitamins and Short-Chain Fatty Acids in Obese Adults
A. V. Shestopalov, L. A. Ganenko, I. M. Kolesnikova, T. V. Grigoryeva, I. Yu. Vasilyev, Yu. L. Naboka, N. I. Volkova, O. V. Borisenko, S. A. Roumiantsev
Journal of Evolutionary Biochemistry and Physiology.2023; 59(5): 1510. CrossRef
PREDICTION OF VITAMINS AND SHORT-CHAIN FATTY ACIDS SYNTHESIS PATHWAYS IN OBESE ADULTS
A. V. Shestopalov, L. A. Ganenko, I. M. Kolesnikova, T. V. Grigoryeva, I. Yu. Vasilyev, Yu. L. Naboka, N. I. Volkova, O. V Borisenko, S. A. Roumiantsev
Журнал эволюционной биохимии и физиологии.2023; 59(5): 389. CrossRef
Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity
Nam Hoon Kim, Kyeong Jin Kim, Jimi Choi, Sin Gon Kim
Metabolism.2022; 128: 154894. CrossRef
Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women
Boyoung Park
Journal of Gynecologic Oncology.2022;[Epub] CrossRef
Insulin and cancer: a tangled web
Brooks P. Leitner, Stephan Siebel, Ngozi D. Akingbesote, Xinyi Zhang, Rachel J. Perry
Biochemical Journal.2022; 479(5): 583. CrossRef
Relationships Between Metabolic Body Composition Status and Rapid Kidney Function Decline in a Community-Based Population: A Prospective Observational Study
Shao-Chi Chu, Po-Hsi Wang, Kuan-Ying Lu, Chia-Chun Ko, Yun-Hsuan She, Chin-Chan Lee, I-Wen Wu, Chiao-Yin Sun, Heng-Jung Hsu, Heng-Chih Pan
Frontiers in Public Health.2022;[Epub] CrossRef
Dissecting the clinical relevance of polygenic risk score for obesity—a cross-sectional, longitudinal analysis
Eun Kyung Choe, Manu Shivakumar, Seung Mi Lee, Anurag Verma, Dokyoon Kim
International Journal of Obesity.2022; 46(9): 1686. CrossRef
Metabolic and Obesity Phenotype Trajectories in Taiwanese Medical Personnel
Hsin-Yun Chang, Jer-Hao Chang, Yin-Fan Chang, Chih-Hsing Wu, Yi-Ching Yang
International Journal of Environmental Research and Public Health.2022; 19(13): 8184. CrossRef
Sex Differences in Cardiovascular Impact of Early Metabolic Impairment: Interplay between Dysbiosis and Adipose Inflammation
Haneen S. Dwaib, Ibrahim AlZaim, Ghina Ajouz, Ali H. Eid, Ahmed El-Yazbi
Molecular Pharmacology.2022; 102(1): 60. CrossRef
Reduced leukocyte mitochondrial copy number in metabolic syndrome and metabolically healthy obesity
Rachel Agius, Nikolai Paul Pace, Stephen Fava
Frontiers in Endocrinology.2022;[Epub] CrossRef
Changes in BMI and physical activity from youth to adulthood distinguish normal-weight, metabolically obese adults from those who remain healthy
A. Viitasalo, K. Pahkala, T. Lehtimäki, JSA. Viikari, TH. Tammelin, O. Raitakari, TO. Kilpeläinen
Frontiers in Endocrinology.2022;[Epub] CrossRef
Pathogenesis, Murine Models, and Clinical Implications of Metabolically Healthy Obesity
Yun Kyung Cho, Yoo La Lee, Chang Hee Jung
International Journal of Molecular Sciences.2022; 23(17): 9614. CrossRef
Metabolically healthy obesity: it is time to consider its dynamic changes
Yun Kyung Cho, Chang Hee Jung
Cardiovascular Prevention and Pharmacotherapy.2022; 4(4): 123. CrossRef
Obesity as a Risk Factor for Breast Cancer—The Role of miRNA
Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, Katarzyna Urbańska, Filip Ambrozkiewicz, Andrzej Kwiatkowski, Lidia Martyńska, Anita Domańska, Wojciech Bik, Agnieszka Paziewska
International Journal of Molecular Sciences.2022; 23(24): 15683. CrossRef
Niveles elevados de fibrinógeno en el sujeto delgado metabólicamente obeso: un estudio transversal analítico a partir de una muestra de pobladores peruanos
Victor Juan Vera-Ponce, Gianella Zulema Zeñas-Trujillo, Jenny Raquel Torres-Malca, Liliana Cruz-Ausejo, Mario J. Valladares-Garrido, Jesus Enrique Talavera Ramirez, Jose M Vela-Ruiz, Jhony A. De la Cruz Vargas
Revista Española de Nutrición Humana y Dietética.2022; 26(4): 303. CrossRef
Propensity Score–Matching Sleeve Gastrectomy (SG) vs. Gastric Bypass (RYGB) in Patients ≥ 60 Years
Omar Thaher, Stefanie Wolf, Martin Hukauf, Christine Stroh
Obesity Surgery.2021; 31(6): 2682. CrossRef
Associations between obesity, metabolic health, and the risk of breast cancer in East Asian women
Boyoung Park, Soyeoun Kim, Hayoung Kim, Chihwan Cha, Min Sung Chung
British Journal of Cancer.2021; 125(12): 1718. CrossRef

Original Article

Clinical Study
Relationships between Thigh and Waist Circumference, Hemoglobin Glycation Index, and Carotid Plaque in Patients with Type 2 Diabetes: Myung Ki Yoon, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm, Kap Bum Huh, Chul Sik Kim; Endocrinol Metab. 2020;35(2):319-328. Published online June 24, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.2.319

13,246 View
174 Download
6 Web of Science
7 Crossref

Abstract PDF PubReader ePub

Background
This study investigated the relationships of thigh and waist circumference with the hemoglobin glycation index (HGI) and carotid atherosclerosis in patients with type 2 diabetes.
Methods
This observational study included 3,075 Korean patients with type 2 diabetes, in whom anthropometric measurements and carotid ultrasonography were conducted. HGI was defined as the measured hemoglobin A1c (HbA1c) level minus the predicted HbA1c level, which was calculated using the linear relationship between HbA1c and fasting plasma glucose levels. Carotid atherosclerosis was defined as a clearly isolated focal plaque or focal wall thickening >50% of the surrounding intima-media thickness.
Results
The frequency of a positive HGI decreased with increasing thigh circumference in men and increased with increasing waist circumference in women after adjusting for potential confounding variables. Thigh and waist circumference had a combined augmentative effect on the likelihood of positive HGI, which was dramatically higher in patients in higher waist-to-thigh ratio quartiles (adjusted odds ratios for the highest compared to the lowest quartile: 1.595 in men and 1.570 in women). Additionally, the larger the thigh circumference, the lower the risk of carotid atherosclerosis, although in women, this relationship lacked significance after adjustment for potential confounders.
Conclusion
HGI was associated with thigh circumference in men and waist circumference in women. In addition, the combination of low thigh circumference and high waist circumference was strongly associated with a higher HGI in Korean patients with type 2 diabetes. In particular, thigh circumference was associated with carotid atherosclerosis in men. However, further longitudinal studies are warranted.

Citations

Citations to this article as recorded by

PROFIL ANTROPOMETRI OBESITAS ANTARA MAHASISWA DENGAN METABOLIC HEALTHY OBESE (MHO) DAN METABOLIC UNHEALTHY OBESE (MUO)
Fillah Fithra Dieny, Puji Rahayu, Ani Margawati, Hartanti Sandi Wijayanti
Journal of Nutrition College.2026; 15(1): 94. CrossRef
Comprehensive analysis of risk factors associated with carotid plaque in patients with type 2 diabetes mellitus
Lei Shi, Neng-Juan Li
World Journal of Diabetes.2025;[Epub] CrossRef
The additive effect of glycemic variability and systolic blood pressure variability on mortality in patients with sepsis
Hong-Jin Zhang, Wen-Liang Shuai, Meng-Bo Wu, Wen-Cheng Yan, Yang Fu, Hong-Zhou Zhang
BMC Infectious Diseases.2025;[Epub] CrossRef
Muscle and cardiometabolic health in community-living adults with type 2 diabetes
Allison Espinoza Ribadenera, Javier Gálvez-Celi, Cecilia Liceth Arteaga Pazmiño, Evelyn Frias-Toral
Revista Española de Nutrición Humana y Dietética.2025;[Epub] CrossRef
Association between hemoglobin glycation index and subclinical myocardial injury in the general population free from cardiovascular disease
Zhenwei Wang, Yihai Liu, Jing Xie, Nai-Feng Liu
Nutrition, Metabolism and Cardiovascular Diseases.2022; 32(2): 469. CrossRef
Association of Hemoglobin Glycation Index With Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Retrospective Study
Zhezhe Chen, Duanbin Li, Maoning Lin, Hangpan Jiang, Tian Xu, Yu Shan, Guosheng Fu, Min Wang, Wenbin Zhang
Frontiers in Physiology.2022;[Epub] CrossRef
Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes
Naohiro Taya, Naoto Katakami, Tomoya Mita, Yosuke Okada, Satomi Wakasugi, Hidenori Yoshii, Toshihiko Shiraiwa, Akihito Otsuka, Yutaka Umayahara, Kayoko Ryomoto, Masahiro Hatazaki, Tetsuyuki Yasuda, Tsunehiko Yamamoto, Masahiko Gosho, Iichiro Shimomura, Hi
Cardiovascular Diabetology.2021;[Epub] CrossRef

Review Articles

Obesity and Metabolism
Effects of Cardiovascular Risk Factor Variability on Health Outcomes: Seung-Hwan Lee, Mee Kyoung Kim, Eun-Jung Rhee; Endocrinol Metab. 2020;35(2):217-226. Published online June 24, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.2.217

14,480 View
228 Download
33 Web of Science
37 Crossref

Abstract PDF PubReader ePub

Innumerable studies have suggested “the lower, the better” for cardiovascular risk factors, such as body weight, lipid profile, blood pressure, and blood glucose, in terms of health outcomes. However, excessively low levels of these parameters cause health problems, as seen in cachexia, hypoglycemia, and hypotension. Body weight fluctuation is related to mortality, diabetes, obesity, cardiovascular disease, and cancer, although contradictory findings have been reported. High lipid variability is associated with increased mortality and elevated risks of cardiovascular disease, diabetes, end-stage renal disease, and dementia. High blood pressure variability is associated with increased mortality, myocardial infarction, hospitalization, and dementia, which may be caused by hypotension. Furthermore, high glucose variability, which can be measured by continuous glucose monitoring systems or self-monitoring of blood glucose levels, is associated with increased mortality, microvascular and macrovascular complications of diabetes, and hypoglycemic events, leading to hospitalization. Variability in metabolic parameters could be affected by medications, such as statins, antihypertensives, and hypoglycemic agents, and changes in lifestyle patterns. However, other mechanisms modify the relationships between biological variability and various health outcomes. In this study, we review recent evidence regarding the role of variability in metabolic parameters and discuss the clinical implications of these findings.

Citations

Citations to this article as recorded by

Capsiate attenuates atherosclerosis by activating Nrf2/GPX4 pathway and reshaping the intestinal microbiota in ApoE −/− mice
Yongbin Shen, Chuanqi Zhang, Xue Jiang, Xianwei Li, Bo Chen, Weiliang Jiang, Yunhe Fu
Microbiology Spectrum.2025;[Epub] CrossRef
Correlation between self-management, psychological cognitive impairment, and quality of life in elderly chronic obstructive pulmonary disease patients
Xiao-Li Zhang, Su-Shu Li, Jian-Qing Qin, Xiao-Yu Han, Xing-Hui Su, Liu-Mei Qin, Chang Pan
World Journal of Psychiatry.2025;[Epub] CrossRef
Investigating the relationship between cardiac autonomic modulation and resting heart rate in youth across physical activity levels
Belkadi Adel, Asli Houcine, Cherara Lalia, Benhammou Saddek, Mokrani Djemal, Sebbane Mohamed
Physical education and sport through the centuries.2025; 12(2): 17. CrossRef
Deep learning for cardiovascular management: optimizing pathways and cost control under diagnosis-related group models
Haohao Chen, Ying Zeng, De Cai
Frontiers in Artificial Intelligence.2025;[Epub] CrossRef
Lipid Variability and the Risk of Incident Peripheral Artery Disease
Ying-Chang Tung, Tsung-Han Tsai, Yu-Jui Hsieh, Tzyy-Jer Hsu, Fu-Chih Hsiao, Chia-Pin Lin, Pao-Hsien Chu
Circulation Journal.2025;[Epub] CrossRef
Sex Differences in Low-Density Lipoprotein Cholesterol Treatment Among Young Israeli Patients Following Premature Acute Coronary Syndrome
Feras Haskiah, Karam Abdelhai, Ranin Hilu, Abid Khaskia
Metabolic Syndrome and Related Disorders.2024; 22(6): 439. CrossRef
Relationship between Alzheimer dementia and QT interval: A meta‐analysis
Simon W. Rabkin
AGING MEDICINE.2024; 7(2): 214. CrossRef
Exendin-4 intervention attenuates atherosclerosis severity by modulating myeloid-derived suppressor cells and inflammatory cytokines in ApoE-/- mice
Miaoxin Fu, Qingmei Li, Hang Qian, Xinwen Min, Handong Yang, Zhixin Liu, Wenwen Wu, Jixin Zhong, Hao Xu, Aihua Mei, Jun Chen
International Immunopharmacology.2024; 140: 112844. CrossRef
All-cause and cause-specific mortality risks in individuals with diabetes living alone: A large-scale population-based cohort study
Jae-Seung Yun, Kyungdo Han, Bongseong Kim, Seung-Hyun Ko, Hyuk-Sang Kwon, Yu-Bae Ahn, Yong-Moon Mark Park, Seung-Hwan Lee
Diabetes Research and Clinical Practice.2024; 217: 111876. CrossRef
Long-term variability in physiological measures in relation to mortality and epigenetic aging: prospective studies in the USA and China
Hui Chen, Tianjing Zhou, Shaowei Wu, Yaying Cao, Geng Zong, Changzheng Yuan
BMC Medicine.2023;[Epub] CrossRef
Big Data Research in the Field of Endocrine Diseases Using the Korean National Health Information Database
Sun Wook Cho, Jung Hee Kim, Han Seok Choi, Hwa Young Ahn, Mee Kyoung Kim, Eun Jung Rhee
Endocrinology and Metabolism.2023; 38(1): 10. CrossRef
Relationship between Short- and Mid-Term Glucose Variability and Blood Pressure Profile Parameters: A Scoping Review
Elena Vakali, Dimitrios Rigopoulos, Petros C. Dinas, Ioannis-Alexandros Drosatos, Aikaterini G. Theodosiadi, Andriani Vazeou, George Stergiou, Anastasios Kollias
Journal of Clinical Medicine.2023; 12(6): 2362. CrossRef
Lipid treatment status and goal attainment among patients with premature acute coronary syndrome in Israel
Feras Haskiah, Abid Khaskia
Journal of Clinical Lipidology.2023; 17(3): 367. CrossRef
Research on obesity using the National Health Information Database: recent trends
Eun-Jung Rhee
Cardiovascular Prevention and Pharmacotherapy.2023; 5(2): 35. CrossRef
Risk of fracture according to temporal changes of low body weight changes in adults over 40 years: a nationwide population-based cohort study
Jung Guel Kim, Jae-Young Hong, Jiwon Park, Sang-Min Park, Kyungdo Han, Ho-Joong Kim, Jin S. Yeom
BMC Public Health.2023;[Epub] CrossRef
Factors Affecting High Body Weight Variability
Kyungdo Han, Mee Kyoung Kim
Journal of Obesity & Metabolic Syndrome.2023; 32(2): 163. CrossRef
Puerarin Attenuates High-Glucose and High-Lipid-Induced Inflammatory Injury in H9c2 Cardiomyocytes via CAV3 Protein Upregulation
YiFu Tian, CaiXia Zhou, XiaoYang Bu, Qian Lv, Qin Huang
Journal of Inflammation Research.2023; Volume 16: 2707. CrossRef
Visit-to-Visit Glucose Variability, Cognition, and Global Cognitive Decline: The Multi-Ethnic Study of Atherosclerosis
Christopher L Schaich, Michael P Bancks, Kathleen M Hayden, Jingzhong Ding, Stephen R Rapp, Alain G Bertoni, Susan R Heckbert, Timothy M Hughes, Morgana Mongraw-Chaffin
The Journal of Clinical Endocrinology & Metabolism.2023; 109(1): e243. CrossRef
Association between lipid variability and the risk of mortality in cancer patients not receiving lipid-lowering agents
Seohyun Kim, Gyuri Kim, So Hyun Cho, Rosa Oh, Ji Yoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim
Frontiers in Oncology.2023;[Epub] CrossRef
The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study
Natsumi Matsuoka-Uchiyama, Haruhito A. Uchida, Shugo Okamoto, Yasuhiro Onishi, Katsuyoshi Katayama, Mariko Tsuchida-Nishiwaki, Hidemi Takeuchi, Rika Takemoto, Yoshiko Hada, Ryoko Umebayashi, Naoko Kurooka, Kenji Tsuji, Jun Eguchi, Hirofumi Nakajima, Kenic
Journal of Diabetes Research.2022; 2022: 1. CrossRef
Associations of variability in body weight and glucose levels with the risk of hip fracture in people with diabetes
Jeongmin Lee, Kyungdo Han, Sang Hyun Park, Mee Kyoung Kim, Dong-Jun Lim, Kun-Ho Yoon, Moo-Il Kang, Seung-Hwan Lee
Metabolism.2022; 129: 155135. CrossRef
The Influence of Obesity and Metabolic Health on Vascular Health
Eun-Jung Rhee
Endocrinology and Metabolism.2022; 37(1): 1. CrossRef
Variability of Metabolic Risk Factors: Causative Factor or Epiphenomenon?
Hye Jin Yoo
Diabetes & Metabolism Journal.2022; 46(2): 257. CrossRef
Changes in Underweight Status and Risk of Hip Fracture: A Korean Nationwide Population-Based Cohort Study
Sangsoo Han, Jiwon Park, Hae-Dong Jang, Kyungdo Han, Choungah Lee, Wonseok Kim, Jae-Young Hong
Journal of Clinical Medicine.2022; 11(7): 1913. CrossRef
Dynamic physical examination indicators of cardiovascular health: A single-center study in Shanghai, China
Rongren Kuang, Yiling Liao, Xinhan Xie, Biao Li, Xiaojuan Lin, Qiang Liu, Xiang Liu, Wenya Yu, Yajing Wang
PLOS ONE.2022; 17(5): e0268358. CrossRef
Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Study
Nami Lee, So Jeong Park, Dongwoo Kang, Ja Young Jeon, Hae Jin Kim, Dae Jung Kim, Kwan-Woo Lee, Edward J. Boyko, Seung Jin Han
Diabetes Care.2022; 45(5): 1141. CrossRef
Lipid Variability and Risk of Cardiovascular Diseases and All-Cause Mortality: A Systematic Review and Meta-Analysis of Cohort Studies
Shuting Li, Leying Hou, Siyu Zhu, Qian Yi, Wen Liu, Yang Zhao, Feitong Wu, Xue Li, An Pan, Peige Song
Nutrients.2022; 14(12): 2450. CrossRef
Impact of Visit-to-Visit Triglyceride-Glucose Index Variability on the Risk of Cardiovascular Disease in the Elderly
Fei Chen, Ying Pan, Ziqing Liu, Rong Huang, Jing Wang, Jian Shao, Yaqin Gong, Xiyi Sun, Xiaobo Jiang, Weihao Wang, Zhaoqiang Li, Shao Zhong, Qi Pan, Kaixin Zhou, Muhammad Furqan Akhtar
International Journal of Endocrinology.2022; 2022: 1. CrossRef
Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
Metabolism.2022; 137: 155327. CrossRef
Mean versus variability of lipid measurements over 6 years and incident cardiovascular events: More than a decade follow-up
Soroush Masrouri, Leila Cheraghi, Niloofar Deravi, Neda Cheraghloo, Maryam Tohidi, Fereidoun Azizi, Farzad Hadaegh
Frontiers in Cardiovascular Medicine.2022;[Epub] CrossRef
Long-Term Variability in Physiological Measures in Relation to Mortality and Epigenetic Aging: Prospective Studies in the US and China
Hui Chen, Tianjing Zhou, Shaowei Wu, Yaying Cao, Geng Zong, Changzheng Yuan
SSRN Electronic Journal .2022;[Epub] CrossRef
Acute Glucose Shift Induces the Activation of the NLRP3 Inflammasome in THP-1 Cells
Ji Yeon Lee, Yup Kang, Hae Jin Kim, Dae Jung Kim, Kwan Woo Lee, Seung Jin Han
International Journal of Molecular Sciences.2021; 22(18): 9952. CrossRef
Body Weight Change and Cardiovascular Disease: Effect of Weight Gain, Weight Loss, and Weight Cycling
Jung-Hwan Cho, Eun-Jung Rhee, Won-Young Lee
Cardiovascular Prevention and Pharmacotherapy.2021; 3(4): 73. CrossRef
Fasting Glucose Variability as a Risk Indicator for End-Stage Kidney Disease in Patients with Diabetes: A Nationwide Population-Based Study
Da Young Lee, Jaeyoung Kim, Sanghyun Park, So Young Park, Ji Hee Yu, Ji A. Seo, Nam Hoon Kim, Hye Jin Yoo, Sin Gon Kim, Kyung Mook Choi, Sei Hyun Baik, Kyungdo Han, Nan Hee Kim
Journal of Clinical Medicine.2021; 10(24): 5948. CrossRef
Characteristics and Clinical Course of Diabetes of the Exocrine Pancreas: A Nationwide Population-Based Cohort Studybrief Title: Diabetes of the Exocrine Pancreas
Nami Lee, So Jeong Park, Dongwoo Kang, Ja Young Jeon, Hae Jin Kim, Dae Jung Kim, Kwan-Woo Lee, Edward J. Boyko, Seung Jin Han
SSRN Electronic Journal .2021;[Epub] CrossRef
Effects of aerobic, resistance, and combined exercise on metabolic syndrome parameters and cardiovascular risk factors: a systematic review and network meta-analysis
Minyu Liang, Yichao Pan, Tong Zhong, Yingchun Zeng, Andy S.K. Cheng
Reviews in Cardiovascular Medicine.2021;[Epub] CrossRef
Validation of a wearable cuff-less wristwatch-type blood pressure monitoring device
Joon Ho Moon, Myung-Kyun Kang, Chang-Eun Choi, Jeonghee Min, Hae-Young Lee, Soo Lim
Scientific Reports.2020;[Epub] CrossRef

Thyroid
Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers: Seong-Keun Yoo, Young Shin Song, Young Joo Park, Jeong-Sun Seo; Endocrinol Metab. 2020;35(1):44-54. Published online March 19, 2020; DOI: https://doi.org/10.3803/EnM.2020.35.1.44

12,098 View
293 Download
21 Web of Science
20 Crossref

Abstract PDF PubReader ePub

Anaplastic thyroid cancer (ATC) is a lethal human cancer with a 5-year survival rate of less than 10%. Recently, its genomic and transcriptomic characteristics have been extensively elucidated over 5 years owing to advance in high throughput sequencing. These efforts have extended molecular understandings into the progression mechanisms and therapeutic vulnerabilities of aggressive thyroid cancers. In this review, we provide an overview of genomic and transcriptomic alterations in ATC and poorly-differentiated thyroid cancer, which are distinguished from differentiated thyroid cancers. Clinically relevant genomic alterations and deregulated signaling pathways will be able to shed light on more effective prevention and stratified therapeutic interventions for affected patients.

Citations

Citations to this article as recorded by

A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer
Yefeng Cai, Yawen Guo, Wenli Ma, Pu Cheng, Liehao Jiang, Shuyan Shen, Fahuan Song, Lei Zhu, Yiqun Hu, Yao Chen, Yanting Duan, Xiujun Cai, Quan Li, Guowan Zheng, Minghua Ge
European Journal of Endocrinology.2025; 192(2): 128. CrossRef
Validation of Diagnostic Utility of Washout CYFRA 21-1 in Lymph Node Metastasis of Thyroid Cancer
Jeongmin Lee, Yuri Shin, Jeongun Kwak, Hye Lim Park, Sohee Lee, Mee Kyung Kim, Ja Seong Bae, Chan Kwon Jung, So Lyung Jung, Jung-Min Lee, Sang-Ah Chang, Dong-Jun Lim
Clinical Cancer Research.2025; 31(10): 1922. CrossRef
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Peter Y.F. Zeng, Stephenie D. Prokopec, Stephen Y. Lai, Nicole Pinto, Michelle A. Chan-Seng-Yue, Roderick Clifton-Bligh, Michelle D. Williams, Christopher J. Howlett, Paul Plantinga, Matthew J. Cecchini, Alfred K. Lam, Iram Siddiqui, Jianxin Wang, Ren X.
Cell Reports.2024; 43(3): 113826. CrossRef
Comparative study between poorly differentiated thyroid cancer and anaplastic thyroid cancer: real-world pathological distribution, death attribution, and prognostic factor estimation
Kun Zhang, Xinyi Wang, Tao Wei, Zhihui Li, Jingqiang Zhu, Ya-Wen Chen
Frontiers in Endocrinology.2024;[Epub] CrossRef
Dabrafenib and Trametinib Therapy for Advanced Anaplastic Thyroid Cancer – Real-World Outcomes From UK Centres
C. Lorimer, L. Cheng, R. Chandler, K. Garcez, V. Gill, K. Graham, W. Grant, S. Sardo Infirri, J. Wadsley, L. Wall, N. Webber, K.H. Wong, K. Newbold
Clinical Oncology.2023; 35(1): e60. CrossRef
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions
E. Macerola, A. M. Poma, P. Vignali, A. Proietti, L. Torregrossa, C. Ugolini, A. Basolo, A. Matrone, R. Elisei, F. Santini, F. Basolo
Journal of Endocrinological Investigation.2023; 46(8): 1651. CrossRef
RBX1 regulates PKM alternative splicing to facilitate anaplastic thyroid carcinoma metastasis and aerobic glycolysis by destroying the SMAR1/HDAC6 complex
Debin Xu, Jichun Yu, Yuting Yang, Yunyan Du, Hongcheng Lu, Shouhua Zhang, Qian Feng, Yi Yu, Liang Hao, Jun Shao, Leifeng Chen
Cell & Bioscience.2023;[Epub] CrossRef
Multi-Omics and Management of Follicular Carcinoma of the Thyroid
Thifhelimbilu Emmanuel Luvhengo, Ifongo Bombil, Arian Mokhtari, Maeyane Stephens Moeng, Demetra Demetriou, Claire Sanders, Zodwa Dlamini
Biomedicines.2023; 11(4): 1217. CrossRef
Genomic landscape of anaplastic thyroid cancer and implications on therapy
Leslie Cheng, Kate Newbold
Current Opinion in Endocrine and Metabolic Research.2023; 30: 100458. CrossRef
Modeling the tumor microenvironment of anaplastic thyroid cancer: an orthotopic tumor model in C57BL/6 mice
Zhen Xu, Hyo Shik Shin, Yoo Hyung Kim, Seong Yun Ha, Jae-Kyung Won, Su-jin Kim, Young Joo Park, Sareh Parangi, Sun Wook Cho, Kyu Eun Lee
Frontiers in Immunology.2023;[Epub] CrossRef
Characterization of the genomic alterations in poorly differentiated thyroid cancer
Yeeun Lee, SeongRyeol Moon, Jae Yeon Seok, Joon-Hyop Lee, Seungyoon Nam, Yoo Seung Chung
Scientific Reports.2023;[Epub] CrossRef
Genetica del carcinoma anaplastico della tiroide
Teresa Ramone, Chiara Mulè, Cristina Romei, Raffaele Ciampi, Eleonora Molinaro, Rossella Elisei
L'Endocrinologo.2022; 23(2): 208. CrossRef
Tissue and circulating PD-L2: moving from health and immune-mediated diseases to head and neck oncology
Elena Muraro, Rebecca Romanò, Giuseppe Fanetti, Emanuela Vaccher, Irene Turturici, Valentina Lupato, Fabio Biagio La Torre, Jerry Polesel, Elisabetta Fratta, Vittorio Giacomarra, Giovanni Franchin, Agostino Steffan, Michele Spina, Salvatore Alfieri
Critical Reviews in Oncology/Hematology.2022; 175: 103707. CrossRef
Recent Improvements in the Treatment of High-Risk Thyroid Cancer
Eun Kyung Lee
Korean Society for Head and Neck Oncology.2022; 38(1): 1. CrossRef
Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice
Cole D Davidson, Jennifer A Tomczak, Eyal Amiel, Frances E Carr
Endocrinology.2022;[Epub] CrossRef
Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis
Hao Zhao, Chun-Hao Liu, Yue Cao, Li-Yang Zhang, Ya Zhao, Yue-Wu Liu, Hong-Feng Liu, Yan-Song Lin, Xiao-Yi Li
Frontiers in Oncology.2022;[Epub] CrossRef
2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
Keith C. Bible, Electron Kebebew, James Brierley, Juan P. Brito, Maria E. Cabanillas, Thomas J. Clark, Antonio Di Cristofano, Robert Foote, Thomas Giordano, Jan Kasperbauer, Kate Newbold, Yuri E. Nikiforov, Gregory Randolph, M. Sara Rosenthal, Anna M. Saw
Thyroid®.2021; 31(3): 337. CrossRef
Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine
Antonio Ieni, Roberto Vita, Cristina Pizzimenti, Salvatore Benvenga, Giovanni Tuccari
Journal of Personalized Medicine.2021; 11(5): 333. CrossRef
The Role of Altered Mitochondrial Metabolism in Thyroid Cancer Development and Mitochondria-Targeted Thyroid Cancer Treatment
Siarhei A. Dabravolski, Nikita G. Nikiforov, Alexander D. Zhuravlev, Nikolay A. Orekhov, Liudmila M. Mikhaleva, Alexander N. Orekhov
International Journal of Molecular Sciences.2021; 23(1): 460. CrossRef
Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
Young Shin Song, Young Joo Park
Endocrinology and Metabolism.2020; 35(3): 515. CrossRef

Original Articles

Relationships Among Pubertal Development, Anthropometric Measurement, Bone Mineral Density in Males and Females 7-23 Years of Age.: Hee Ja Lee, In Kyu Lee; J Korean Endocr Soc. 1996;11(4):455-467. Published online November 7, 2019

1,453 View
20 Download

Abstract PDF: Background
Maximizing peak bone mass is advocated as a way to prevent osteoporosis. As a prerequisite to the elaboration of any preventive program aimed at rnaximizing peak bone mass, it is important to determine how the rate of skeletal growth at elinically relevant sites, such as lumbar spine(LS), femoral neck(FN), proceeds in relation to age and pubertal stages in both sexes. The present study was performed to measure bone mineral density(BMD) of Korean children and adolescents and to assess the influence of age, sex, puberty and body size on bone mineral density (BMD) during the period of bone growth. Method: Lumbar spine(LS), femoral neck(FN) BMD were measured in 199 healthy males and fernales 7~23 years of age using dual energy x-ray absorptiometry(DEXA), Tanner staging(TS) was used to assess stage of puberty. Results: Anthropometric measurements generally increased with tanner stage in both sexes. Sex differences were observed. In males, compared to females there were significantly higher in height(TS1, TS3, TS4, TS5), weight(TS1, TS3, TS5), dorsal hand skinfold thickness(TS1, TS5), and lean body mass(TS1, TS3, TS4, TS5): while in females, compared to males there were significantly higher in BMI(TS4), skinfold thickness except dorsal hand and fat %(TS3-TS5), and total fat mass(TS3, TS4)(p

In Situ Hybridization Analysis of Human Growth Hormone and Prolactin Secreting Pitultary Adenomas.: Jae Wha Jo, Eun Jig Lee, Moon Suk Nam, Kyung Rae Kim, Sung Kil Lim, Hyun Chul Lee, Kap Bum Huh, Tae Seung Kim, Sun Ho Kim, Joong Uhn Choi, Kyu Chang Lee, Hyun Joo Jung, Sang Seop Chung; J Korean Endocr Soc. 1994;9(2):82-92. Published online November 6, 2019

1,949 View
30 Download

Abstract PDF: A non-isotopic in situ hybridization method with biotin-labelled oligonucleotide probes was used to examine growth hormone(GH) and prolactin(PRL) gene expression in 32 patients with pituitary adenomas; 13 were prolactinomas, 8 GH secreting adenomas, and 11 mixed GH and PRL secreting adenomas.Positive immunostaining for GH was found in all patients with GH secreting adenomas, and mixed GH and PRL secreting adenomas. Positive immunostaining for PRL was found in all patients with prolactinomas and 9(81.8%) of 11 mixed GH and PRL secreting adenomas, 5(62.5%) of 8 GH secreting adenomas. Immunohistochemistry revealed that 13 were lactotrope adenomas, 5 somatotrope adenomas, and 14 GH and PRL cell adenomas.In situ hybridization revealed that GH mRNA expression was found in all the patients with somatotrope adenomas and GH and PRL cell adenomas, and 6(46.1%) of 13 lactotrope adenomas. PRL mRNA expression was 100% in lactotrope and GH and PRL cell adenomas, and 4(80.0%) of 5 somatotrope adenomas.The patients with a clinical diagnosis of acromegaly had detectable PRL mRNA in their neoplasm and it is suggested that the PRL cells in the adenomas did not result from dedifferentiation, but from the neoplastic stimulus for some mixed tumors probably occurred in cells previously committed to produce PRL and GH. In lactotrope adenomas, the PRL cells of the patients without expression of GH mRNA may be arised from cells programmed to secrete PRL or precussor PRL cells rather than from mixed GH-PRL cells. The finding that some patients produced mRNA detectable by in situ hybridization, but no hormone detectable by immunohistochemistry within tumor was suggested of a silent adenoma.These observations indicated that in situ hybridization studies may improve the classification of pituitary adenomas and may provide a precise knowledge of the biology of these neoplasms.

Changes of Bone Turnover Markers after Treatment with Growth Hormone Therapy in Children with Growth Retardation.: In Myung Yang, Jeong Taek Woo, Sung Woon Kim, Jin Woo Kim, Young Seol Kim, Young Kil Choi, Ki Oak han, Duk Yoon Kim, Hyung In Yang; J Korean Endocr Soc. 1994;9(4):344-349. Published online November 6, 2019

1,751 View
26 Download

Abstract PDF: The effects of growth hormone(GH) deficiency and recombinant human GH replacement(0.5IU/kg per week) on bone mineral metabolism in 21GH-deficiency children were studied. All children had significantly reduction of bone density(Z score;-1.4+-0.71). After 1 month of therapy, the levels of serum insulin-like growth factor 1(IGF-1), osteocalcin(OC) and carboxyterminal propeptede of type 1 procollagen(PICP) were significantly elevated. But IGFBP-3 were not shown to change significantly. The changes in serum levels of PICP during the first month of recombinant human GH treatment were positively related to growth velocity, whereas the changes in IGF-1 and OC during the first month of therapy were not. We conclude that the recombinant human GH treatment caused significant modifications of mineral metablism and that the measurement of the changes of biochemical markers of bone metablism espacially PICP may be a useful tool in prediction improved growth velocity during long term GH replacement therpy.

Review Articles

Diabetes
A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans: Jack Alistair Sargeant, Joseph Henson, James Adam King, Thomas Yates, Kamlesh Khunti, Melanie Jane Davies; Endocrinol Metab. 2019;34(3):247-262. Published online September 26, 2019; DOI: https://doi.org/10.3803/EnM.2019.34.3.247

25,083 View
753 Download
154 Web of Science
166 Crossref

Abstract PDF PubReader ePub

Weight loss is an important goal in the management of several chronic conditions, including type 2 diabetes mellitus, and pharmacological therapies that aid weight loss are appealing. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT2is) are novel glucose-lowering therapies that have been shown to induce clinically significant reductions in body weight. However, this weight loss may not be attributed solely to fat mass (FM). Given the importance of skeletal muscle and lean body mass (LBM) on cardio-metabolic health and physical function, we reviewed the available literature reporting the effects of GLP-1RAs and SGLT2is on body composition. Results demonstrate that, in most circumstances, the weight loss associated with both therapies predominantly comprises a reduction in FM, although significant heterogeneity exists between studies. In over half of the studies identified, the proportion of LBM reduction ranged between 20% and 50% of total weight lost, which is consistent with diet-induced weight loss and bariatric surgery. No clear differences existed between GLP-1RAs and SGLT2is. Consequently, the loss of LBM and skeletal muscle associated with weight loss induced by GLP-1RAs and SGLT2is warrants attention. Strategies to preserve skeletal muscle and improve physical function, for example through structured exercise, are of great importance.

Citations

Citations to this article as recorded by

Narrative Review of Perioperative Glucagon-like Peptide-1 (GLP-1) Agonists in Spine Surgery
James W. Connelly, Rajkishen Narayanan, Teeto Ezeonu, Parth Kothari, Nicholas Spina, William Ryan Spiker, Brandon Lawrence, Darrel S. Brodke, Gregory D. Schroeder, Brian A. Karamian
Clinical Spine Surgery.2026; 39(2): 47. CrossRef
Mechanisms of insulin resistance in elderly sarcopenia patients and their bidirectional relationship
Haiyan Du, Yuqing Qu, Zhouyang Huai, Shumin Wang
Geriatric Nursing.2026; 69: 103907. CrossRef
Relevance and Safe Utilization of Amino Acids in Supplements for Human Nutrition: Lessons from Clinical and Preclinical Studies
François Blachier
Nutrients.2026; 18(2): 296. CrossRef
Semaglutide augments vascular proliferation and cardiac performance in a large animal model of ischemic cardiomyopathy
Kelsey C. Muir, Christopher Stone, Dwight D. Harris, Meghamsh Kanuparthy, Mark Broadwin, Jad Hamze, Jun Feng, Frank W. Sellke
American Journal of Physiology-Heart and Circulatory Physiology.2026; 330(3): H651. CrossRef
Body composition changes after 6 and 12 months of dietary weight loss: insights from the DIETFITS trial
Sun H Kim, Ji Hye Heo, Kristen Cunanan, Christopher D Gardner
Journal of the Endocrine Society.2026;[Epub] CrossRef
Advancing sarcopenia assessment with wearable and app-based technology: a scoping review
Ayush Mehra, Justo Perez, Jessica L. Krok-Schoen, Roberto M. Benzo, Colleen K. Spees, Shang-Jui Wang, Steven K. Clinton, Stefan A. Czerwinski, Brett S. Nickerson
The Journal of nutrition, health and aging.2026; 30(5): 100824. CrossRef
Obesity and Weight Management in HIV: Epidemiology, Complications, and Emerging Treatments
Luke Pryke, John R. Koethe, Samuel Bailin
Current HIV/AIDS Reports.2026;[Epub] CrossRef
Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity
Joseph L. Herman, Peter Dornbos, Karl Landheer, Benjamin J. Geraghty, Marc A. Egerman, Duc Phan, Mary Germino, Jason W. Mastaitis, Johnathon R. Walls, Luca A. Lotta, Gonçalo Abecasis, Aris Baras, Judith Y. Altarejos, Mark W. Sleeman, Olle Melander, Tea Sh
Nature Communications.2026;[Epub] CrossRef
Effects of caloric restriction with different doses of exercise on fat loss in people living with type 2 diabetes: A secondary analysis of the DOSE-EX randomized clinical trial
Mark P.P. Lyngbæk, Grit E. Legaard, Nina S. Nielsen, Cody Durrer, Thomas P. Almdal, Morten Asp Vonsild Lund, Benedikte Liebetrau, Caroline Ewertsen, Carsten Lauridsen, Thomas P.J. Solomon, Kristian Karstoft, Bente K. Pedersen, Mathias Ried-Larsen
Journal of Sport and Health Science.2025; 14: 100999. CrossRef
Worldwide burden of antidiabetic drug-induced sarcopenia: An international pharmacovigilance study
Jaehyun Kong, Seoyoung Park, Tae Hyeon Kim, Jae E. Lee, Hanseul Cho, Jiyeon Oh, Sooji Lee, Hyesu Jo, Hayeon Lee, Kyeongmin Lee, Jaeyu Park, Louis Jacob, Damiano Pizzol, Sang Youl Rhee, Sunyoung Kim, Dong Keon Yon
Archives of Gerontology and Geriatrics.2025; 129: 105656. CrossRef
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
Albert Do, Frhaan Zahrawi, Wajahat Z. Mehal
Nature Reviews Drug Discovery.2025; 24(3): 171. CrossRef
Medically Tailored Meals in Heart Failure: A Systematic Review of the Literature, 2013-2023
NATHALIE MCINTOSH, HAYLEY BILLINGSLEY, SCOTT L. HUMMEL, WHITNEY L. MILLS
Journal of Cardiac Failure.2025; 31(6): 939. CrossRef
Medical Weight Management Considerations in Plastic Surgery
Alisha B. Paranzino, Brittany Vieira, Caroline M. Apovian, Shailesh Agarwal
Plastic & Reconstructive Surgery.2025; 155(1): 207. CrossRef
GLP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials
Kristen M. Beavers, Tiffany M. Cortes, Colleen M. Foy, Lauren Dinkla, Fernando Reyes San Martin, Jamy D. Ard, Monica C. Serra, Daniel P. Beavers
Obesity.2025; 33(2): 225. CrossRef
Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure
Yi-Fei Zhang, Yu-Xiang Liu, Wu-Xiao Yang
World Journal of Cardiology.2025;[Epub] CrossRef
The Effects of Glucagon‐Like Peptide‐1 Receptor Agonists on Mitochondrial Function Within Skeletal Muscle: A Systematic Review
Victoria J. Old, Melanie J. Davies, Dimitris Papamargaritis, Pratik Choudhary, Emma L. Watson
Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults
Ashkan Hashemi, Min Ji Kwak, Parag Goyal
Drugs & Aging.2025; 42(2): 95. CrossRef
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
Areesha Moiz, Kristian B. Filion, Helia Toutounchi, Michael A. Tsoukas, Oriana H.Y. Yu, Tricia M. Peters, Mark J. Eisenberg
Annals of Internal Medicine.2025; 178(2): 199. CrossRef
Hypoglycemic drugs and sarcopenia
Yu. A. Dolgikh, S. V. Bulgakova, D. P. Kurmaev, E. V. Treneva, O. V. Kosareva, P. Ya. Merzlova, L. A. Sharonova, A. S. Bulgakov
Experimental and Clinical Gastroenterology.2025; (8): 216. CrossRef
Resistance Exercise in Treating Heart Failure with Preserved Ejection Fraction (HFpEF) and Obesity: Targeting Skeletal Muscle Abnormalities and Ectopic Adipose Depots
Daniel J. McDonough
Physiologia.2025; 5(1): 10. CrossRef
Are strategies to increase muscle mass and strength as effective in people with type 2 diabetes?
Amina A. Al-Awadi, Stuart R. Gray, Ebaa Al-Ozairi
Reviews in Endocrine and Metabolic Disorders.2025; 26(5): 857. CrossRef
Challenges, current innovations, and opportunities for managing type 2 diabetes in frail older adults: a position paper of the European Geriatric Medicine Society (EuGMS)—Special Interest Group in Diabetes
Virginia Boccardi, Gülistan Bahat, Cafer Balci, Isabelle Bourdel-Marchasson, Antoine Christiaens, Lorenzo Maria Donini, Sibel Cavdar, Stefania Maggi, Serdar Özkök, Tajana Pavic, Stany Perkisas, Stefano Volpato, Muhammad Shoaib Zaidi, Andrej Zeyfang, Alan
European Geriatric Medicine.2025; 16(4): 1231. CrossRef
Exploring the Potential Effect of GLP1R Agonism on Common Aging-Related Diseases via Glucose Reduction: A Mendelian Randomization Study
Wei Jiang, Kaixi Ding, Maoyi Yang, Zhipeng Hu, Rensong Yue, Lewis A Lipsitz
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.2025;[Epub] CrossRef
Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent W. S. Wong, Mary E. Rinella, Jerome Boursier, Jeffrey V. Lazarus, Hannele Yki-Järvinen, Rohit Loomba
Nature Reviews Disease Primers.2025;[Epub] CrossRef
Body composition changes during weight reduction with tirzepatide in the SURMOUNT‐1 study of adults with obesity or overweight
Michelle Look, Julia P. Dunn, Robert F. Kushner, Dachuang Cao, Charles Harris, Theresa Hunter Gibble, Adam Stefanski, Ryan Griffin
Diabetes, Obesity and Metabolism.2025; 27(5): 2720. CrossRef
Longitudinal association of SGLT2 inhibitors and GLP-1RAs on falls in persons with type 2 diabetes
Yasuhiro Suzuki, Hiroaki Suzuki, Kazushi Maruo, Takaaki Matsuda, Yuki Murayama, Yoko Sugano, Yoshinori Osaki, Hitoshi Iwasaki, Motohiro Sekiya, Yasushi Hada, Hitoshi Shimano
Scientific Reports.2025;[Epub] CrossRef
Non-invasive vestibular nerve stimulation (VeNS) reduces visceral adipose tissue: results of a randomised controlled trial
Erik Viirre, Julie Sittlington, David Wing, Ruth Price, Caomhan Logue, Daniel Moreno, Jeff Ledford-Mills, Cynthia Knott, Carel W. le Roux, David Grieve, Sinead Watson, Jason McKeown, Paul D. McGeoch
Scientific Reports.2025;[Epub] CrossRef
Role of GLP‑1 receptor agonists in sepsis and their therapeutic potential in sepsis‑induced muscle atrophy (Review)
Xuan Zhao, Yukun Liu, Dongfang Wang, Tonghan Li, Zhikai Xu, Zhanfei Li, Xiangjun Bai, Yuchang Wang
International Journal of Molecular Medicine.2025; 55(5): 1. CrossRef
Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial
Sujoy Ghosh, Bipin Sethi, Sanjay Kalra, Manash P. Baruah, Abhishek Mane, Sanjay Choudhari, Anup Petare, Mayur Jadhav, Saiprasad Patil, Hanmant Barkate
Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub] CrossRef
Effectiveness of tele‐guidance for physiotherapy in older patients with type 2 diabetes: A randomized controlled trial
Hiroaki Kataoka, Takuo Nomura, Hiroyuki Oka, Yukio Ikeda
Journal of Diabetes Investigation.2025; 16(7): 1284. CrossRef
How do glucagon‐like Peptide‐1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: A systematic review and meta‐analysis
Oluwaseun Anyiam, Arash Ardavani, Rushdina Sofia Abdul Rashid, Avinash Panesar, Iskandar Idris
Obesity Reviews.2025;[Epub] CrossRef
Changes in body composition and handgrip strength during dapagliflozin administration in patients with chronic kidney disease
Takahiro Yajima, Kaoru Noda, Kumiko Yajima
Clinical Kidney Journal.2025;[Epub] CrossRef
Exercise for Postmenopausal Bone Health – Can We Raise the Bar?
Shejil Kumar, Cassandra Smith, Roderick J. Clifton-Bligh, Belinda R. Beck, Christian M. Girgis
Current Osteoporosis Reports.2025;[Epub] CrossRef
Mechanosensitive Channels Mediate Pancreatic β Cells Reactive Oxygen Species Formation and Downregulation of Essential Genes During Therapeutic Ultrasound Treatment
Mallory Brayer, Vesna Zderic, Aleksandar Jeremic
Journal of Ultrasound in Medicine.2025; 44(9): 1577. CrossRef
Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure
Winston Wang, Danielle Green, Ramzi Ibrahim, Mahmoud Abdelnabi, Hoang Nhat Pham, Beani Forst, Mohamed Allam, Patrick Sarkis, George Bcharah, Juan Farina, Chadi Ayoub, Dan Sorajja, Reza Arsanjani
Biomedicines.2025; 13(5): 1108. CrossRef
Aerobic, resistance, and specialized exercise training in heart failure with preserved ejection fraction: A state-of-the-art review
Saeid Mirzai, Uttsav Sandesara, Mark J. Haykowsky, Peter H. Brubaker, Dalane W. Kitzman, Anthony E. Peters
Heart Failure Reviews.2025; 30(5): 1015. CrossRef
The Effects of GLP-1 Agonists on Musculoskeletal Health and Orthopedic Care
Andrew Gatto, Kevin Liu, Nesa Milan, Stephanie Wong
Current Reviews in Musculoskeletal Medicine.2025; 18(10): 469. CrossRef
GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates
Jason W. Mastaitis, Daniel Gomez, José G. Raya, Diana Li, Soo Min, Michael Stec, Sandra Kleiner, Toya McWilliams, Judith Y. Altarejos, Andrew J. Murphy, George D. Yancopoulos, Mark W. Sleeman
Nature Communications.2025;[Epub] CrossRef
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
Christopher S. Walker, Jacqueline F. Aitken, Greeshma Vazhoor Amarsingh, Shaoping Zhang, Garth J. S. Cooper
Nature Reviews Endocrinology.2025; 21(8): 482. CrossRef
Obesity medications in patients with recurrent weight gain or suboptimal clinical response following bariatric surgery: a meta-analysis
Mahdieh Golzarand, Karamollah Toolabi, Parvin Mirmiran
International Journal of Obesity.2025; 49(9): 1676. CrossRef
Exploring the disconnect: mechanisms underpinning the absence of physical function improvement with SGLT2 inhibitors
Cian Sutcliffe, Jack A. Sargeant, Thomas Yates, Melanie J. Davies, Luke A. Baker
Frontiers in Systems Biology.2025;[Epub] CrossRef
Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M Apovian, Shagun Bindlish, Jonathan Bonnet, W Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M Kane, Jasdeep Saluja, Deepa San
The American Journal of Clinical Nutrition.2025; 122(1): 344. CrossRef
Nutritional priorities to support GLP‐1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society
Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa
Obesity.2025; 33(8): 1475. CrossRef
Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa
American Journal of Lifestyle Medicine.2025;[Epub] CrossRef
Targeting intramyocellular lipids to improve aging muscle function
David W. Russ, Ravikumar Manickam, Srinivas M. Tipparaju
Lipids in Health and Disease.2025;[Epub] CrossRef
Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, Lydia Alexander, Caroline M. Apovian, Shagun Bindlish, Jonathan Bonnet, W. Scott Butsch, Sandra Christensen, Eugenia Gianos, Mahima Gulati, Alka Gupta, Debbie Horn, Ryan M. Kane, Jasdeep Saluja, Deepa
Obesity Pillars.2025; 15: 100181. CrossRef
Glucagon-Like Peptide-1 Receptor Agonist Medications Alter Outcomes of Spine Surgery
Joshua M. Wiener, Parshva A. Sanghvi, Katelyn Vlastaris, Thomas Mroz, Jonathan Belding, David C. Kaelber, Thomas Olson, Kevin P. Francis, John S. Adams, Nicholas Bernthal, William L. Sheppard
Spine.2025; 50(13): 871. CrossRef
Ultra-processed food consumption is associated with knee osteoarthritis: Data from the Osteoarthritis Initiative
Zehra Akkaya, Wynton M. Sims, John A. Lynch, Maximilian T. Löffler, Felix Gassert, Michael Nevitt, Charles E. McCulloch, Nancy E. Lane, Valentina Pedoia, Katharina Ziegeler, Thomas M. Link, Gabby B. Joseph
Osteoarthritis and Cartilage.2025; 33(9): 1130. CrossRef
Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study
W. Scott Butsch, Suela Sulo, Andrew T. Chang, Jeeyun A. Kim, Kirk W. Kerr, Dominique R. Williams, Refaat Hegazi, Thadchaigeni Panchalingam, Scott Goates, Steven B. Heymsfield
Obesity Pillars.2025; 15: 100186. CrossRef
Lifestyle Interventions for Treatment and Remission of Type 2 Diabetes and Prediabetes in Adults: A Clinical Practice Guideline From the American College of Lifestyle Medicine
Richard M. Rosenfeld, Meagan L. Grega, Micaela C. Karlsen, Abd Moain Abu Dabrh, R. Nisha Aurora, Jonathan P. Bonnet, Lori Donnell, Stephanie L. Fitzpatrick, Beth Frates, Elizabeth A. Joy, Jane F. Kapustin, Dawn R. Noe, Gunadhar Panigrahi, Arun Ram, Lianna
American Journal of Lifestyle Medicine.2025;[Epub] CrossRef
Serum uric acid reduction through SGLT2 inhibitors: evidence from a systematic review and meta-analysis
Shiwen Yang, Qiaozhi Hu, Kexin Liu, Binjie Xiao, Bofei Zhang, Na Su
Frontiers in Pharmacology.2025;[Epub] CrossRef
GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies
André J. Scheen
Diabetes & Metabolism.2025; 51(5): 101681. CrossRef
Incretin Receptor Agonism, Fat-free Mass, and Cardiorespiratory Fitness: A Narrative Review
Zhenqi Liu, Nathan R Weeldreyer, Siddhartha S Angadi
The Journal of Clinical Endocrinology & Metabolism.2025; 110(10): 2709. CrossRef
Redefining obesity: beyond body mass index
Javed Butler, Francesco Fioretti, Melanie J Davies
European Heart Journal.2025; 46(38): 3758. CrossRef
Utilization of Proteomic Measures for Early Detection of Drug Benefits and Adverse Effects
Jessica Chadwick, Colin Berry, Meredith A. Carpenter, Geeta Gulati, Siri Lagethon Heck, Michael A. Hinterberg, Rury R. Holman, Matthew M.Y. Lee, Torbjørn Omland, Clare Paterson, Mark C. Petrie, Naveed Sattar, Svati H. Shah, Sama Shrestha, Harald Sourij, E
The Journal of Clinical Pharmacology.2025; 65(11): 1460. CrossRef
Emerging evidence and potential avenues to achieve durable outcomes in patients with obesity: the confluence of nutrition, and Microbiome on body composition
Dra. M. Isabel T. D. Correia, Nitin Kapoor, Emma Chávez-Manzanera, Luís Henrique Wolff Gowdak, Amira Al Kharusi, Felipe F. Casanueva, Bruno Halpern, Gary Frost, Raed Aldahash
Reviews in Endocrine and Metabolic Disorders.2025; 26(5): 745. CrossRef
Pattern of Antidiabetic Drug Prescription in Older Persons With Type 2 Diabetes: Results From the German DPV Registry
Andrej Zeyfang, Stefan Gölz, Federica Iraci, Christian Wagner, Christian Scheer, Thomas Kubiak, Latife Bozkurt, Martin Heni, Reinhard W. Holl
Journal of the American Medical Directors Association.2025; 26(8): 105724. CrossRef
GLP-1 Receptor Agonists in Spine Surgery: Current Evidence and Future Directions
Luis M. Salazar, Samuel Alfonsi, Vincent P. Federico, Arash Sayari
Contemporary Spine Surgery.2025; 26(8): 1. CrossRef
The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions
Areesha Moiz, Kristian B. Filion, Michael A. Tsoukas, Oriana H.Y. Yu, Tricia M. Peters, Mark J. Eisenberg
eClinicalMedicine.2025; 86: 103363. CrossRef
The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP‐1 Agonists: A Literature Review
Jimmy Wen, Ubaid Ansari, Mouhamad Shehabat, Zaid Ansari, Burhaan Syed, Adam Razick, Daniel Razick, Muzammil Akhtar, Eldo Frezza
Journal of Diabetes.2025;[Epub] CrossRef
Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024
Amrutha S Alibilli, Vidur Jain, Heran Mane, Xiaohe Yue, Alexandria Ratzki-Leewing, Junaid S Merchant, Shaniece Criss, Quynh C Nguyen, Rozalina G McCoy, Thu T Nguyen
JMIR Infodemiology.2025; 5: e73619. CrossRef
Effects of Blood-Glucose Lowering Therapies on Body Composition and Muscle Outcomes in Type 2 Diabetes: A Narrative Review
Ioana Bujdei-Tebeică, Doina Andrada Mihai, Anca Mihaela Pantea-Stoian, Simona Diana Ștefan, Claudiu Stoicescu, Cristian Serafinceanu
Medicina.2025; 61(8): 1399. CrossRef
Discovery of pan-EphB tyrosine kinase inhibitor for metabolic syndrome sparing EphB3 signaling in mice
Syed Tareq, Heba A. Ewida, Sumaih Zoubi, Harrison Benson, Dhavalkumar Patel, Hanin Diab, Souvik Patra, Daniela Redrovan, Ehsan Nozohouri, Taysa Berivan Bassani, Alisson Campos Cardoso, Kofi Frimpong-Manson, Lida Khodavirdilou, Md Tareq Aziz, Jenny L. Wilk
Pharmacological Research.2025; 219: 107900. CrossRef
Mortality Risk of Sarcopenia and Malnutrition in Older Patients with Type 2 Diabetes Mellitus
Shinta Yamamoto, Yoshitaka Hashimoto, Fuyuko Takahashi, Ryosuke Sakai, Yuto Saijo, Chihiro Munekawa, Hanako Nakajima, Noriyuki Kitagawa, Rieko Nakatani, Takafumi Osaka, Hiroshi Okada, Naoko Nakanishi, Saori Majima, Emi Ushigome, Masahide Hamaguchi, Michia
Nutrients.2025; 17(16): 2622. CrossRef
Glucagon-like peptide-1 receptor agonists and muscle mass effects
Alexandr Ceasovschih, Andreea Asaftei, Maria Giovanna Lupo, Stanislav Kotlyarov, Hana Bartušková, Anastasia Balta, Victorita Sorodoc, Laurentiu Sorodoc, Maciej Banach
Pharmacological Research.2025; 220: 107927. CrossRef
Cardiometabolic and renal benefits of sodium–glucose cotransporter 2 inhibitors
Yong-ho Lee, Soo Lim, Melanie J. Davies
Nature Reviews Endocrinology.2025; 21(12): 783. CrossRef
The Pharmacist's Role in the Use of Incretin‐Based Therapies for Weight Management: An Opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy
Sara Lingow, Nicholas Carris, Jennifer Clements, Lindsay Courtney, Abby Lennon, Christina H. Sherrill, Elizabeth Van Dril
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2025; 8(10): 1078. CrossRef
KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the inhibition of MASH progression
Xueqin lu, Shengjun Wang, Yanchun Du, Bixian Xie, Qingyan Chen, Jinzhen Lin, Bailing Chen, Kunyuan Cui, Hanbing Li,
PLOS One.2025; 20(9): e0331768. CrossRef
GLP-1 receptor agonists and sarcopenia: Weight loss at a cost? A brief narrative review
Dimitrios Pantazopoulos, Evanthia Gouveri, Dimitrios Papazoglou, Nikolaos Papanas
Diabetes Research and Clinical Practice.2025; 229: 112924. CrossRef
Frailty and Effects of Semaglutide in Obesity-Related HFpEF
Ambarish Pandey, Dalane W. Kitzman, Khaja M. Chinnakondepalli, Shachi Patel, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Sanjiv J. Shah, Subodh Verma, Cecilia Rönnbäck, Anne Domdey, Karoline Liisberg, Morten Schou, Eduardo Perna, Fozia Z. Ahmed, Mi
JACC: Heart Failure.2025; 13(10): 102610. CrossRef
Cannabis improves metabolic dysfunction and macrophage signatures in obese mice
Brandon N. VanderVeen, Thomas D. Cardaci, Christian A. Unger, Mitchell M. NeSmith, Jeffrey C. Freeman, Arianna V. Bastian, Kasie Roark, Mansi Upadhyay, Andrew G. Levy, Brooke M. Bullard, Sierra J. McDonald, Kandy T. Velázquez, Reilly T. Enos, Jason L. Kub
American Journal of Physiology-Cell Physiology.2025; 329(4): C1316. CrossRef
Thermogenic Targets for Obesity Management in the Era of Incretin-Based Therapies
Sahar Soliman, Rebecca Andrews-Dickert, Petra Rocic, Mihail Mitov
Pharmaceuticals.2025; 18(10): 1519. CrossRef
Agonistes du récepteur du GLP-1 et sarcopénie : question émergente ou véritable enjeu clinique ?
Serge Halimi
Médecine des Maladies Métaboliques.2025; 19(8): 593. CrossRef
Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatment
Ainhoa González-Luis, Vicente Llinares-Arvelo, Carlos E Martínez-Alberto, Carolina Hernández-Carballo, Carmen Mora-Fernández, Juan F Navarro-González, Javier Donate-Correa
European Journal of Endocrinology.2025; 193(5): R31. CrossRef
Effects of Semaglutide in Obesity-Related Heart Failure with Preserved Ejection Fraction Across the Age Spectrum: Findings from the STEP-HFpEF Programme
Ambarish Pandey, Michael Moroney, Subodh Verma, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Dalane W. Kitzman, Sanjiv J. Shah, Mark C. Petrie, Cecilia Rönnbäck, Anne Domdey, Søren Rasmussen, Khaja M. Chinnakondepalli, Shachi Patel, Mikhail N. Kosib
European Journal of Heart Failure.2025; 27(11): 2537. CrossRef
Clinician Guidance on the Benefits of Healthy Nutrition and Increased Physical Activity for People With Type 2 Diabetes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation
Pamela Kushner, Carlos Campos, Aaron King, Davida F. Kruger, Javier Morales
Clinical Diabetes.2025; 43(5): 681. CrossRef
Preserving the Metabolic Engine: Muscle as the Therapeutic Target for Cardiovascular Prevention in Obesity Pharmacotherapy
Fabian Sanchis-Gomar, Ian J. Neeland, Pilar Ruiz-Lozano, Osama Alnahar, Fatima Rodriguez
Current Cardiology Reports.2025;[Epub] CrossRef
Sarcopenia and obesity: Two sides of the same coin. Incretin technologies in addressing the problem
T. Yu. Demidova, K. A. Tolmacheva, S. A. Prilepa
FOCUS. Endocrinology.2025; 6(4): 43. CrossRef
Liraglutide Protects Against Diastolic Dysfunction and Improves Ventricular Protein Translation
Cody Rutledge, Angela Enriquez, Kevin Redding, Mabel Lopez, Steven Mullett, Stacy L. Gelhaus, Michael Jurczak, Eric Goetzman, Brett A. Kaufman
Cardiovascular Drugs and Therapy.2024; 38(6): 1289. CrossRef
Drug‐related sarcopenia as a secondary sarcopenia
Masafumi Kuzuya
Geriatrics & Gerontology International.2024; 24(2): 195. CrossRef
Exercise induces tissue-specific adaptations to enhance cardiometabolic health
Stephen P. Ashcroft, Ben Stocks, Brendan Egan, Juleen R. Zierath
Cell Metabolism.2024; 36(2): 278. CrossRef
Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes
Rieko Kanai, Sachiho Kinoshita, Izumi Kanbe, Mariko Sameda, Shuhei Yamaoka, Osamu Horikawa, Yasuhiro Watanabe, Ichiro Tatsuno, Kohji Shirai, Takashi Oshiro, Atsuhito Saiki
Obesity Pillars.2024; 9: 100098. CrossRef
Twenty‐four‐hour physical behaviour profiles across type 2 diabetes mellitus subtypes
Joseph Henson, Aikaterina Tziannou, Alex V. Rowlands, Charlotte L. Edwardson, Andrew P. Hall, Melanie J. Davies, Thomas Yates
Diabetes, Obesity and Metabolism.2024; 26(4): 1355. CrossRef
The Current Landscape of Pharmacotherapies for Sarcopenia
Gulistan Bahat, Serdar Ozkok
Drugs & Aging.2024; 41(2): 83. CrossRef
Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF
ELISSA DRIGGIN, PARAG GOYAL
Journal of Cardiac Failure.2024; 30(4): 610. CrossRef
Is the GLP-1 receptor agonist, semaglutide, a good option for weight loss in persons with HIV?
Daniel Lee, Jacqueline Capeau
AIDS.2024; 38(4): 603. CrossRef
Efficacy and safety of tirzepatide, GLP‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Xin‐Hui Pan, Bryan Tan, Yip Han Chin, Ethan Cheng Zhe Lee, Gwyneth Kong, Bryan Chong, Martin Kueh, Chin Meng Khoo, Anurag Mehta, Priyanka Majety, Gowtham R. Grandhi, Georgios K. Dimitriadis, Roger Foo, Nicholas W. S. Chew, Carel W. Le Roux, Mamas A. Mamas
Obesity.2024; 32(5): 840. CrossRef
Glucagon-Like Peptide-1 Receptor Agonists and Sodium Glucose Cotransporter-2 Inhibitors and Cardiorespiratory Fitness Interaction
David Ni, Peter Kokkinos, Eric S Nylen
Military Medicine.2024; 189(11-12): 2369. CrossRef
Dual and Triple Incretin-Based Co-agonists: Novel Therapeutics for Obesity and Diabetes
Robert M. Gutgesell, Rubén Nogueiras, Matthias H. Tschöp, Timo D. Müller
Diabetes Therapy.2024; 15(5): 1069. CrossRef
GPR75: A Newly Identified Receptor for Targeted Intervention in the Treatment of Obesity and Metabolic Syndrome
Michael L. Fragner, Manish A. Parikh, Kaedrea A. Jackson, Michal Laniado Schwartzman, William H. Frishman, Stephen J. Peterson
Cardiology in Review.2024;[Epub] CrossRef
The effects of myosteatosis on skeletal muscle function in older adults
Kathleen Dondero, Ben Friedman, Julie Rekant, Rian Landers‐Ramos, Odessa Addison
Physiological Reports.2024;[Epub] CrossRef
Preservation of healthy lean body mass and function during weight loss
T. J. Wilkinson, D. Papamargaritis, J. A. King, J. A. Sargeant, C. Sutcliffe, L. A. Baker, S. Taheri, T. Yates, M. J. Davies
Clinical Obesity.2024;[Epub] CrossRef
The novel adrenergic agonist ATR-127 targets skeletal muscle and brown adipose tissue to tackle diabesity and steatohepatitis
Emanuela Talamonti, Jelena Davegardh, Anastasia Kalinovich, Sten M.M. van Beek, Nodi Dehvari, Carina Halleskog, Hamza M. Bokhari, Dana S. Hutchinson, Seungmin Ham, Laura J. Humphrys, Nicola C. Dijon, Aikaterini Motso, Anna Sandstrom, Evelyn Zacharewicz, I
Molecular Metabolism.2024; 85: 101931. CrossRef
Core Trainee Prize Winner: Weight loss drugs: their role and potential future in orthopaedic surgery
Tom Doyle
Bone & Joint 360.2024; 13(3): 12. CrossRef
Challenges and opportunities in the management of type 2 diabetes in patients with lower extremity peripheral artery disease: a tailored diagnosis and treatment review
Guillaume Mahé, Victor Aboyans, Emmanuel Cosson, Kamel Mohammedi, Gabrielle Sarlon-Bartoli, Damien Lanéelle, Tristan Mirault, Patrice Darmon
Cardiovascular Diabetology.2024;[Epub] CrossRef
Changes in lean body mass with glucagon‐like peptide‐1‐based therapies and mitigation strategies
Ian J. Neeland, Jennifer Linge, Andreas L. Birkenfeld
Diabetes, Obesity and Metabolism.2024; 26(S4): 16. CrossRef
Changes in body weight and composition, metabolic parameters, and quality of life in patients with type 2 diabetes treated with subcutaneous semaglutide in real-world clinical practice
Paola Pantanetti, Giovanni Cangelosi, Sara Alberti, Sandra Di Marco, Grazia Michetti, Gianluca Cerasoli, Marco Di Giacinti, Silvia Coacci, Nadia Francucci, Fabio Petrelli, Giuseppe Ambrosio, Roberto Grinta
Frontiers in Endocrinology.2024;[Epub] CrossRef
Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging
Zainab Ridha, Sabrina Guillen Fabi, Raheel Zubair, Steven H Dayan
Aesthetic Surgery Journal.2024; 44(11): NP809. CrossRef
Second Generation Anti-Obesity Medications
Sri Nikhita Chimatapu, Steven D. Mittelman, Vibha Singhal
Current Pediatrics Reports.2024; 12(4): 138. CrossRef
Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus
Oluwaseun Anyiam, Bethan Phillips, Katie Quinn, Daniel Wilkinson, Kenneth Smith, Philip Atherton, Iskandar Idris
Clinical Nutrition.2024; 43(8): 1907. CrossRef
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs
Sandra Christensen, Katie Robinson, Sara Thomas, Dominique R. Williams
Obesity Pillars.2024; 11: 100121. CrossRef
Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss
Jordan Wean, Salisha Baranwal, Nicole Miller, Jae Hoon Shin, Robert W. O'Rourke, Charles F. Burant, Randy J. Seeley, Amy E. Rothberg, Nadejda Bozadjieva-Kramer
Diabetes & Metabolism.2024; 50(5): 101570. CrossRef
The Effects of Imeglimin on Muscle Strength in Patients with Type 2 Diabetes: A Prospective Cohort Study
Takeshi Oyanagi, Shin Kawanabe, Hidekazu Tsukiyama, Ami Nishine, Yuta Nakamura, Tomoko Nakagawa, Mayuko Kanou, Juri Kubota, Shingo Tsunemi, Kenichi Yokota, Masakatsu Sone
Diabetes Therapy.2024; 15(11): 2323. CrossRef
Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes
Lidiya Kukova, Kashif M. Munir, Ahmed Sayeed, Stephen N. Davis
Expert Opinion on Drug Metabolism & Toxicology.2024; 20(10): 939. CrossRef
Sarcopenia
Avan A. Sayer, Rachel Cooper, Hidenori Arai, Peggy M. Cawthon, Marie-Josiane Ntsama Essomba, Roger A. Fielding, Miranda D. Grounds, Miles D. Witham, Alfonso J. Cruz-Jentoft
Nature Reviews Disease Primers.2024;[Epub] CrossRef
Glucagon‐like peptide‐1 receptor agonist‐based agents and weight loss composition: Filling the gaps
Robert L. Dubin, Steven B. Heymsfield, Eric Ravussin, Frank L. Greenway
Diabetes, Obesity and Metabolism.2024; 26(12): 5503. CrossRef
Geriatric Pharmacotherapy Case Series: Medications for Diabetes—A Focus on Secondary Stroke Prevention
Sabrina Warren, Shayla McKee, Erin Yakiwchuk
The Senior Care Pharmacist.2024; 39(10): 350. CrossRef
Effectiveness and Side Effect Incidence in a Real-World Digital Weight-Loss Service Using Compounded Semaglutide: A Retrospective Comparative Study
Louis Talay, Matt Vickers
Obesities.2024; 4(4): 399. CrossRef
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Jennifer Linge, Andreas L. Birkenfeld, Ian J. Neeland
Circulation.2024; 150(16): 1288. CrossRef
Sculpting Success: The Importance of Diet and Physical Activity to Support Skeletal Muscle Health during Weight Loss with New Generation Anti-Obesity Medications
Gregory J Grosicki, Nikhil V Dhurandhar, Jessica L Unick, Shawn M Arent, J Graham Thomas, Holly Lofton, Madelyn C Shepherd, Jessica Kiel, Christopher Coleman, Satya S Jonnalagadda
Current Developments in Nutrition.2024; 8(11): 104486. CrossRef
Malnutrition in patients with obesity: An overview perspective
Cagney Cristancho, Kris M. Mogensen, Malcolm K. Robinson
Nutrition in Clinical Practice.2024; 39(6): 1300. CrossRef
Changes in 24-Hour Urine Chemistry in Patients with Nephrolithiasis during Weight Loss with Glucagon-Like Peptide 1–Based Therapies
Karen Feghali, Xilong Li, Naim M. Maalouf
Kidney360.2024; 5(11): 1706. CrossRef
Nutritional Supplementation to Preserve Healthy Lean Mass and Function During Periods of Pharmacological and Nonpharmacological‐Induced Weight Loss: Protocol for a Systematic Review and Meta‐Analysis
Emily James, Ryan J. Kelsey, Jack A. Sargeant, Joe Henson, Tom Yates, Thomas J. Wilkinson
Health Science Reports.2024;[Epub] CrossRef
Semaglutide Improves Myocardial Perfusion and Performance in a Large Animal Model of Coronary Artery Disease
Christopher R. Stone, Dwight D. Harris, Mark Broadwin, Meghamsh Kanuparthy, Ju-Woo Nho, Keertana Yalamanchili, Jad Hamze, M. Ruhul Abid, Frank W. Sellke
Arteriosclerosis, Thrombosis, and Vascular Biology.2024;[Epub] CrossRef
Spotlight on the Mechanism of Action of Semaglutide
Ilias Papakonstantinou, Konstantinos Tsioufis, Vasiliki Katsi
Current Issues in Molecular Biology.2024; 46(12): 14514. CrossRef
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure
José C. De La Flor, Blanca Coto Morales, Elena Basabe, María Rey Hernandez, Rocío Zamora González-Mariño, Celia Rodríguez Tudero, Irwing Benites Flores, Carlos Espinoza, Michael Cieza Terrones, Secundino Cigarrán Guldris, Jesús Hernández Vaquero
Medicina.2024; 60(12): 2096. CrossRef
Malnutrition in real-world patients hospitalized for heart failure with preserved ejection fraction and its potential impact on generalizability of EMPEROR-Preserved trial
Shinsuke Takeuchi, Takashi Kohno, Ayumi Goda, Yasuyuki Shiraishi, Mike Saji, Yuji Nagatomo, Toshikazu D. Tanaka, Makoto Takei, Shintaro Nakano, Kyoko Soejima, Shun Kohsaka, Tsutomu Yoshikawa
International Journal of Cardiology.2023; 370: 263. CrossRef
Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
Sara Santini, Nathalie Vionnet, Jérôme Pasquier, Elena Gonzalez‐Rodriguez, Montserrat Fraga, Nelly Pitteloud, Lucie Favre
Obesity.2023; 31(1): 74. CrossRef
Early type 2 diabetes treatment intensification with glucagon‐like peptide‐1 receptor agonists in primary care: An Australian perspective on guidelines and the global evidence
Roy Rasalam, Sarah Abdo, Gary Deed, Richard O'Brien, Jane Overland
Diabetes, Obesity and Metabolism.2023; 25(4): 901. CrossRef
The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials
Rishi Jobanputra, Jack A. Sargeant, Abdullah Almaqhawi, Ehtasham Ahmad, Franciskos Arsenyadis, David R. Webb, Louisa Y. Herring, Kamlesh Khunti, Melanie J. Davies, Thomas Yates
Obesity Reviews.2023;[Epub] CrossRef
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial
Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, Jens-Erik B. Jensen, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad
Cardiovascular Diabetology.2023;[Epub] CrossRef
Impact of novel glucose‐lowering therapies on physical function in people with type 2 diabetes: A systematic review and meta‐analysis of randomised placebo‐controlled trials
Ehtasham Ahmad, Franciskos Arsenyadis, Abdullah Almaqhawi, Mary Barker, Rishi Jobanputra, Jack A. Sargeant, David R. Webb, Thomas Yates, Melanie J. Davies
Diabetic Medicine.2023;[Epub] CrossRef
Cancer cachexia as a blueprint for treating obesity
Nikolai P. Jaschke, Tilman D. Rachner
Trends in Endocrinology & Metabolism.2023; 34(7): 395. CrossRef
The sun is rising on a new era of pharmacotherapy for obesity: some words of caution
Peter N. Benotti, Bruce R. Bistrian
Surgery for Obesity and Related Diseases.2023; 19(9): 1075. CrossRef
Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Sha Zhang, Zhan Qi, Yidong Wang, Danfei Song, Deqiu Zhu
Frontiers in Endocrinology.2023;[Epub] CrossRef
Cysteine‐lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose‐finding study
Kathrine J. Vinknes, Thomas Olsen, Hasse Khiabani Zaré, Nasser E. Bastani, Emma Stolt, Anja F. Dahl, Roger D. Cox, Helga Refsum, Kjetil Retterstøl, Anders Åsberg, Amany Elshorbagy
Diabetes, Obesity and Metabolism.2023; 25(11): 3161. CrossRef
Repurposing Drugs for Diabetes Mellitus as Potential Pharmacological Treatments for Sarcopenia – A Narrative Review
Miles D. Witham, Antoneta Granic, Ewan Pearson, Sian M. Robinson, Avan A. Sayer
Drugs & Aging.2023; 40(8): 703. CrossRef
Introduction to the dietary management of obesity in adults
Vivian Lee
Clinical Medicine.2023; 23(4): 304. CrossRef
Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial (EMPA‐ELDERLY)
Daisuke Yabe, Kosuke Shiki, Gosuke Homma, Thomas Meinicke, Yuji Ogura, Yutaka Seino
Diabetes, Obesity and Metabolism.2023; 25(12): 3538. CrossRef
Independent Link Between Use of Mineralocorticoid Receptor Antagonists and Muscle Wasting in Heart Failure Patients Not Receiving Renin-Angiotensin System Inhibitors
Ryo Numazawa, Satoshi Katano, Toshiyuki Yano, Ryohei Nagaoka, Katsuhiko Ohori, Hidemichi Kouzu, Suguru Honma, Yusuke Fujisawa, Kotaro Yamano, Arata Osanami, Masayuki Koyama, Akiyoshi Hashimoto, Masato Furuhashi
Circulation Journal.2023; 88(1): 10. CrossRef
Sodium-glucose co-transporter 2 inhibitors and Sarcopenia: A controversy that must be solved
Baris Afsar, Rengin Elsurer Afsar
Clinical Nutrition.2023; 42(12): 2338. CrossRef
Oral semaglutide improves body composition and preserves lean mass in patients with type 2 diabetes: a 26-week prospective real-life study
Sara Volpe, Giuseppe Lisco, Margherita Fanelli, Davide Racaniello, Valentina Colaianni, Valentina Lavarra, Domenico Triggiani, Lucilla Crudele, Vincenzo Triggiani, Carlo Sabbà, Giovanni De Pergola, Giuseppina Piazzolla
Frontiers in Endocrinology.2023;[Epub] CrossRef
The Effects of Sodium–Glucose Cotransporter 2 Inhibitors on Body Composition in Type 2 Diabetes Mellitus: A Narrative Review
Soodeh Jahangiri, Mojtaba Malek, Sanjay Kalra, Mohammad E. Khamseh
Diabetes Therapy.2023; 14(12): 2015. CrossRef
Relationship between sodium–glucose cotransporter-2 inhibitors and muscle atrophy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Chengdong Xia, Yufeng Han, Chunhui Yin, Ruyue Geng, Zhenfei Liu, Yongle Du, Mingkun Yu
Frontiers in Endocrinology.2023;[Epub] CrossRef
The Role of Lifestyle Modification with Second-Generation Anti-obesity Medications: Comparisons, Questions, and Clinical Opportunities
Thomas A. Wadden, Ariana M. Chao, Molly Moore, Jena S. Tronieri, Adam Gilden, Anastassia Amaro, Sharon Leonard, John M. Jakicic
Current Obesity Reports.2023; 12(4): 453. CrossRef
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Giuseppe Lisco, Olga Eugenia Disoteo, Anna De Tullio, Vincenzo De Geronimo, Vito Angelo Giagulli, Fabio Monzani, Emilio Jirillo, Renato Cozzi, Edoardo Guastamacchia, Giovanni De Pergola, Vincenzo Triggiani
Nutrients.2023; 16(1): 63. CrossRef
Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis
Sabine Kahl, Jennifer Pützer, Michael Roden
Seminars in Liver Disease.2022; 42(01): 048. CrossRef
Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial
Yu Hoshika, Yoshiaki Kubota, Kosuke Mozawa, Shuhei Tara, Yukichi Tokita, Kenji Yodogawa, Yu-Ki Iwasaki, Takeshi Yamamoto, Hitoshi Takano, Yayoi Tsukada, Kuniya Asai, Masaaki Miyamoto, Yasushi Miyauchi, Eitaro Kodani, Mitsunori Maruyama, Jun Tanabe, Wataru
Journal of Cardiac Failure.2022; 28(1): 56. CrossRef
Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats
Shohei Yamada, Yuji Ogura, Kazuho Inoue, Jun Tanabe, Takeshi Sugaya, Keiichi Ohata, Yoshio Nagai, Yasunori Natsuki, Seiko Hoshino, Shiika Watanabe, Daisuke Ichikawa, Kenjiro Kimura, Yugo Shibagaki, Atsuko Kamijo-Ikemori
Molecular and Cellular Endocrinology.2022; 539: 111472. CrossRef
Exendin-4 alleviates steatosis in an in vitro cell model by lowering FABP1 and FOXA1 expression via the Wnt/-catenin signaling pathway
Olfa Khalifa, Neyla S. AL-Akl, Khaoula Errafii, Abdelilah Arredouani
Scientific Reports.2022;[Epub] CrossRef
Body composition changes at 12 months following different surgical weight loss interventions in adults with obesity: A systematic review and meta‐analysis of randomized control trials
Amy Sylivris, Jakub Mesinovic, David Scott, Paul Jansons
Obesity Reviews.2022;[Epub] CrossRef
Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: final results of a 3-year post-marketing surveillance study
Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Hristo Lliev, Atsutaka Yasui
Expert Opinion on Drug Safety.2022; 21(10): 1315. CrossRef
Safety and effectiveness of empagliflozin according to body mass index in Japanese patients with type 2 diabetes: a subgroup analysis of a 3-year post-marketing surveillance study
Kohei Kaku, Kazuhiro Yamamoto, Yumiko Fukushima, Seiko Mizuno, Daisuke Nitta
Expert Opinion on Drug Safety.2022; 21(11): 1411. CrossRef
Le risque de dénutrition chez le sujet âgé diabétique : une limite à l’utilisation des « nouvelles » classes thérapeutiques ?
Lyse Bordier, Jean Doucet, Bernard Bauduceau
Médecine des Maladies Métaboliques.2022; 16(5): 422. CrossRef
Emerging evidence of the relationship between fat-free mass and ghrelin, glucagon-like peptide-1, and peptide-YY
Austin J. Graybeal, Jada L. Willis, Elisa Morales-Marroquin, Grant M. Tinsley, Sarah E. Messiah, Meena Shah
Nutrition.2022; 103-104: 111815. CrossRef
The Effectiveness of GLP-1 Receptor Agonist Semaglutide on Body Composition in Elderly Obese Diabetic Patients: A Pilot Study
Yoshinori Ozeki, Takayuki Masaki, Akari Kamata, Shotaro Miyamoto, Yuichi Yoshida, Mitsuhiro Okamoto, Koro Gotoh, Hirotaka Shibata
Medicines.2022; 9(9): 47. CrossRef
Distribution of lean mass and mortality risk in patients with type 2 diabetes
Li Ding, Yuxin Fan, Jingting Qiao, Jing He, Ruodan Wang, Qing He, Jingqiu Cui, Zhongshu Ma, Fangqiu Zheng, Hua Gao, Chenlin Dai, Hongyan Wei, Jun Li, Yuming Cao, Gang Hu, Ming Liu
Primary Care Diabetes.2022; 16(6): 824. CrossRef
Cardio-sarcopenia: A syndrome of concern in aging
De Rong Loh, Ru-San Tan, Wee Shiong Lim, Angela S. Koh
Frontiers in Medicine.2022;[Epub] CrossRef
Type 2 diabetes
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, David R Webb, Melanie J Davies
The Lancet.2022; 400(10365): 1803. CrossRef
Elevated circulating level of β-aminoisobutyric acid (BAIBA) in heart failure patients with type 2 diabetes receiving sodium-glucose cotransporter 2 inhibitors
Satoshi Katano, Toshiyuki Yano, Hidemichi Kouzu, Ryohei Nagaoka, Ryo Numazawa, Kotaro Yamano, Yusuke Fujisawa, Katsuhiko Ohori, Nobutaka Nagano, Takefumi Fujito, Ryo Nishikawa, Wataru Ohwada, Masaki Katayose, Tatsuya Sato, Atsushi Kuno, Masato Furuhashi
Cardiovascular Diabetology.2022;[Epub] CrossRef
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia
Guilherme Wesley Peixoto Da Fonseca, Stephan von Haehling
Expert Opinion on Pharmacotherapy.2021; 22(7): 889. CrossRef
Liraglutide Does Not Adversely Impact Fat‐Free Mass Loss
Andrew Grannell, William P. Martin, Babak Dehestani, Werd Al‐Najim, John C. Murphy, Carel W. le Roux
Obesity.2021; 29(3): 529. CrossRef
Rationale and design of the EMPA-ELDERLY trial: a randomised, double-blind, placebo-controlled, 52-week clinical trial of the efficacy and safety of the sodium–glucose cotransporter-2 inhibitor empagliflozin in elderly Japanese patients with type 2 diabet
Daisuke Yabe, Kosuke Shiki, Keiko Suzaki, Thomas Meinicke, Yutaro Kotobuki, Kenichiro Nishida, Douglas Clark, Atsutaka Yasui, Yutaka Seino
BMJ Open.2021; 11(4): e045844. CrossRef
Cancer Risk in Normal Weight Individuals with Metabolic Obesity: A Narrative Review
Bethina Liu, Hugh E. Giffney, Rhonda S. Arthur, Thomas E. Rohan, Andrew J. Dannenberg
Cancer Prevention Research.2021; 14(5): 509. CrossRef
Comprehensive analysis of LncRNAs expression profiles in an in vitro model of steatosis treated with Exendin-4
Khaoula Errafii, Neyla S. Al-Akl, Olfa Khalifa, Abdelilah Arredouani
Journal of Translational Medicine.2021;[Epub] CrossRef
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus
Vaneza Lira W. Wolf, Ikaro Breder, Luiz Sérgio F. de Carvalho, Alexandre A. S. Soares, Riobaldo M. Cintra, Joaquim Barreto, Daniel B. Munhoz, Sheila T. Kimura-Medorima, Wilson Nadruz, Gil Guerra-Júnior, Thiago Quinaglia, Elza Muscelli, Andrei C. Sposito
Nutrition & Diabetes.2021;[Epub] CrossRef
Optimising the Heart Failure Treatment Pathway: The Role of SGLT2 Inhibitors
Marc Evans, Angharad R. Morgan, Zaheer Yousef, Gethin Ellis, Umesh Dashora, Dipesh C. Patel, Pam Brown, Wasim Hanif, Johnathan N. Townend, Naresh Kanumilli, Jim Moore, John P. H. Wilding, Stephen C. Bain
Drugs.2021; 81(11): 1243. CrossRef
Glucose-lowering Drugs and Hospitalization for Heart Failure: A Systematic Review and Additive-effects Network Meta-analysis With More Than 500 000 Patient-years
Riobaldo M Cintra, Ana Claudia Nogueira, Isabella Bonilha, Beatriz M Luchiari, Otavio R Coelho-Filho, Otavio R Coelho, Pedro Schwartzmann, Elza Muscellie, Wilson Nadruz, Luiz Sergio F Carvalho, Andrei C Sposito
The Journal of Clinical Endocrinology & Metabolism.2021; 106(10): 3060. CrossRef
Physical activity and exercise in the management of type 2 diabetes: where to start?
Deirdre Harrington, Joe Henson
Practical Diabetes.2021; 38(5): 35. CrossRef
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes

New England Journal of Medicine.2021; 385(22): 2105. CrossRef
Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
Satoshi Ida, Ryutaro Kaneko, Kanako Imataka, Kaoru Okubo, Yoshitaka Shirakura, Kentaro Azuma, Ryoko Fujiwara, Kazuya Murata
Current Diabetes Reviews.2021; 17(3): 293. CrossRef
Relationship between serum bilirubin concentration and sarcopenia in patients with type 2 diabetes: a cross-sectional study
Chuan Wang, Chen Jin, Xiaofei Yin, Jidong Liu, Jinbo Liu
Journal of International Medical Research.2021;[Epub] CrossRef
Effects of liraglutide and empagliflozin added to insulin therapy in patients with type 2 diabetes: A randomized controlled study
Hirotatsu Nakaguchi, Yoshinobu Kondo, Mayu Kyohara, Hiromi Konishi, Koji Oiwa, Yasuo Terauchi
Journal of Diabetes Investigation.2020; 11(6): 1542. CrossRef
Sodium Glucose Co-Transporter 2 Inhibition Does Not Favorably Modify the Physiological Responses to Dietary Counselling in Diabetes-Free, Sedentary Overweight and Obese Adult Humans
Shane P.P. Ryan, Alissa A. Newman, Jessie R. Wilburn, Lauren D. Rhoades, S. Raj J. Trikha, Ellen C. Godwin, Hayden M. Schoenberg, Micah L. Battson, Taylor R. Ewell, Gary J. Luckasen, Laurie M. Biela, Christopher L. Melby, Christopher Bell
Nutrients.2020; 12(2): 510. CrossRef
GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report
Eva W. Iepsen, Christian T. Have, Simon Veedfald, Sten Madsbad, Jens J. Holst, Niels Grarup, Oluf Pedersen, Ivan Brandslund, Jens-Christian Holm, Torben Hansen, Signe S. Torekov
Cell Reports Medicine.2020; 1(1): 100006. CrossRef
Glucagon‐like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle
Haitham Abdulla, Bethan E. Phillips, Daniel J. Wilkinson, Marie Limb, Tereza Jandova, Joseph J. Bass, Debbie Rankin, Jessica Cegielski, Mariwan Sayda, Hannah Crossland, John P. Williams, Kenneth Smith, Iskandar Idris, Philip J. Atherton
Aging Cell.2020;[Epub] CrossRef

Obesity and Metabolism
Myths about Insulin Resistance: Tribute to Gerald Reaven: Sun H. Kim, Fahim Abbasi; Endocrinol Metab. 2019;34(1):47-52. Published online March 21, 2019; DOI: https://doi.org/10.3803/EnM.2019.34.1.47

12,075 View
189 Download
3 Web of Science
4 Crossref

Abstract PDF PubReader ePub

Gerald Reaven was often called the “father of insulin resistance.” On the 1-year anniversary of his death in 2018, we challenge three myths associated with insulin resistance: metformin improves insulin resistance; measurement of waist circumference predicts insulin resistance better than body mass index; and insulin resistance causes weight gain. In this review, we highlight Reaven's relevant research that helped to dispel these myths associated with insulin resistance.

Citations

Citations to this article as recorded by

Assessment of Antidiabetic and Anti-Inflammatory Activities of Carissa carandas Linn Extract: In Vitro and In Vivo Study
Manaschanok Lailerd, Thiri Wai Linn, Narissara Lailerd, Duangporn Amornlerdpison, Arisa Imsumran
Applied Sciences.2023; 13(11): 6454. CrossRef
Association of primary allostatic load mediators and metabolic syndrome (MetS): A systematic review
Francis Osei, Andrea Block, Pia-Maria Wippert
Frontiers in Endocrinology.2022;[Epub] CrossRef
Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study
Seyyed Saeed Moazzeni, Seyed Saeed Tamehri Zadeh, Samaneh Asgari, Fereidoun Azizi, Farzad Hadaegh
Diabetology & Metabolic Syndrome.2021;[Epub] CrossRef
Metabolic Syndrome or Insulin Resistance: Evolution, Controversies and Association With Cardiovascular Disease Risk
Arun K. Chopra
Indian Journal of Clinical Cardiology.2020; 1(2): 77. CrossRef

Miscellaneous
Search for Novel Mutational Targets in Human Endocrine Diseases: So Young Park, Myeong Han Seo, Sihoon Lee; Endocrinol Metab. 2019;34(1):23-28. Published online March 21, 2019; DOI: https://doi.org/10.3803/EnM.2019.34.1.23

6,838 View
97 Download
1 Web of Science
1 Crossref

Abstract PDF PubReader ePub

The identification of disease-causing genetic variations is an important goal in the field of genetics. Advancements in genetic technology have changed scientific knowledge and made it possible to determine the basic mechanism and pathogenesis of human disorders rapidly. Many endocrine disorders are caused by genetic variations of a single gene or by mixed genetic factors. Various genetic testing methods are currently available, enabling a more precise diagnosis of many endocrine disorders and facilitating the development of a concrete therapeutic plan. In this review article, we discuss genetic testing technologies for genetic endocrine disorders, with relevant examples. We additionally describe our research on implementing genetic analysis strategies to identify novel causal mutations in hypocalcemia-related disorders.

Citations

Citations to this article as recorded by

EndoGene database: reported genetic variants for 5,926 Russian patients diagnosed with endocrine disorders
Anton A. Buzdin, Marianna A. Zolotovskaia, Sergey A. Roumiantsev, Aleksandra G. Emelyanova, Olga O. Golounina, Polina A. Pugacheva, Daniil V. Luppov, Anastasia V. Kuzminyh, Arseniya O. Alexeeva, Anna A. Emelianova, Alexey L. Novoselov, Alina Matrosova, An
Frontiers in Endocrinology.2025;[Epub] CrossRef

Namgok Lecture 2018

Thyroid
Genomic Characterization of Differentiated Thyroid Carcinoma: Young Shin Song, Young Joo Park; Endocrinol Metab. 2019;34(1):1-10. Published online March 21, 2019; DOI: https://doi.org/10.3803/EnM.2019.34.1.1

12,575 View
311 Download
48 Web of Science
49 Crossref

Abstract PDF PubReader ePub

Since the release of The Cancer Genome Atlas study of papillary thyroid carcinoma (PTC) in 2014, additional genomic studies of differentiated thyroid carcinoma (DTC) using massively-parallel sequencing (MPS) have been published. Recent advances in MPS technology have started to provide important insights into the molecular pathogenesis of DTC. In the genomic landscape, the most recurrently altered genes in DTC, which has a low mutational burden relative to other cancers, are BRAF, RAS, and fusion genes. Some novel driver candidates also have been identified. The frequency of these genomic alterations varies across the subtypes of DTC (classical PTC, follicular variant of PTC, and follicular thyroid carcinoma). Telomerase reverse transcriptase (TERT) promoter mutations are the alteration that makes the most important contribution to the progression of DTC. In the transcriptomic landscape, DTC can be classified according to its gene expression profile, and each subtype has a distinct mutational profile, intracellular signaling output, and clinicopathological characteristics. Herein, we review the results of genomic studies using MPS technology, and describe the types and frequencies of genomic alterations according to histological classifications of DTC and the characteristics and significance of the gene expression signatures of DTC.

Citations

Citations to this article as recorded by

Paradigm Transformation of Precision Management of Thyroid Cancer
樱袁
Advances in Clinical Medicine.2026; 16(02): 2361. CrossRef
Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer after prior vascular endothelial growth factor receptor-targeted therapy (COSMIC-311): outcomes by BRAF status
Marcia S. Brose, Bhumsuk Keam, Jolanta Krajewska, Ana O. Hoff, Fernanda Vaisman, Chia-Chi Lin, Erika Hitre, Daniel W. Bowles, Bruce Robinson, Steven I. Sherman, Nuttapong Ngamphaiboon, Xiang Guo, Andrew Simmons, Denise Williamson, Svetlana Andrianova, Nic
Frontiers in Oncology.2026;[Epub] CrossRef
Diagnostic value of thyroglobulin levels in fine-needle aspiration for evaluating metastatic cervical lymph nodes in papillary thyroid cancer
Song song Fan, Hai yan Xu
Irish Journal of Medical Science (1971 -).2026;[Epub] CrossRef
MAX phase coatings: synthesis, protective performance, and functional characteristics
Guanshui Ma, Anfeng Zhang, Zhenyu Wang, Kaihang Wang, Jiayue Zhang, Kaixuan Xu, Yuxi Xu, Shenghao Zhou, Aiying Wang
Materials Horizons.2025; 12(6): 1689. CrossRef
Detection of PTEN Mutations in Fine Needle Aspiration Biopsies of Indeterminate Thyroid Nodules: Impact on Diagnosis and Prognosis
Lauren E. Schlegel, Madelaine Brill‐Edwards, Zi‐Xuan Wang, Christopher McNair, Stacey Gargano, Elizabeth Cottrill
Head & Neck.2025; 47(8): 2145. CrossRef
Molecular alteration patterns predict tumor behavior in papillary thyroid carcinoma independent of tumor size: insights from an international multicenter retrospective study
Grégoire B. Morand, Idit Tessler, Simon E. Thurnheer, Kayla E. Payne, Maxine Noik, Josh Krasner, Tzahi Yamin, Marc P. Pusztaszeri, Richard J. Payne, Galit Avior
Thyroid Research.2025;[Epub] CrossRef
High RAS Allele Frequency Signals Increased Risk of TERT Promoter Mutations in Thyroid Tumors
Coralie Lefebvre, Hannah Greenspoon, Kayla E. Payne, Emily Steinberg, Felicia Tewfik, Gianluca Savoia, Sabrina Daniela da Silva, Marc Pusztaszeri, Véronique-Isabelle Forest, Richard J. Payne
Cancers.2025; 17(17): 2851. CrossRef
Evaluation of common genetic risk factors for differentiated thyroid cancer in the Thai population
Patra Yeetong, Aunchalee Laipiriyakun, Jiraporn Sriprapaporn, Surasawadee Ausavarat
Biomedical Reports.2025; 23(4): 1. CrossRef
Comprehensive analysis of the papillary thyroid carcinoma identifies CSGALNACT1 as a proliferation driver and prognostic biomarker
Yu Zhao, Juan Zhang, Yong Yao, Linna Yu
Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef
Homologous Recombination in Thyroid Tumor Samples
Liudmila V. Spirina, Matvey M. Tsyganov, Svetlana Yu. Chizhevskaya, Natalia V. Tarasenko, Veronika A. Bogdanova
International Journal of Molecular Sciences.2025; 26(19): 9716. CrossRef
Pathological point of view on the atomic bomb-related solid cancers
Masahiro Nakashima, Hirokazu Kurohama, Yuko Akazawa
Carcinogenesis.2025;[Epub] CrossRef
Radiation-Related Thyroid Cancer
Vladimir Saenko, Norisato Mitsutake
Endocrine Reviews.2024; 45(1): 1. CrossRef
TERT RNAscope analysis of sub-centimetric papillary thyroid carcinomas and synchronous lymph node metastases
Marie-Lisa Eich, Wiebke Jeske, Uschi Zenz, Costanza Chiapponi, Christina Alidousty, Sabine Merkelbach-Bruse, Reinhard Büttner, Anne M. Schultheis
Thyroid Research.2024;[Epub] CrossRef
Small Multi-Gene DNA Panel Can Aid in Reducing the Surgical Resection Rate and Predicting the Malignancy Risk of Thyroid Nodules
Moon Young Oh, Hye-Mi Choi, Jinsun Jang, Heejun Son, Seung Shin Park, Minchul Song, Yoo Hyung Kim, Sun Wook Cho, Young Jun Chai, Woosung Chung, Young Joo Park
Endocrinology and Metabolism.2024; 39(5): 777. CrossRef
IX. Chemotherapy Therapy for Thyroid Cancer
Tomoko Yamazaki
Nihon Naika Gakkai Zasshi.2024; 113(4): 668. CrossRef
Molecular testing in fine‐needle aspiration of thyroid nodules
Valarie McMurtry, Sule Canberk, Georgios Deftereos
Diagnostic Cytopathology.2023; 51(1): 36. CrossRef
A Triumvirate:
Jaylou M. Velez Torres, Youley Tjendra, Darcy A. Kerr
Surgical Pathology Clinics.2023; 16(1): 1. CrossRef
Current Status and Prospects of Chemotherapy in Treatment of Distant Metastatic or Recurrent Thyroid Cancer
T. Yamazaki
Nihon Kikan Shokudoka Gakkai Kaiho.2023; 74(2): 141. CrossRef
FDG uptake reflects an immune‐enriched subtype of thyroid cancer: Clinical implications of imaging‐based molecular characterization
Hoon Young Suh, Hongyoon Choi, Sun Wook Cho, Jin Chul Paeng, Gi Jeong Cheon, Young Joo Park, Keon Wook Kang
Cancer Medicine.2023; 12(16): 17068. CrossRef
Advances in transcriptomics and proteomics in differentiated thyroid cancer: An updated perspective (Review)
Shici Yang, Gaohong Zhu, Rui He, Dong Fang, Jiaojiao Feng
Oncology Letters.2023;[Epub] CrossRef
Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
Jinsun Lim, Han Sai Lee, Jiyun Park, Kyung-Soo Kim, Soo-Kyung Kim, Yong-Wook Cho, Young Shin Song
Endocrinology and Metabolism.2023; 38(4): 445. CrossRef
Anaplastic thyroid cancer: Pathogenesis, prognostic factors and genetic landscape (Review)
Abdul-Mohsen Alhejaily, Omar Alhuzim, Yazeed Alwelaie
Molecular and Clinical Oncology.2023;[Epub] CrossRef
Comparative Analysis of Driver Mutations and Transcriptomes in Papillary Thyroid Cancer by Region of Residence in South Korea
Jandee Lee, Seonhyang Jeong, Hwa Young Lee, Sunmi Park, Meesson Jeong, Young Suk Jo
Endocrinology and Metabolism.2023; 38(6): 720. CrossRef
Problems of follicular thyroid carcinoma diagnostics
S. E. Titov, S. A. Lukyanov, S. V. Sergiyko, Yu. A. Veryaskina, T. E. Ilyina, E. S. Kozorezov, S. L. Vorobyov
Head and neck tumors (HNT).2023; 13(3): 10. CrossRef
Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies
María San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa
Cancer Treatment Reviews.2022; 105: 102372. CrossRef
Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid Cancer With Papillary Histology
Myat Han Soe, Janet M Chiang, Robert R Flavell, Elham Khanafshar, Laura Mendoza, Hyunseok Kang, Chienying Liu
The Journal of Clinical Endocrinology & Metabolism.2022; 107(8): e3206. CrossRef
Recent Improvements in the Treatment of High-Risk Thyroid Cancer
Eun Kyung Lee
Korean Society for Head and Neck Oncology.2022; 38(1): 1. CrossRef
Prognosis of Patients with 1–4 cm Papillary Thyroid Cancer Who Underwent Lobectomy: Focus on Gross Extrathyroidal Extension Invading Only the Strap Muscles
Ahreum Jang, Meihua Jin, Won Woong Kim, Min Ji Jeon, Tae-Yon Sung, Dong Eun Song, Tae Yong Kim, Ki-Wook Chung, Won Bae Kim, Young Kee Shong, Yu-Mi Lee, Won Gu Kim
Annals of Surgical Oncology.2022; 29(12): 7835. CrossRef
Tackling Thyroid Cancer in Europe—The Challenges and Opportunities
Denis Horgan, Dagmar Führer-Sakel, Paula Soares, Clara V. Alvarez, Laura Fugazzola, Romana T. Netea-Maier, Barbara Jarzab, Marta Kozaric, Beate Bartes, James Schuster-Bruce, Luigino Dal Maso, Martin Schlumberger, Furio Pacini
Healthcare.2022; 10(9): 1621. CrossRef
The role of EZH1 and EZH2 in development and cancer
Soo Hyun Lee, Yingying Li, Hanbyeol Kim, Seounghyun Eum, Kyumin Park, Chul-Hwan Lee
BMB Reports.2022; 55(12): 595. CrossRef
The mutation profile of differentiated thyroid cancer coexisting with undifferentiated anaplastic cancer resembles that of anaplastic thyroid cancer but not that of archetypal differentiated thyroid cancer
Justyna Mika, Wojciech Łabaj, Mykola Chekan, Agata Abramowicz, Monika Pietrowska, Andrzej Polański, Piotr Widłak
Journal of Applied Genetics.2021; 62(1): 115. CrossRef
Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer
Ying Wang, Zhigang Hu, Weiyuan Ma, Yong Niu, Jingwei Su, Lingxiang Zhang, Pengxin Zhao
Investigational New Drugs.2021; 39(3): 764. CrossRef
Thyroid Cancer Identified After Positron Emission Tomography (PET) Shows Aggressive Histopathology
Tim Beck, Ning Zhang, Akeesha Shah, Sarah Khoncarly, Christopher McHenry, Judy Jin
Journal of Surgical Research.2021; 260: 245. CrossRef
Associations between artificial light at night and risk for thyroid cancer: A large US cohort study
Dong Zhang, Rena R. Jones, Peter James, Cari M. Kitahara, Qian Xiao
Cancer.2021; 127(9): 1448. CrossRef
Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study (Endocrinol Metab 2020;35:925-32, Chaiho Jeong et al.)
Chaiho Jeong, Jeonghoon Ha, Moo Il Kang
Endocrinology and Metabolism.2021; 36(1): 205. CrossRef
Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine
Antonio Ieni, Roberto Vita, Cristina Pizzimenti, Salvatore Benvenga, Giovanni Tuccari
Journal of Personalized Medicine.2021; 11(5): 333. CrossRef
Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis
Yan Liu, Gen Chen, Bo Wang, Hanjin Wu, Yi Zhang, Hui Ye
Endocrine Journal.2021; 68(6): 713. CrossRef
Multiparametric Photoacoustic Analysis of Human Thyroid Cancers In Vivo
Jeesu Kim, Byullee Park, Jeonghoon Ha, Idan Steinberg, Sarah M. Hooper, Chaiho Jeong, Eun-Yeong Park, Wonseok Choi, Tie Liang, Ja Seong Bae, Ravi Managuli, Yongmin Kim, Sanjiv S. Gambhir, Dong-Jun Lim, Chulhong Kim
Cancer Research.2021; 81(18): 4849. CrossRef
Thyroid Cancer Risk Factors in Children with Thyroid Nodules: A One-Center Study
Iwona Ben-Skowronek, Joanna Sieniawska, Emilia Pach, Wiktoria Wrobel, Anna Skowronek, Zaklina Tomczyk, Anna Mlodawska, Magdalena Makuch, Magdalena Malka, Czeslaw Cielecki, Pawel Nachulewicz
Journal of Clinical Medicine.2021; 10(19): 4455. CrossRef
Can We Predict Differentiated Thyroid Cancer Behavior? Role of Genetic and Molecular Markers
Rita Niciporuka, Jurijs Nazarovs, Arturs Ozolins, Zenons Narbuts, Edvins Miklasevics, Janis Gardovskis
Medicina.2021; 57(10): 1131. CrossRef
Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers
Seong-Keun Yoo, Young Shin Song, Young Joo Park, Jeong-Sun Seo
Endocrinology and Metabolism.2020; 35(1): 44. CrossRef
Genomic and Transcriptomic Characteristics According to Size of Papillary Thyroid Microcarcinoma
Young Shin Song, Byung-Hee Kang, Seungbok Lee, Seong-Keun Yoo, Young Sik Choi, Jungsun Park, Dong Yoon Park, Kyu Eun Lee, Jeong-Sun Seo, Young Joo Park
Cancers.2020; 12(5): 1345. CrossRef
Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Diagnostic updates and molecular advances
Ying-Hsia Chu, Peter M. Sadow
Seminars in Diagnostic Pathology.2020; 37(5): 213. CrossRef
Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy
María San Román Gil, Javier Pozas, Javier Molina-Cerrillo, Joaquín Gómez, Héctor Pian, Miguel Pozas, Alfredo Carrato, Enrique Grande, Teresa Alonso-Gordoa
International Journal of Molecular Sciences.2020; 21(14): 4951. CrossRef
DNA FISH Diagnostic Assay on Cytological Samples of Thyroid Follicular Neoplasms
Philippe Vielh, Zsofia Balogh, Voichita Suciu, Catherine Richon, Bastien Job, Guillaume Meurice, Alexander Valent, Ludovic Lacroix, Virginie Marty, Nelly Motte, Philippe Dessen, Bernard Caillou, Abir Ghuzlan, Jean-Michel Bidart, Vladimir Lazar, Paul Hofma
Cancers.2020; 12(9): 2529. CrossRef
Mechanisms of TERT Reactivation and Its Interaction with BRAFV600E
Young Shin Song, Young Joo Park
Endocrinology and Metabolism.2020; 35(3): 515. CrossRef
Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China
Yuntao Song, Guohui Xu, Tonghui Ma, Yanli Zhu, Hao Yu, Wenbin Yu, Wei Wei, Tianxiao Wang, Bin Zhang
Cancer Medicine.2020; 9(22): 8397. CrossRef
Thyroid Cancer and Circadian Clock Disruption
Roberta Malaguarnera, Caterina Ledda, Agnese Filippello, Francesco Frasca, Vincenzo Cristian Francavilla, Tiziana Ramaci, Maria Chiara Parisi, Venerando Rapisarda, Salvatore Piro
Cancers.2020; 12(11): 3109. CrossRef
Molecular testing approaches in thyroid cancer diagnosis
Abdul-Mohsen Gaeth AlHejaily, Naji Jamil AlJohani
Journal of Biochemical and Clinical Genetics.2020; 3(2): 77. CrossRef

Original Articles

Miscellaneous
Effects of Serum Albumin, Calcium Levels, Cancer Stage and Performance Status on Weight Loss in Parathyroid Hormone-Related Peptide Positive or Negative Patients with Cancer: Ji-Yeon Lee, Namki Hong, Hye Ryun Kim, Byung Wan Lee, Eun Seok Kang, Bong-Soo Cha, Yong-ho Lee; Endocrinol Metab. 2018;33(1):97-104. Published online March 21, 2018; DOI: https://doi.org/10.3803/EnM.2018.33.1.97

8,236 View
51 Download
10 Web of Science
8 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background

A recent animal study showed that parathyroid hormone-related peptide (PTHrP) is associated with cancer cachexia by promoting adipose tissue browning, and we previously demonstrated that PTHrP predicts weight loss (WL) in patients with cancer. In this study, we investigated whether prediction of WL by PTHrP is influenced by clinical factors such as serum albumin, corrected calcium levels, cancer stage, and performance status (PS).

Methods

A cohort of 219 patients with cancer whose PTHrP level was measured was enrolled and followed for body weight (BW) changes. Subjects were divided into two groups by serum albumin (cutoff value, 3.7 g/dL), corrected calcium (cutoff value, 10.5 mg/dL), cancer stage (stage 1 to 3 or 4), or PS (Eastern Cooperative Oncology Group 0 to 1 or 2 to 4), respectively. Clinically significant WL was defined as either percent of BW change (% BW) <−5% or % BW <−2% plus body mass index (BMI) <20 kg/m².

Results

After a median follow-up of 327 days, 74 patients (33.8%) experienced clinically significant WL. A positive PTHrP level was associated with a 2-fold increased risk of WL after adjusting for age, baseline BMI, serum albumin, corrected calcium level, cancer stage, and PS. The effect of PTHrP on WL remained significant in patients with low serum albumin, stage 4 cancer, and good PS. Regardless of calcium level, the effect of PTHrP on WL was maintained, although there was an additive effect of higher calcium and PTHrP levels.

Conclusion

Early recognition of patients with advanced cancer who are PTHrP positive with hypercalcemia or hypoalbuminemia is needed for their clinical management.

Citations

Citations to this article as recorded by

Targeting of HIF2-driven cachexia in kidney cancer
Muhannad Abu-Remaileh, Laura A. Stransky, Nikita Bhalerao, Nitin H. Shirole, Qinqin Jiang, Eddy Saad, Marc Machaalani, Sean M. Vigeant, Hilina Woldemichael, Charles Xu, Jing Lu, Hairong Wei, Zhihong Liu, William Sun, Kei Enomoto, Toni K. Choueiri, Jason R
Nature Medicine.2026; 32(1): 245. CrossRef
Cancer knocks you out by fasting: Cachexia as a consequence of metabolic alterations in cancer
Salvatore Cortellino, Margherita D'Angelo, Massimiliano Quintiliani, Antonio Giordano
Journal of Cellular Physiology.2025;[Epub] CrossRef
Can Patients with Electrolyte Disturbances Be Safely and Effectively Treated in a Hospital-at-Home, Telemedicine-Controlled Environment? A Retrospective Analysis of 267 Patients
Cohn May, Gueron Or, Segal Gad, Zubli Daniel, Hakim Hila, Fizdel Boris, Liber Pninit, Amir Hadar, Barkai Galia
Journal of Clinical Medicine.2024; 13(5): 1409. CrossRef
Parathyroid hormone related protein (PTHrP) in patients with pancreatic carcinoma and overt signs of disease progression and host tissue wasting
Britt-Marie Iresjö, Serkan Kir, Kent Lundholm
Translational Oncology.2023; 36: 101752. CrossRef
Development and Characterization of a Cancer Cachexia Rat Model Transplanted with Cells of the Rat Lung Adenocarcinoma Cell Line Sato Lung Cancer (SLC)
Eiji Kasumi, Miku Chiba, Yoshie Kuzumaki, Hiroyuki Kuzuoka, Norifumi Sato, Banyu Takahashi
Biomedicines.2023; 11(10): 2824. CrossRef
Role of Parathyroid Hormone and Parathyroid Hormone-Related Protein in Protein-Energy Malnutrition
Praopilad Srisuwarn, Sinee Disthabanchong
Frontiers in Bioscience-Landmark.2023;[Epub] CrossRef
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia
Bahar Zehra Camurdanoglu Weber, Samet Agca, Aylin Domaniku, Sevval Nur Bilgic, Dilsad H. Arabaci, Serkan Kir
Journal of Cachexia, Sarcopenia and Muscle.2022; 13(3): 1582. CrossRef
Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia
Bahar Zehra Camurdanoglu Weber, Dilsad H. Arabaci, Serkan Kir
Frontiers in Oncology.2022;[Epub] CrossRef

Clinical Study
Leu72Met and Other Intronic Polymorphisms in the GHRL and GHSR Genes Are Not Associated with Type 2 Diabetes Mellitus, Insulin Resistance, or Serum Ghrelin Levels in a Saudi Population: Faris Elbahi Joatar, Ali Ahmed Al Qarni, Muhalab E. Ali, Abdulaziz Al Masaud, Abdirashid M. Shire, Nagalla Das, Khalid Gumaa, Hayder A. Giha; Endocrinol Metab. 2017;32(3):360-369. Published online September 18, 2017; DOI: https://doi.org/10.3803/EnM.2017.32.3.360

7,526 View
51 Download
9 Web of Science
14 Crossref

Abstract PDF PubReader

Background

Ghrelin (GHRL), a gastric peptide encoded by the GHRL gene, is known to be involved in energy homeostasis via its G protein receptor, encoded by the growth hormone secretagogue receptor (GHSR) gene. Some studies have shown associations between plasma GHRL levels and GHRL single-nucleotide polymorphisms (SNPs), namely the Leu72Met polymorphism (rs696217 TG), with type 2 diabetes mellitus (T2DM) and insulin resistance (IR), while others have not. The controversies in these associations raise the issue of ‘which SNPs in which populations.’ The aim of this study was to investigate whether SNPs in GHRL and/or GHSR genes were associated with T2DM, IR, or plasma GHRL levels among Arab Saudis.

Methods

Blood was collected from 208 Saudi subjects with (n=107) and without (n=101) T2DM. DNA samples from these subjects were analyzed by real-time polymerase chain reaction to genotype five intronic SNPs in the GHRL (rs696217 TG, rs27647 CT, rs2075356 CT, and rs4684677 AT) and GHSR (rs509030 GC) genes. In addition, plasma GHRL levels were measured by a radioimmunoassay.

Results

None of the SNPs were associated with T2DM, IR, or plasma GHRL levels. The frequencies of the alleles, genotypes, and haplotypes of the five SNPs were comparable between the T2DM patients and the non-diabetic subjects. A large number of the GHRL haplotypes indicates the molecular heterogeneity of the preproghrelin gene in this region.

Conclusion

Neither the Leu72Met polymorphism nor the other intronic GHRL and GHSR SNPs were associated with T2DM, IR, or GHRL levels. Further investigations should be carried out to explain the molecular basis of the association of the GHRL peptide with T2DM and IR.

Citations

Citations to this article as recorded by

Polikistik Over Sendromlu Kadınlarda Plazma Açilli Ghrelin Düzeylerine GHRL rs696217 Gen Polimorfizminin Etkisi
Dilek Kaya Akyüzlü, Selin Özkan Kotiloğlu, Mukaddes Asena Yıldırım, Ceylan Bal, Gamze Gök, Raziye Desdicioğlu, Ayşe Filiz Yavuz
Akdeniz Medical Journal.2026;[Epub] CrossRef
Exploring the Role of Metabolic Hormones in Amyotrophic Lateral Sclerosis
Anca Moțățăianu, Ion Bogdan Mănescu, Georgiana Șerban, Laura Bărcuțean, Valentin Ion, Rodica Bălașa, Sebastian Andone
International Journal of Molecular Sciences.2024; 25(10): 5059. CrossRef
Relationship between single nucleotide polymorphism studies in ghrelin gene with obesity subjects
May Salem Al-Nbaheen
Journal of King Saud University - Science.2023; 35(1): 102393. CrossRef
Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
Monika Buraczynska, Jakub Golacki, Wojciech Zaluska
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 557. CrossRef
Асоціації варіантів гена GHRL із розвитком ожиріння та метаболічних порушень у дітей
A. Abaturov, A. Nikulina
CHILD`S HEALTH.2023; 18(4): 255. CrossRef
Effect of the GHRL gene (rs696217) polymorphism on the metabolic disorders in patients with obesity in the Ukrainian population
Andrii Prodan, Ihor Dzubanovsky, Oleksandr Kamyshnyi, Natalia Melnyk, Stepan Grytsenko, Stanislava Voloshyn
Endocrine Regulations.2023; 57(1): 173. CrossRef
Impact of gene polymorphism of glutathione S-transferase and ghrelin as a risk factor in Egyptian women with gestational diabetes mellitus
Mai M. Madkour, Afaf M. El-Said, Abd El-Aziz A. El-Refaey, Abd El-Aziz F. Abd El-Aziz, Fardous F. El-Senduny
Egyptian Journal of Medical Human Genetics.2022;[Epub] CrossRef
Association of obesity in T2DM with differential polymorphism of ghrelin, growth hormone secretagogue receptor-1 and telomeres maintenance genes
Hayder A. Giha, Faris E. Joatar, Dhuha M. B. AlDehaini, Zainab H. A. Malalla, Muhalab E. Ali, Ali A. Al Qarni
Hormone Molecular Biology and Clinical Investigation.2022; 43(3): 297. CrossRef
Investigation of GHRL (rs4684677), FTO (rs8044769) and PGC1Α (rs8192678) polymorphisms in type 2 diabetic Turkish population
Osman Oğuz, Arezoo Gheybi, Zeliha Doğan, Feray Akbaş, Ümit Zeybek, Arzu Ergen
Turkish Journal of Biochemistry.2022; 47(5): 564. CrossRef
Grelin ve Grelin Reseptörü Polimorfizmlerinin Tip 2 Diyabetle İlişkisi
Esma SELÇUK, Uğur ŞAHİN, Didem ÖZKAHRAMAN, Mustafa CALAPOĞLU, Nilüfer ŞAHİN CALAPOĞLU
Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi.2022; 13(2): 218. CrossRef
Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Javed Iqbal Wani, Zia Ul Sabah, Mohammed Jeelani, Vijaya Marakala, Shahzada Khalid Sohail, Mohamed O’haj, Muffarah Hamid Alharthi, Mohannad Mohammad S. Alamri
Journal of Personalized Medicine.2022; 12(5): 735. CrossRef
Variation analysis of Ghrelin gene in Chinese patients with obesity, having polycystic ovarian syndrome
Xiaomeng Wang, Fengxiang Qu, Chunlian Wang, Yan Wang, Dan Wang, Min Zhao, Xiangbing Yun, Qingmei Zheng, Lin Xu
Gynecological Endocrinology.2020; 36(7): 594. CrossRef
The flavonoid baicalin improves glucose metabolism by targeting the PH domain of AKT and activating AKT/GSK3β phosphorylation
Shengnan Yang, Yuan Zhang, Fukui Shen, Xiaoyao Ma, Man Zhang, Yuanyuan Hou, Gang Bai
FEBS Letters.2019; 593(2): 175. CrossRef
Ethnicity-Specific Association Between Ghrelin Leu72Met Polymorphism and Type 2 Diabetes Mellitus Susceptibility: An Updated Meta-Analysis
Rong Huang, Sai Tian, Rongrong Cai, Jie Sun, Yanjue Shen, Shaohua Wang
Frontiers in Genetics.2018;[Epub] CrossRef

Association between Body Weight Changes and Menstrual Irregularity: The Korea National Health and Nutrition Examination Survey 2010 to 2012: Kyung Min Ko, Kyungdo Han, Youn Jee Chung, Kun-Ho Yoon, Yong Gyu Park, Seung-Hwan Lee; Endocrinol Metab. 2017;32(2):248-256. Published online June 23, 2017; DOI: https://doi.org/10.3803/EnM.2017.32.2.248

19,800 View
99 Download
16 Web of Science
18 Crossref

Abstract PDF PubReader

Background

Menstrual irregularity is an indicator of endocrine disorders and reproductive health status. It is associated with various diseases and medical conditions, including obesity and underweight. We aimed to assess the association between body weight changes and menstrual irregularity in Korean women.

Methods

A total of 4,621 women 19 to 54 years of age who participated in the 2010 to 2012 Korea National Health and Nutrition Examination Survey were included in this study. Self-reported questionnaires were used to collect medical information assessing menstrual health status and body weight changes. Odds ratios (ORs) and 95% confidence interval (CI) were calculated to evaluate the association between body weight changes and menstrual irregularity.

Results

Significantly higher ORs (95% CI) were observed in the association between menstrual irregularity and both weight loss (OR, 1.74; 95% CI, 1.22 to 2.48) and weight gain (OR, 1.45; 95% CI, 1.13 to 1.86) after adjusting for age, body mass index, current smoking, heavy alcohol drinking, regular exercise, calorie intake, education, income, metabolic syndrome, age of menarche, parity, and stress perception. Of note, significant associations were only observed in subjects with obesity and abdominal obesity, but not in non-obese or non-abdominally obese subjects. U-shaped patterns were demonstrated in both obese and abdominally obese subjects, indicating that greater changes in body weight are associated with higher odds of menstrual irregularity.

Conclusion

We found a U-shaped pattern of association between body weight changes and menstrual irregularity among obese women in the general Korean population. This result indicates that not only proper weight management but also changes in body weight may influence the regulation of the menstrual cycle.

Citations

Citations to this article as recorded by

Within-individual changes in BMI and menstrual irregularity: a cohort study using real-world data
Shiori Itoi, Makiko Sampei, Takayuki Tatsumi, Risa Ishida, Gentaro Izumi, Yutaka Osuga, Kaori Koga, Satoshi Narumi, Naho Morisaki
BMC Women's Health.2026;[Epub] CrossRef
Prevalence and Risk Factors of Menstrual Disorders in Korean Women
Ye-Lin Kim, Jun Young Chang, Suejin Kim, Mira Yoon, Jae-Na Ha, Kang Hyun Um, Boeun Lee, Kyoung Sook Jeong
Healthcare.2025; 13(6): 606. CrossRef
Metabolic hormones are integral regulators of female reproductive health and function
Faria Athar, Muskan Karmani, Nicole M. Templeman
Bioscience Reports.2024;[Epub] CrossRef
Lifestyle changes and Nutrition in Polycystic Ovarian Disorder: A Holistic Review
Archita Tiwari, Arti Verma, Shrishti Mishra, Bharat Mishra
International Journal of Current Innovations in Advanced Research.2024; : 1. CrossRef
Efficacy Confirmation Test of Black Cumin (Nigella sativa L.) Seeds Extract Using a High-Fat Diet Mouse Model
Khawaja Muhammad Imran Bashir, Joo Wan Kim, Jong-Kyu Kim, Yoon-Seok Chun, Jae-Suk Choi, Sae-Kwang Ku
Metabolites.2023; 13(4): 501. CrossRef
Body mass index, menstruation, acne, and hirsutism of polycystic ovary syndrome in women: A cross-sectional study
Jung-Hee Kim, Oksoo Kim, Heeja Jung, Yanghee Pang, Hyunju Dan
Health Care for Women International.2022; 43(1-3): 85. CrossRef
A cross-sectional study on prevalence of menstrual problems, lifestyle, mental health, and PCOS awareness among rural and urban population of Punjab, India
Priya Sharma, Mandeep Kaur, Sachin Kumar, Preeti Khetarpal
Journal of Psychosomatic Obstetrics & Gynecology.2022; 43(3): 349. CrossRef
The global pandemic and changes in women’s reproductive health: an observational study
Liya Haile, Niels van de Roemer, Kristina Gemzell-Danielsson, Josep Perelló Capó, Iñaki Lete Lasa, Silvia Vannuccini, Martin C. Koch, Thomas Hildebrandt, Joaquim Calaf
The European Journal of Contraception & Reproductive Health Care.2022; 27(2): 102. CrossRef
A STUDY TO ESTABLISH RELATIONSHIP BETWEEN VARIOUS FACTORS WITH MENSTRUAL IRREGULARITY AMONG RURAL WOMEN IN BHOPAL DISTRICT, MADHYA PRADESH
Shweta Singh, Avadhesh Diwakar
INDIAN JOURNAL OF APPLIED RESEARCH.2022; : 5. CrossRef
The effects of obesity on the menstrual cycle
Khalida Itriyeva
Current Problems in Pediatric and Adolescent Health Care.2022; 52(8): 101241. CrossRef
The association between obesity and weight loss after bariatric surgery on the vaginal microbiota
Olivia Raglan, David A. MacIntyre, Anita Mitra, Yun S. Lee, Ann Smith, Nada Assi, Jaya Nautiyal, Sanjay Purkayastha, Marc J. Gunter, Hani Gabra, Julian R. Marchesi, Phillip R. Bennett, Maria Kyrgiou
Microbiome.2021;[Epub] CrossRef
Do women with HIV/AIDS on anti-retroviral therapy have a lower incidence of symptoms associated with menstrual dysfunction?
Nicola Tempest, Damitha N Edirisinghe, Steven Lane, Dharani K Hapangama
European Journal of Obstetrics & Gynecology and Reproductive Biology.2021; 265: 137. CrossRef
Influence of overweight and obesity on the development of reproductive disorders in women
O.S. Payenok
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(7): 575. CrossRef
Quality of Life of Pharmacy Students with Polycystic Ovarian Syndrome in South India: A Cross-Sectional Study

Makara Journal of Health Research.2021;[Epub] CrossRef
Diabetes: a metabolic and reproductive disorder in women
Eleanor P Thong, Ethel Codner, Joop S E Laven, Helena Teede
The Lancet Diabetes & Endocrinology.2020; 8(2): 134. CrossRef
Menstrual Cycle Length in Women Ages 20-30 years in Makassar
Andi Asmawati Azis, N Kurnia, Hartati, Andi Bida Purnamasari
Journal of Physics: Conference Series.2018; 1028: 012019. CrossRef
Body Weight Changes in Obese Women and Menstruation
Jung Hee Kim
Endocrinology and Metabolism.2017; 32(2): 219. CrossRef
Nutritional Counseling Promotes Changes in the Dietary Habits of Overweight and Obese Adolescents with Polycystic Ovary Syndrome
Adriana Lúcia Carolo, Maria Célia Mendes, Ana Carolina Japur de Sá Rosa e Silva, Carolina Sales Vieira, Marcos Felipe Silva de Sá, Rui Alberto Ferriani, Rosana Maria dos Reis
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics.2017; 39(12): 692. CrossRef

Intermuscular Adipose Tissue Content and Intramyocellular Lipid Fatty Acid Saturation Are Associated with Glucose Homeostasis in Middle-Aged and Older Adults: Jung Eun Kim, Keagan Dunville, Junjie Li, Ji Xin Cheng, Travis B. Conley, Cortni S. Couture, Wayne W. Campbell; Endocrinol Metab. 2017;32(2):257-264. Published online May 29, 2017; DOI: https://doi.org/10.3803/EnM.2017.32.2.257

9,000 View
75 Download
29 Web of Science
24 Crossref

Abstract PDF Supplementary Material PubReader

Background

Insulin resistance is associated with the higher content of intermuscular adipose tissue (IMAT) and the saturation of intramyocellular lipid (IMCL), but a paucity of data exist in humans. This study examined associations among IMAT content, IMCL saturation, and fasting glucose concentration in middle-aged and older adults with overweight or obesity.

Methods

Seventy-five subjects (26 males, 49 females) were recruited and thigh muscle and IMAT were assessed using magnetic resonance imaging. Vastus lateralis tissue was acquired from a subset of nine subjects and IMCL content and saturation were assessed using nonlinear dual complex microscopy.

Results

The characteristics of the 75 subjects were as follows: age 59±11 years, body mass index 30±5 kg/m², fasting glucose concentration 5.2±0.5 mmol/L, fasting insulin concentration 12.2±7.3 µU/mL, fasting homeostatic model assessment of insulin resistance (HOMA-IR) 2.9±2.0 (mean±SD). IMAT to muscle tissue (MT) volume ratio was positively associated with the saturated fatty acid to unsaturated fatty acid ratio in IMCL. IMAT:MT was positively associated with fasting glucose concentration and HOMA-IR. IMCL saturation was positively associated with fasting glucose concentration while muscle cell area, IMCL area, and % IMCL in muscle cell were not associated with fasting glucose concentration.

Conclusion

These results indicate that higher intermuscular fat content and IMCL saturation may impact fasting glucose concentration in middle-aged and older adults with overweight or obesity. The centralization of adipose tissue in the appendicular region of the body may promote insulin resistance.

Citations

Citations to this article as recorded by

The important role of fatty infiltration of skeletal muscle in aging: skeletal muscle function, pathological mechanisms, and intervention
Mei Yang, Fangli Zhou, Cui Wang, Ting Sun, Wanyu Zhao, Lu Liu, Yang Meng, Li Tian
American Journal of Physiology-Endocrinology and Metabolism.2026; 330(3): E309. CrossRef
Skeletal muscle and MASLD: Mechanistic and clinical insights
Thomas Marjot, Matthew J. Armstrong, Jonathan G. Stine
Hepatology Communications.2025;[Epub] CrossRef
Intermuscular adipose tissue and muscle function in patients on maintenance hemodialysis
R. Gulsah Dilaver, Mert Demirci, Rachelle Crescenzi, Michael Pridmore, Lale A. Ertuglu, Andrew Guide, Robert Greevy, Baback Roshanravan, T. Alp Ikizler, Jorge L. Gamboa
Physiological Reports.2025;[Epub] CrossRef
Impact of Abdominal and Thigh Intermuscular Adipose Tissue on Glucose and Cardiometabolic Risk in Adults With Obesity
Alba Camacho-Cardenosa, Antonio Clavero-Jimeno, Alessandro Gatti, Manuel Dote-Montero, Mara Concepción, Víctor Manuel Alfaro-Magallanes, Juan J Martin-Olmedo, Rafael Cabeza, Fernando Idoate, José L Martín-Rodríguez, Patricia V García Pérez, Manuel Muñoz-T
The Journal of Clinical Endocrinology & Metabolism.2025; 111(1): 24. CrossRef
Abdominal skeletal muscle quality and quantity are independently and jointly associated with cardiometabolic health in children
Emiliano Miranda-Ferrua, Cristina Cadenas-Sanchez, María Medrano, Jonatan R. Ruiz, Fernando Idoate, Maddi Osés, Mara Concepción, Rafael Cabeza, Idoia Labayen
International Journal of Obesity.2025; 49(12): 2511. CrossRef
Intramuscular adipose tissue: from progenitor to pathology
Hailey G. Jones, Daniel Kopinke, Gretchen A. Meyer
American Journal of Physiology-Cell Physiology.2025; 329(4): C1268. CrossRef
Intermuscular adipose tissue in healthy human aging—effects of exercise training and implications to metabolic health
Andrew M. Alexander, Lucy M. Fitzgibbons, Hawley E. Kunz, Zinnarky K. Ortiz Correa, K. Sreekumaran Nair, John Port, Ian R. Lanza
Journal of Applied Physiology.2025; 139(5): 1300. CrossRef
Muscle Imaging Assessments in Sarcopenia: A Statement from China National Center for Orthopedics (NCO) and the East Meets West Action Group of the European Calcified Tissue Society (ECTS)
Ling Wang, Shuai Lu, Jiahua Feng, Kairui Ma, Fangfang Duan, Renxian Wang, Xiaoguang Cheng, Yajun Liu, Yuuki Imai, Hailing Chen, Claus-C. Glüer, Giuseppe Guglielmi, Annegreet G. Vlug, Jianmin Liu, Klaus Engelke, Mei Li, Marc Sim, Salvatore Minisola, Xieyua
Calcified Tissue International.2025;[Epub] CrossRef
Reliability of ultrasound measurements of muscle thickness and echointensity in older adults with type 2 diabetes
Kirsten E. Bell, Michael T. Paris, Maryia Samuel, Marina Mourtzakis
WFUMB Ultrasound Open.2024; 2(1): 100032. CrossRef
Precision MRI phenotyping of muscle volume and quality at a population scale
Marjola Thanaj, Nicolas Basty, Brandon Whitcher, Elena P. Sorokin, Yi Liu, Ramprakash Srinivasan, Madeleine Cule, E. Louise Thomas, Jimmy D. Bell
Frontiers in Physiology.2024;[Epub] CrossRef
Impaired skeletal muscle regeneration in diabetes: From cellular and molecular mechanisms to novel treatments
Ever Espino-Gonzalez, Emilie Dalbram, Rémi Mounier, Julien Gondin, Jean Farup, Niels Jessen, Jonas T. Treebak
Cell Metabolism.2024; 36(6): 1204. CrossRef
Association of daily carbohydrate intake with intermuscular adipose tissue in Korean individuals with obesity: a cross-sectional study
Ha-Neul Choi, Young-Seol Kim, Jung-Eun Yim
Nutrition Research and Practice.2024; 18(1): 78. CrossRef
Fibro-adipogenic progenitors in physiological adipogenesis and intermuscular adipose tissue remodeling
Marcelo Flores-Opazo, Daniel Kopinke, Françoise Helmbacher, Rodrigo Fernández-Verdejo, Mauro Tuñón-Suárez, Gordon S. Lynch, Osvaldo Contreras
Molecular Aspects of Medicine.2024; 97: 101277. CrossRef
Intermuscular adipose tissue in metabolic disease
Bret H. Goodpaster, Bryan C. Bergman, Andrea M. Brennan, Lauren M. Sparks
Nature Reviews Endocrinology.2023; 19(5): 285. CrossRef
Muscle function and architecture in children with juvenile idiopathic arthritis
Pierre Bourdier, Anthony Birat, Emmanuelle Rochette, Éric Doré, Daniel Courteix, Frédéric Dutheil, Bruno Pereira, Sébastien Ratel, Etienne Merlin, Pascale Duché
Acta Paediatrica.2021; 110(1): 280. CrossRef
NLRP3 Inflammasome: Potential Role in Obesity Related Low-Grade Inflammation and Insulin Resistance in Skeletal Muscle
Gonzalo Jorquera, Javier Russell, Matías Monsalves-Álvarez, Gonzalo Cruz, Denisse Valladares-Ide, Carla Basualto-Alarcón, Genaro Barrientos, Manuel Estrada, Paola Llanos
International Journal of Molecular Sciences.2021; 22(6): 3254. CrossRef
Intermuscular Fat Content in Young Chinese Men With Newly Diagnosed Type 2 Diabetes: Based on MR mDIXON-Quant Quantitative Technique
Fuyao Yu, Bing He, Li Chen, Fengzhe Wang, Haidong Zhu, Yanbin Dong, Shinong Pan
Frontiers in Endocrinology.2021;[Epub] CrossRef
A Valid and Precise Semiautomated Method for Quantifying Intermuscular Fat Intramuscular Fat in Lower Leg Magnetic Resonance Images
Andy K.O. Wong, Eva Szabo, Marta Erlandson, Marshall S. Sussman, Sravani Duggina, Anny Song, Shannon Reitsma, Hana Gillick, Jonathan D. Adachi, Angela M. Cheung
Journal of Clinical Densitometry.2020; 23(4): 611. CrossRef
Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait, Laura J. den Hartigh
Frontiers in Cardiovascular Medicine.2020;[Epub] CrossRef
Effects of weight loss during a very low carbohydrate diet on specific adipose tissue depots and insulin sensitivity in older adults with obesity: a randomized clinical trial
Amy M Goss, Barbara Gower, Taraneh Soleymani, Mariah Stewart, May Pendergrass, Mark Lockhart, Olivia Krantz, Shima Dowla, Nikki Bush, Valene Garr Barry, Kevin R. Fontaine
Nutrition & Metabolism.2020;[Epub] CrossRef
Local In Vivo Measures of Muscle Lipid and Oxygen Consumption Change in Response to Combined Vitamin D Repletion and Aerobic Training in Older Adults
D. Thomas, David Schnell, Maja Redzic, Mingjun Zhao, Hideat Abraha, Danielle Jones, Howard Brim, Guoqiang Yu
Nutrients.2019; 11(4): 930. CrossRef
Impact of different ectopic fat depots on cardiovascular and metabolic diseases
Daniele Ferrara, Fabrizio Montecucco, Franco Dallegri, Federico Carbone
Journal of Cellular Physiology.2019; 234(12): 21630. CrossRef
Differential Relationship between Intermuscular Adipose Depots with Indices of Cardiometabolic Health
Robert E. Bergia, Jung Eun Kim, Wayne W. Campbell
International Journal of Endocrinology.2018; 2018: 1. CrossRef
Association of sarcopenic obesity predicted by anthropometric measurements and 24-y all-cause mortality in elderly men: The Kuakini Honolulu Heart Program
Kiyoshi Sanada, Randi Chen, Bradley Willcox, Tomoyuki Ohara, Aida Wen, Cody Takenaka, Kamal Masaki
Nutrition.2018; 46: 97. CrossRef

Association of Plasma Ghrelin Levels with Insulin Resistance in Type 2 Diabetes Mellitus among Saudi Subjects: Ali Ahmed Al Qarni, Faris Elbahi Joatar, Nagalla Das, Mohamed Awad, Mona Eltayeb, Ahmed Gasim Al-Zubair, Muhalab E. Ali, Abdulaziz Al Masaud, Abdirashid M. Shire, Khalid Gumaa, Hayder A. Giha; Endocrinol Metab. 2017;32(2):230-240. Published online May 29, 2017; DOI: https://doi.org/10.3803/EnM.2017.32.2.230

9,364 View
79 Download
22 Web of Science
21 Crossref

Abstract PDF PubReader

Background

Although the exact mechanism of insulin resistance (IR) has not yet been established, IR is the hallmark characteristic of type 2 diabetes mellitus (T2DM). The aim of this study was to examine the relationship between plasma ghrelin levels and IR in Saudi subjects with T2DM.

Methods

Patients with T2DM (n=107, cases) and non-diabetic apparently healthy subjects (n=101, controls) from Saudi Arabia were included in this study. The biochemical profiles and plasma insulin levels of all subjects were analyzed, and IR was estimated using the homeostatic model assessment of insulin resistance (HOMA-IR) index. Active ghrelin levels in plasma were measured using the radioimmunoassay technique.

Results

Only 46.7% (50 of 107) of the T2DM subjects had IR, including 26% (28 of 107) with severe IR (HOMA-IR ≥5), while 5.9% (six of 101) of the controls had moderate IR (3 ≤HOMA-IR <5). HOMA-IR values were not associated with age, disease duration, or gender. Importantly, T2DM itself and the co-occurrence of IR with T2DM were significantly associated with low plasma ghrelin levels. However, ghrelin levels were inversely correlated with the HOMA-IR index, body weight, and fasting plasma insulin levels, mainly in the control subjects, which was indicative of the breakdown of metabolic homeostasis in T2DM.

Conclusion

The prevalence of IR was relatively low, and IR may be inversely associated with plasma ghrelin levels among Saudi patients with T2DM.

Citations

Citations to this article as recorded by

Ghrelin levels and changes in eating behaviour in the early stages of obesity-related chronic kidney disease
N.V. Gubina, V.H. Mishchuk, I.H. Kupnovytska
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2025; 21(6): 599. CrossRef
Leu72Met Polymorphism in Ghrelin Gene: A Potential Risk Factor for Hypertension in Type 2 Diabetes Patients
Monika Buraczynska, Jakub Golacki, Wojciech Zaluska
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 557. CrossRef
Hormonal and metabolic profiles of obese and nonobese type 2 diabetes patients: implications of plasma insulin, ghrelin, and vitamin D levels
Hayder A. Giha, Dhuha M. B. AlDehaini, Faris E. Joatar, Muhalab E. Ali, Einas M. Al-Harbi, Ali A. Al Qarni
Cardiovascular Endocrinology & Metabolism.2022;[Epub] CrossRef
Association of obesity in T2DM with differential polymorphism of ghrelin, growth hormone secretagogue receptor-1 and telomeres maintenance genes
Hayder A. Giha, Faris E. Joatar, Dhuha M. B. AlDehaini, Zainab H. A. Malalla, Muhalab E. Ali, Ali A. Al Qarni
Hormone Molecular Biology and Clinical Investigation.2022; 43(3): 297. CrossRef
TLR4 mutation protects neurovascular function and cognitive decline in high-fat diet-fed mice
Nathalie Obadia, Giulia Andrade, Marina Leardini-Tristão, Letícia Albuquerque, Celina Garcia, Flavia Lima, Júlio Daleprane, Hugo C. Castro-Faria-Neto, Eduardo Tibiriçá, Vanessa Estato
Journal of Neuroinflammation.2022;[Epub] CrossRef
Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study
Mohammad Muzaffar Mir, Rashid Mir, Mushabab Ayed Abdullah Alghamdi, Javed Iqbal Wani, Zia Ul Sabah, Mohammed Jeelani, Vijaya Marakala, Shahzada Khalid Sohail, Mohamed O’haj, Muffarah Hamid Alharthi, Mohannad Mohammad S. Alamri
Journal of Personalized Medicine.2022; 12(5): 735. CrossRef
C-peptide is a predictor of telomere shortening: A five-year longitudinal study
Racha Ghoussaini, Hani Tamim, Martine Elbejjani, Maha Makki, Lara Nasreddine, Hussain Ismaeel, Mona P. Nasrallah, Nathalie K. Zgheib
Frontiers in Endocrinology.2022;[Epub] CrossRef
Relationship Between Acyl and Desacyl Ghrelin Levels with Insulin Resistance and Body Fat Mass in Type 2 Diabetes Mellitus
Pu Zang, Cui-Hua Yang, Jun Liu, Hai-Yan Lei, Wei Wang, Qing-Yu Guo, Bin Lu, Jia-Qing Shao
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2022; Volume 15: 2763. CrossRef
The Association of Pre-Transplant C-Peptide Level with the Development of Post-Transplant Diabetes: A Cohort Study
Amanda J. Vinson, Aran Thanamayooran, Bryce A. Kiberd, Kenneth West, Ferhan S. Siddiqi, Lakshman Gunaratnam, Karthik K. Tennankore
Kidney360.2022; 3(10): 1738. CrossRef
Secondary analysis of gut hormone data from children with and without in utero exposure to gestational diabetes: Differences in the associations among ghrelin, GLP‐1, and insulin secretion
Ayse G. Zengul, Sarah ET Hoover, Paula C. Chandler‐Laney
Pediatric Obesity.2021;[Epub] CrossRef
The Links of Ghrelin to Incretins, Insulin, Glucagon, and Leptin After Bariatric Surgery
Daria Skuratovskaia, Maria Vulf, Nataliya Chasovskikh, Aleksandra Komar, Elena Kirienkova, Egor Shunkin, Pavel Zatolokin, Larisa Litvinova
Frontiers in Genetics.2021;[Epub] CrossRef
Анализ причин нарушения моторно-эвакуаторной функции желудка у больных с метаболическим синдромом
Сергей Николаевич Чернуха , Ирина Александровна Вильцанюк
Естественные и Технические Науки.2021; (№05): 220. CrossRef
Variation analysis of Ghrelin gene in Chinese patients with obesity, having polycystic ovarian syndrome
Xiaomeng Wang, Fengxiang Qu, Chunlian Wang, Yan Wang, Dan Wang, Min Zhao, Xiangbing Yun, Qingmei Zheng, Lin Xu
Gynecological Endocrinology.2020; 36(7): 594. CrossRef
Leu72Met polymorphism of GHRL gene decreases susceptibility to type 2 diabetes mellitus in a Mexican population
Edgar Alfonso Rivera-León, Mara Anaís Llamas-Covarrubias, Sergio Sánchez-Enríquez, Erika Martínez-López, Mercedes González-Hita, Iris Monserrat Llamas-Covarrubias
BMC Endocrine Disorders.2020;[Epub] CrossRef
Ghrelin Levels and Decreased Kidney Function in Patients with Early Stages of Chronic Kidney Disease Against the Background of Obesity
Nataliia Vasylivna Gubina, Iryna Hryhorivna Kupnovytska, Vasyl Hryhorovych Mishchuk, Halyna Dmytrivna Markiv
Journal of Medicine and Life.2020; 13(4): 530. CrossRef
Ghrelin fiber projections from the hypothalamic arcuate nucleus into the dorsal vagal complex and the regulation of glycolipid metabolism
Manqing Su, Meixing Yan, Yanling Gong
Neuropeptides.2019; 78: 101972. CrossRef
Ghrelin deficiency in patients with type 2 diabetes: the relationships with obesity, adipose tissue dysfunction and glucose variability
V V Klimontov, D M Bulumbaeva, O N Fazullina, N B Orlov, V I Konenkov
Terapevticheskii arkhiv.2019; 91(10): 28. CrossRef
The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis
Cai-Shun Zhang, Liu-Xin Wang, Rui Wang, Yuan Liu, Li-Min Song, Jun-Hua Yuan, Bin Wang, Jing Dong
Frontiers in Physiology.2018;[Epub] CrossRef
Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals
Haseeb A. Khan, Samia H. Sobki, Aishah Ekhzaimy, Isra Khan, Mona A. Almusawi
Saudi Journal of Biological Sciences.2018; 25(8): 1729. CrossRef
Leu72Met and Other Intronic Polymorphisms in theGHRLandGHSRGenes Are Not Associated with Type 2 Diabetes Mellitus, Insulin Resistance, or Serum Ghrelin Levels in a Saudi Population
Faris Elbahi Joatar, Ali Ahmed Al Qarni, Muhalab E. Ali, Abdulaziz Al Masaud, Abdirashid M. Shire, Nagalla Das, Khalid Gumaa, Hayder A. Giha
Endocrinology and Metabolism.2017; 32(3): 360. CrossRef
Expanded Normal Weight Obesity and Insulin Resistance in US Adults of the National Health and Nutrition Examination Survey
Keilah E. Martinez, Larry A. Tucker, Bruce W. Bailey, James D. LeCheminant
Journal of Diabetes Research.2017; 2017: 1. CrossRef

Review Article

Obesity and Metabolism
Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss: Anna Gavrieli, Christos S. Mantzoros; Endocrinol Metab. 2016;31(3):361-372. Published online July 26, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.3.361

9,418 View
60 Download
19 Web of Science
17 Crossref

Abstract PDF PubReader

Excess energy intake, without a compensatory increase of energy expenditure, leads to obesity. Several molecules are involved in energy homeostasis regulation and new ones are being discovered constantly. Appetite regulating hormones such as ghrelin, peptide tyrosine-tyrosine and amylin or incretins such as the gastric inhibitory polypeptide have been studied extensively while other molecules such as fibroblast growth factor 21, chemerin, irisin, secreted frizzle-related protein-4, total bile acids, and heme oxygenase-1 have been linked to energy homeostasis regulation more recently and the specific role of each one of them has not been fully elucidated. This mini review focuses on the above mentioned molecules and discusses them in relation to their regulation by the macronutrient composition of the diet as well as diet-induced weight loss.

Citations

Citations to this article as recorded by

IUPHAR review: From foe to friend: Repurposing glucagon to treat obesity and type 2 diabetes
Andrew J. Elmendorf, Mostafa Yousefian, Il-Man Kim, J. Andrew Hardaway, Kirk Habegger, Jonathan N. Flak
Pharmacological Research.2026; 223: 108077. CrossRef
CMKLR1 senses chemerin/resolvin E1 to control adipose thermogenesis and modulate metabolic homeostasis
Zewei Zhao, Siqi Liu, Bingxiu Qian, Lin Zhou, Jianglin Shi, Junxi Liu, Lin Xu, Zhonghan Yang
Fundamental Research.2024; 4(3): 575. CrossRef
Extracts of Dunkelfelder Grape Seeds and Peel Increase the Metabolic Rate and Reduce Fat Deposition in Mice Maintained on a High-Fat Diet
Chenlu Yang, Xuelin Tian, Yulei Han, Xueqing Shi, Hua Wang, Hua Li
Foods.2023; 12(17): 3251. CrossRef
Insulin Resistance and Glucose Metabolism during Infection
Borros Arneth
Endocrines.2023; 4(4): 685. CrossRef
Dissecting biological activities of fibroblast growth factor receptors by the coiled-coil-mediated oligomerization of FGF1
Natalia Porebska, Marta Pozniak, Mateusz Adam Krzyscik, Agata Knapik, Aleksandra Czyrek, Marika Kucinska, Kamil Jastrzebski, Malgorzata Zakrzewska, Jacek Otlewski, Lukasz Opalinski
International Journal of Biological Macromolecules.2021; 180: 470. CrossRef
Oral Semaglutide, the First Ingestible Glucagon-Like Peptide-1 Receptor Agonist: Could It Be a Magic Bullet for Type 2 Diabetes?
Hwi Seung Kim, Chang Hee Jung
International Journal of Molecular Sciences.2021; 22(18): 9936. CrossRef
Serum interleukin 15 in anorexia nervosa: Comparison to normal weight and obese girls
Wojciech Roczniak, Agata Mikołajczak-Będkowska, Elżbieta Świętochowska, Zofia Ostrowska, Katarzyna Ziora, Sylwia Balcerowicz, Karolina Górska-Flak, Magdalena Milan, Joanna Oświęcimska
The World Journal of Biological Psychiatry.2020; 21(3): 203. CrossRef
Physiology of energy homeostasis: Models, actors, challenges and the glucoadipostatic loop
Didier Chapelot, Keyne Charlot
Metabolism.2019; 92: 11. CrossRef
Correlates of zinc finger BED domain-containing protein 3 and ghrelin in metabolic syndrome patients with and without prediabetes
Rawan AbuZayed, Nailya Bulatova, Violet Kasabri, Maysa Suyagh, Lana Halaseh, Sundus AlAlawi
Hormone Molecular Biology and Clinical Investigation.2019;[Epub] CrossRef
Pharmacotherapy of obesity: Available medications and drugs under investigation
Eleni Pilitsi, Olivia M. Farr, Stergios A. Polyzos, Nikolaos Perakakis, Eric Nolen-Doerr, Aimilia-Eirini Papathanasiou, Christos S. Mantzoros
Metabolism.2019; 92: 170. CrossRef
Pancreatic Blood Flow with Special Emphasis on Blood Perfusion of the Islets of Langerhans
Leif Jansson, Per‐Ola Carlsson
Comprehensive Physiology.2019; 9(2): 799. CrossRef
Link between chemerin, central obesity, and parameters of the Metabolic Syndrome: findings from a longitudinal study in obese children participating in a lifestyle intervention
Petra Niklowitz, Juliane Rothermel, Nina Lass, Andre Barth, Thomas Reinehr
International Journal of Obesity.2018; 42(10): 1743. CrossRef
The relationship between the leptin/ghrelin ratio and meals with various macronutrient contents in men with different nutritional status: a randomized crossover study
Edyta Adamska-Patruno, Lucyna Ostrowska, Joanna Goscik, Barbara Pietraszewska, Adam Kretowski, Maria Gorska
Nutrition Journal.2018;[Epub] CrossRef
The Science of Obesity Management: An Endocrine Society Scientific Statement
George A Bray, William E Heisel, Ashkan Afshin, Michael D Jensen, William H Dietz, Michael Long, Robert F Kushner, Stephen R Daniels, Thomas A Wadden, Adam G Tsai, Frank B Hu, John M Jakicic, Donna H Ryan, Bruce M Wolfe, Thomas H Inge
Endocrine Reviews.2018; 39(2): 79. CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
Weight loss technology for people with treated type 2 diabetes: a randomized controlled trial
Kuat Oshakbayev, Bibazhar Dukenbayeva, Gulnar Togizbayeva, Aigul Durmanova, Meruyert Gazaliyeva, Abdul Sabir, Aliya Issa, Alisher Idrisov
Nutrition & Metabolism.2017;[Epub] CrossRef
Salivary, gingival crevicular fluid and serum levels of ghrelin and chemerin in patients with periodontitis and overweight
H. F. R. Jentsch, N. Arnold, V. Richter, J. Deschner, T. Kantyka, S. Eick
Journal of Periodontal Research.2017; 52(6): 1050. CrossRef

Original Articles

Endocrine Research
The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes: Cheol Ryong Ku, Yoon Hee Cho, Zhen-Yu Hong, Ha Lee, Sue Ji Lee, Seung-soo Hong, Eun Jig Lee; Endocrinol Metab. 2016;31(2):328-335. Published online April 8, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.2.328

7,163 View
56 Download
30 Web of Science
30 Crossref

Abstract PDF PubReader

Background

Resveratrol (RSV) is a polyphenolic phytoalexin that has many effects on metabolic diseases such as diabetes and obesity. Given the importance of brown adipose tissue (BAT) for energy expenditure, we investigated the effects of RSV on brown adipocytes.

Methods

For the in vitro study, interscapular BAT was isolated from 7-week-old male Sprague Dawley rats. For the in vivo study, 7-week-old male Otsuka Long Evans Tokushima Fatty (OLETF) rats were divided into four groups and treated for 27 weeks with: standard diet (SD); SD+RSV (10 mg/kg body weight, daily); high fat diet (HFD); HFD+RSV. RSV was provided via oral gavage once daily during the in vivo experiments.

Results

RSV treatment of primary cultured brown preadipocytes promoted mitochondrial activity, along with over-expression of estrogen receptor α (ER-α). In OLETF rats, both HFD and RSV treatment increased the weight of BAT and the differentiation of BAT. However, only RSV increased the mitochondrial activity and ER-α expression of BAT in the HFD-fed group. Finally, RSV improved the insulin sensitivity of OLETF rats by increasing the mitochondrial activity of BAT, despite having no effects on white adipocytes and muscles in either diet group.

Conclusion

RSV could improve insulin resistance, which might be associated with mitochondrial activity of brown adipocyte. Further studies evaluating the activity of RSV for both the differentiation and mitochondrial activity of BAT could be helpful in investigating the effects of RSV on metabolic parameters.

Citations

Citations to this article as recorded by

The Effects of Resveratrol Supplementation on the Metabolism of Lipids in Metabolic Disorders
Farideh Ghavidel, Seyed Isaac Hashemy, Mahdeyeh Aliari, Arezoo Rajabian, Masoud Homayouni Tabrizi, Stephen L. Atkin, Tannaz Jamialahmadi, Hossein Hosseini, Amirhossein Sahebkar
Current Medicinal Chemistry.2025; 32(11): 2219. CrossRef
Food-derived polysaccharides and anti-obesity effects through enhancing adipose thermogenesis: structure-activity relationships, mechanisms, and regulation of gut microecology
Zhenyu Wang, Qiyu Xu, Lijuan Hou, Zhiyong He, Mark Christian, Xianjun Dai
Critical Reviews in Food Science and Nutrition.2025; 65(33): 8425. CrossRef
Natural Bioactive Compounds from Foods Inhibited Pigmentation Especially Potential Application of Fucoxanthin to Chloasma: a Mini-Review
Yida Wang, Hang Qi
Food Reviews International.2024; 40(1): 20. CrossRef
Resveratrol combats chronic diseases through enhancing mitochondrial quality
Weichu Tao, Hu Zhang, Xia Jiang, Ning Chen
Food Science and Human Wellness.2024; 13(2): 597. CrossRef
Polyphenol Compound 18a Modulates UCP1-Dependent Thermogenesis to Counteract Obesity
Xueping Wen, Yufei Song, Mei Zhang, Yiping Kang, Dandan Chen, Hui Ma, Fajun Nan, Yanan Duan, Jingya Li
Biomolecules.2024; 14(6): 618. CrossRef
Detraining after short‐term exercise induces hyperphagia and obesity with fatty liver and brown adipose tissue whitening in young male OLETF rats
Takaya Oshima, Kaho Takaishi, Misuzu Nishihira, Son Tien Nguyen, Susumu Urakawa, Haruya Ohno, Naoto Fujita
Physiological Reports.2024;[Epub] CrossRef
Effects of Resveratrol on Adipocytes: Evidence from In Vitro and In Vivo Studies
Matthew Terzo, Michael Iantomasi, Evangelia Tsiani
Molecules.2024; 29(22): 5359. CrossRef
The Potential to Fight Obesity with Adipogenesis Modulating Compounds
Jiaqi Zhao, Ailin Zhou, Wei Qi
International Journal of Molecular Sciences.2022; 23(4): 2299. CrossRef
Macrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases
Liwen Wang, Jie Hu, Haiyan Zhou
The World Journal of Men's Health.2021; 39(4): 606. CrossRef
Precision Nutrition to Activate Thermogenesis as a Complementary Approach to Target Obesity and Associated-Metabolic-Disorders
Marina Reguero, Marta Gómez de Cedrón, Sonia Wagner, Guillermo Reglero, José Carlos Quintela, Ana Ramírez de Molina
Cancers.2021; 13(4): 866. CrossRef
Natural Antioxidant Application on Fat Accumulation: Preclinical Evidence
Proshanta Roy, Daniele Tomassoni, Enea Traini, Ilenia Martinelli, Maria Vittoria Micioni Di Bonaventura, Carlo Cifani, Francesco Amenta, Seyed Khosrow Tayebati
Antioxidants.2021; 10(6): 858. CrossRef
Activation of Brown Adipose Tissue and Promotion of White Adipose Tissue Browning by Plant-based Dietary Components in Rodents: A Systematic Review
Francisco J Osuna-Prieto, Borja Martinez-Tellez, Antonio Segura-Carretero, Jonatan R Ruiz
Advances in Nutrition.2021; 12(6): 2147. CrossRef
Role of Dietary Polyphenols in Adipose Tissue Browning: A Narrative Review
Juan Salazar, Clímaco Cano, José L. Pérez, Ana Castro, María P. Díaz, Bermary Garrido, Rubén Carrasquero, Maricarmen Chacín, Manuel Velasco, Luis D´Marco, Joselyn Rojas-Quintero, Valmore Bermúdez
Current Pharmaceutical Design.2020; 26(35): 4444. CrossRef
Brown and Brite: The Fat Soldiers in the Anti-obesity Fight
Shireesh Srivastava, Richard L. Veech
Frontiers in Physiology.2019;[Epub] CrossRef
Effect of resveratrol on adipokines and myokines involved in fat browning: Perspectives in healthy weight against obesity
Oh Yoen Kim, Ji Yeon Chung, Juhyun Song
Pharmacological Research.2019; 148: 104411. CrossRef
Ginsenoside Rb2 Alleviates Obesity by Activation of Brown Fat and Induction of Browning of White Fat
Yilian Hong, Yi Lin, Qiya Si, Lijuan Yang, Weisong Dong, Xuejiang Gu
Frontiers in Endocrinology.2019;[Epub] CrossRef
Programming of the Beige Phenotype in White Adipose Tissue of Adult Mice by Mild Resveratrol and Nicotinamide Riboside Supplementations in Early Postnatal Life
Alba Serrano, Madhu Asnani-Kishnani, Ana María Rodríguez, Andreu Palou, Joan Ribot, María Luisa Bonet
Molecular Nutrition & Food Research.2018;[Epub] CrossRef
Effects of Polyphenols on Thermogenesis and Mitochondrial Biogenesis
Tanila Wood dos Santos, Quélita Cristina Pereira, Lucimara Teixeira, Alessandra Gambero, Josep A. Villena, Marcelo Lima Ribeiro
International Journal of Molecular Sciences.2018; 19(9): 2757. CrossRef
Programming mediated by fatty acids affects uncoupling protein 1 (UCP-1) in brown adipose tissue
Perla P. Argentato, Helena de Cássia César, Débora Estadella, Luciana P. Pisani
British Journal of Nutrition.2018; 120(6): 619. CrossRef
Effects of Genistein on Differentiation and Viability of Human Visceral Adipocytes
Elena Grossini, Serena Farruggio, Giulia Raina, David Mary, Giacomo Deiro, Sergio Gentilli
Nutrients.2018; 10(8): 978. CrossRef
A comprehensive review of the health perspectives of resveratrol
Abdur Rauf, Muhammad Imran, Hafiz Ansar Rasul Suleria, Bashir Ahmad, Dennis G. Peters, Mohammad S. Mubarak
Food & Function.2017; 8(12): 4284. CrossRef
The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
Yea Eun Kang, Sorim Choung, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku
Endocrinology and Metabolism.2017; 32(3): 383. CrossRef
A nutritional perspective on UCP1-dependent thermogenesis
M. Luisa Bonet, Josep Mercader, Andreu Palou
Biochimie.2017; 134: 99. CrossRef
The Beneficial Effects of Quercetin, Curcumin, and Resveratrol in Obesity
Yueshui Zhao, Bo Chen, Jing Shen, Lin Wan, Yinxin Zhu, Tao Yi, Zhangang Xiao, Lin-sen Qing
Oxidative Medicine and Cellular Longevity.2017;[Epub] CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
Antiobesity effects of resveratrol: which tissues are involved?
Alfredo Fernández‐Quintela, Iñaki Milton‐Laskibar, Marcela González, Maria P. Portillo
Annals of the New York Academy of Sciences.2017; 1403(1): 118. CrossRef
Resveratrol attenuates triglyceride accumulation associated with upregulation of Sirt1 and lipoprotein lipase in 3T3-L1 adipocytes
Haruki Imamura, Daiji Nagayama, Noriko Ishihara, Syo Tanaka, Rena Watanabe, Yasuhiro Watanabe, Yuta Sato, Takashi Yamaguchi, Noriko Ban, Hidetoshi Kawana, Masahiro Ohira, Kei Endo, Atsuhito Saiki, Kohji Shirai, Ichiro Tatsuno
Molecular Genetics and Metabolism Reports.2017; 12: 44. CrossRef
Resveratrol has dose-dependent effects on DNA fragmentation and mitochondrial activity of ovine secondary follicles cultured in vitro
T.J.S. Macedo, V.R.P. Barros, A.P.O. Monte, B.B. Gouveia, M.É.S. Bezerra, A.Y.P. Cavalcante, R.S. Barberino, V.G. Menezes, M.H.T. Matos
Zygote.2017; 25(4): 434. CrossRef
Response: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab2016;31:328-35, Cheol Ryong Ku et al.)
Cheol Ryong Ku, Eun Jig Lee
Endocrinology and Metabolism.2016; 31(3): 482. CrossRef
Letter: The Effects of High Fat Diet and Resveratrol on Mitochondrial Activity of Brown Adipocytes (Endocrinol Metab2016;31:328-35, Cheol Ryong Ku et al.)
Ji-Young Cha
Endocrinology and Metabolism.2016; 31(3): 480. CrossRef

Clinical Study
The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease: Jeong In Lee, Min Chul Kim, Byung Sub Moon, Young Seok Song, Eun Na Han, Hyo Sun Lee, Yoonjeong Son, Jihyun Kim, Eun Jin Han, Hye-Jeong Park, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee; Endocrinol Metab. 2016;31(1):86-92. Published online March 16, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.1.86

8,123 View
48 Download
22 Web of Science
24 Crossref

Abstract PDF PubReader

Background

We investigated the association between the severity of non-alcoholic fatty liver disease (NAFLD) and the estimated 10-year risk of cardiovascular disease (CVD) calculated by Pooled Cohort Equation (PCE) and Framingham risk score (FRS).

Methods

A total of 15,913 participants (mean age, 46.3 years) in a health screening program were selected for analysis. The presence and severity of fatty liver was assessed by abdominal ultrasonogram. Subjects who drank alcohol more than three times a week were excluded from the study.

Results

Among the participants, 57.6% had no NAFLD, 35.4% had grade I, 6.5% had grade II, and 0.5% had grade III NAFLD. Mean estimated 10-year CVD risk was 2.59%, 3.93%, 4.68%, and 5.23% calculated using the PCE (P for trend <0.01) and 4.55%, 6.39%, 7.33%, and 7.13% calculated using FRS, according to NAFLD severity from none to severe (P for trend <0.01). The odds ratio for ≥7.5% estimated CVD risk calculated using the PCE showed a higher correlation with increasing severity of NAFLD even after adjustment for conventional CVD risk factors (1.52, 2.56, 3.35 vs. the no NAFLD group as a reference, P<0.01) compared with calculated risk using FRS (1.65, 1.62, 1.72 vs. no NAFLD group as a reference, P<0.01).

Conclusion

In our study of apparently healthy Korean adults, increasing severity of NAFLD showed a higher correlation with estimated 10-year CVD risk when calculated using the PCE than when calculated using FRS.

Citations

Citations to this article as recorded by

Insulin Resistance, Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Clinical and Experimental Perspective
Inha Jung, Dae-Jeong Koo, Won-Young Lee
Diabetes & Metabolism Journal.2024; 48(3): 327. CrossRef
Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases
Dana Kablawi, Faisal Aljohani, Chiara Saroli Palumbo, Sophie Restellini, Alain Bitton, Gary Wild, Waqqas Afif, Peter L Lakatos, Talat Bessissow, Giada Sebastiani
Crohn's & Colitis 360.2023;[Epub] CrossRef
Low Relative Handgrip Strength Is Associated with a High Risk of Non-Alcoholic Fatty Liver Disease in Italian Adults: A Retrospective Cohort Study
Samantha Maurotti, Roberta Pujia, Elisa Mazza, Maria Francesca Pileggi, Franco Arturi, Maria Grazia Tarsitano, Tiziana Montalcini, Arturo Pujia, Yvelise Ferro
Applied Sciences.2023; 13(22): 12489. CrossRef
Fatty Liver Disease: Diagnosis and Stratification
Yedidya Saiman, Andres Duarte-Rojo, Mary E. Rinella
Annual Review of Medicine.2022; 73(1): 529. CrossRef
“Dangerous liaisons: NAFLD and liver fibrosis increase cardiovascular risk in HIV”
Adriana Cervo, Giada Sebastiani, Jovana Milic, Thomas Krahn, Sergio Mazzola, Salvatore Petta, Antonio Cascio, Giovanni Guaraldi, Giovanni Mazzola
HIV Medicine.2022; 23(8): 911. CrossRef
Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes
Nong Li, Huiwen Tan, Aixia Xie, Cheng Li, Xuan Fu, Weiting Xang, Amina Kirim, Xuefang Huang
BMC Endocrine Disorders.2022;[Epub] CrossRef
The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease
Seyed Moayed Alavian, Hosein Zadi
Multidisciplinary Cardiovascular Annals.2022;[Epub] CrossRef
Risk factors for cardiovascular disease among individuals with hepatic steatosis
Julia Karády, Maros Ferencik, Thomas Mayrhofer, Nandini M. Meyersohn, Daniel O. Bittner, Pedro V. Staziaki, Balint Szilveszter, Travis R. Hallett, Michael T. Lu, Stefan B. Puchner, Tracey G. Simon, Borek Foldyna, Geoffrey S. Ginsburg, Robert W. McGarrah,
Hepatology Communications.2022; 6(12): 3406. CrossRef
Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity
Mohammad E. Khamseh, Mojtaba Malek, Rowshanak Abbasi, Hoda Taheri, Maryam Lahouti, Fariba Alaei-Shahmiri
Metabolic Syndrome and Related Disorders.2021; 19(3): 167. CrossRef
Interplay between non‐alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population
Grazia Pennisi, Vito Di Marco, Carola Buscemi, Giovanni Mazzola, Cristiana Randazzo, Federica Spatola, Antonio Craxì, Silvio Buscemi, Salvatore Petta
Journal of Gastroenterology and Hepatology.2021; 36(9): 2389. CrossRef
Non-Laboratory-Based Simple Screening Model for Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Developed Using Multi-Center Cohorts
Jiwon Kim, Minyoung Lee, Soo Yeon Kim, Ji-Hye Kim, Ji Sun Nam, Sung Wan Chun, Se Eun Park, Kwang Joon Kim, Yong-ho Lee, Joo Young Nam, Eun Seok Kang
Endocrinology and Metabolism.2021; 36(4): 823. CrossRef
Coronary Artery Disease is More Severe in Patients with Non-Alcoholic Steatohepatitis than Fatty Liver
Toshihiro Niikura, Kento Imajo, Anna Ozaki, Takashi Kobayashi, Michihiro Iwaki, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima
Diagnostics.2020; 10(3): 129. CrossRef
Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management
Hersh Shroff, Lisa B. VanWagner
Current Hepatology Reports.2020; 19(3): 315. CrossRef
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults
Sang Bae Lee, Min Kyung Kim, Shinae Kang, Kahui Park, Jung Hye Kim, Su Jung Baik, Ji Sun Nam, Chul Woo Ahn, Jong Suk Park
Endocrinology and Metabolism.2019; 34(2): 179. CrossRef
Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease
Pegah Golabi, Natsu Fukui, James Paik, Mehmet Sayiner, Alita Mishra, Zobair M. Younossi
Hepatology Communications.2019; 3(8): 1050. CrossRef
Lower hand grip strength in older adults with non-alcoholic fatty liver disease: a nationwide population-based study
Beom-Jun Kim, Seong Hee Ahn, Seung Hun Lee, Seongbin Hong, Mark W. Hamrick, Carlos M. Isales, Jung-Min Koh
Aging.2019; 11(13): 4547. CrossRef
Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
Ga Eun Nam, Soon Young Hwang, Hye Soo Chung, Ju Hee Choi, Hyun Jung Lee, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
International Journal of Endocrinology.2018; 2018: 1. CrossRef
Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study
Kyung Mook Choi, Kyungdo Han, Sanghyun Park, Hye Soo Chung, Nam Hoon Kim, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Yong Gyu Park, Seon Mee Kim
Scientific Reports.2018;[Epub] CrossRef
Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance
Mariana Verdelho Machado
GE - Portuguese Journal of Gastroenterology.2017; 24(4): 157. CrossRef
Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case‐control study
Gyuri Kim, Suk‐Yong Jang, Eugene Han, Yong‐ho Lee, Se‐young Park, Chung Mo Nam, Eun Seok Kang
International Journal of Cancer.2017; 140(4): 798. CrossRef
Clinical Characteristics of Non-Alcoholic Fatty Liver Disease Based on Analyses from the Kangbuk Samsung Health Study
Eun-Jung Rhee
The Journal of Korean Diabetes.2017; 18(2): 81. CrossRef
Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation
Jihyun Kim, Da Young Lee, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee, Susanne Kaser
PLOS ONE.2017; 12(7): e0180118. CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
Eugene Han, Yong-ho Lee
Diabetes & Metabolism Journal.2017; 41(6): 430. CrossRef

Clinical Study
Association of Waist-Height Ratio with Diabetes Risk: A 4-Year Longitudinal Retrospective Study: Yoon Jeong Son, Jihyun Kim, Hye-Jeong Park, Se Eun Park, Cheol-Young Park, Won-Young Lee, Ki-Won Oh, Sung-Woo Park, Eun-Jung Rhee; Endocrinol Metab. 2016;31(1):127-133. Published online March 16, 2016; DOI: https://doi.org/10.3803/EnM.2016.31.1.127

8,164 View
47 Download
30 Web of Science
29 Crossref

Abstract PDF PubReader

Background

Waist-to-height ratio (WHtR) is an easy and inexpensive adiposity index that reflects central obesity. In this study, we examined the association of various baseline adiposity indices, including WHtR, with the development of diabetes over 4 years of follow-up in apparently healthy Korean individuals.

Methods

A total of 2,900 nondiabetic participants (mean age, 44.3 years; 2,078 men) in a health screening program, who repeated the medical check-up in 2005 and 2009, were recruited. Subjects were divided into two groups according to development of diabetes after 4 years. The cut-off values of baseline body mass index (BMI), waist circumference (WC), and WHtR for the development of diabetes over 4 years were calculated. The sensitivity, specificity, and mean area under the receiver operator characteristic curve (AUROC) of each index were assessed. The odds ratio (OR) for diabetes development was analyzed for each of the three baseline adiposity indices.

Results

During the follow-up period, 101 new cases (3.5%) of diabetes were diagnosed. The cut-off WHtR value for diabetes development was 0.51. Moreover, WHtR had the highest AUROC value for diabetes development among the three adiposity indices (0.716, 95% confidence interval [CI], 0.669 to 0.763; 0.702, 95% CI, 0.655 to 0.750 for WC; 0.700, 95% CI, 0.651 to 0.750 for BMI). After adjusting for confounding variables, the ORs of WHtR and WC for diabetes development were 1.95 (95% CI, 1.14 to 3.34) and 1.96 (95% CI, 1.10 to 3.49), respectively. No significant differences were observed between the two groups regarding BMI.

Conclusion

Increased baseline WHtR and WC correlated with the development of diabetes after 4 years. WHtR might be a useful screening measurement to identify individuals at high risk for diabetes.

Citations

Citations to this article as recorded by

Novel anthropometric indices for predicting diabetes mellitus: A population-based study
Fatemeh Baberi, Shayan Rezaeianzadeh, Abbas Rezaianzadeh, Andishe Hamedi
Primary Care Diabetes.2026; 20(1): 30. CrossRef
A Comparative Assessment of Body Shape and Size Index (BSSI), Body Mass Index (BMI), and Body Surface Area (BSA) in Predicting Diabetes Prevalence Among Pakistani Adults
Farrukh Shehzad, Waqas Ghulam Hussain, Atif Akbar
Sage Open Aging.2025;[Epub] CrossRef
Conicity index increases the risk of female infertility: An analysis of NHANES 2013 to 2018
Jia-Yi Zhao, Meng-Hui Hong, Xiao-Ming Yang, Tao Zhou, Shao-Cong Liang
Medicine.2025; 104(37): e44457. CrossRef
Comparison of waist circumference and waist‐to‐height ratio as predictors of clustering of cardiovascular risk factors among middle‐aged people in rural Khanh Hoa, Vietnam
Rachana Manandhar Shrestha, Thuy Thi Phuong Pham, Shohei Yamamoto, Chau Que Nguyen, Ami Fukunaga, Phan Cong Danh, Masahiko Hachiya, Huy Xuan Le, Hung Thai Do, Tetsuya Mizoue, Yosuke Inoue
American Journal of Human Biology.2024;[Epub] CrossRef
Novel anthropometric indices for predicting type 2 diabetes mellitus
Erfan Sadeghi, Alireza Khodadadiyan, Seyed Ali Hosseini, Sayed Mohsen Hosseini, Ashraf Aminorroaya, Massoud Amini, Sara Javadi
BMC Public Health.2024;[Epub] CrossRef
Association between two novel anthropometric measures and type 2 diabetes in a Chinese population
Di Wang, Ziting Chen, Yinru Wu, Jiaojiao Ren, Dong Shen, Guifang Hu, Chen Mao
Diabetes, Obesity and Metabolism.2024; 26(8): 3238. CrossRef
Body Composition and Cardiovascular Risk: A Study of Polish Military Flying Personnel
Agata Gaździńska, Stefan Gaździński, Paweł Jagielski, Paweł Kler
Metabolites.2023; 13(10): 1102. CrossRef
Cues of pregnancy decrease female physical attractiveness for males
Pavol Prokop, Martina Zvaríková, Milan Zvarík, Peter Fedor
Current Psychology.2022; 41(2): 697. CrossRef
Waist-to-height ratio has a stronger association with cardiovascular risks than waist circumference, waist-hip ratio and body mass index in type 2 diabetes
Jiang-Feng Ke, Jun-Wei Wang, Jun-Xi Lu, Zhi-Hui Zhang, Yun Liu, Lian-Xi Li
Diabetes Research and Clinical Practice.2022; 183: 109151. CrossRef
Diagnostic accuracy of anthropometric indices for discriminating elevated blood pressure in pediatric population: a systematic review and a meta-analysis
Jun-Min Tao, Wei Wei, Xiao-Yang Ma, Ying-Xiang Huo, Meng-Die Hu, Xiao-Feng Li, Xin Chen
BMC Pediatrics.2022;[Epub] CrossRef
The utilization of BMI in patients with high WHtR as to cardiovascular risk
Meliha Melin UYGUR
Journal of Health Sciences and Medicine.2022; 5(4): 1133. CrossRef
Assessment of obesity indices for prediction of hyperglycemia in adult population of Varanasi (Uttar Pradesh), India
Neha Rai, Hanjabam Barun Sharma, Renu Kumari, Jyotsna Kailashiya
Indian Journal of Physiology and Pharmacology.2021; 64: 195. CrossRef
Waist-to-height ratio and metabolic phenotype compared to the Matsuda index for the prediction of insulin resistance
Katharina Lechner, Benjamin Lechner, Alexander Crispin, Peter E. H. Schwarz, Helene von Bibra
Scientific Reports.2021;[Epub] CrossRef
Waist-to-Height Ratio (WHtR) in Predicting Coronary Artery Disease Compared to Body Mass Index and Waist Circumference in a Single Center from Saudi Arabia
Mostafa Q. Alshamiri, Faisal Mohd A Habbab, Saad Saeed AL-Qahtani, Khalil Abdullah Alghalayini, Omar Mohammed Al-Qattan, Fayez El-shaer, Anne Knowlton
Cardiology Research and Practice.2020; 2020: 1. CrossRef
A simple cut-off for waist-to-height ratio (0·5) can act as an indicator for cardiometabolic risk: recent data from adults in the Health Survey for England
Sigrid Gibson, Margaret Ashwell
British Journal of Nutrition.2020; 123(6): 681. CrossRef
Glucose Levels as a Mediator of the Detrimental Effect of Abdominal Obesity on Relative Handgrip Strength in Older Adults
Miguel Ángel Pérez-Sousa, Jesús del Pozo-Cruz, Carlos A. Cano-Gutiérrez, Atilio J. Ferrebuz, Carolina Sandoval-Cuellar, Mikel Izquierdo, Paula A. Hernández-Quiñonez, Robinson Ramírez-Vélez
Journal of Clinical Medicine.2020; 9(8): 2323. CrossRef
Abnormal Glucose Metabolism and Associated Risk Factors Among Adults in Mekelle City, Ethiopia

Gebremedhin Gebreegziabiher, Tefera Belachew, Dessalegn Tamiru
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 4017. CrossRef
Anthropometric Indexes for Predicting High Blood Pressure in Vietnamese Adults: A Cross-Sectional Study

Quan Nguyen Minh, Minh Hoang Nguyen Vo
Integrated Blood Pressure Control.2020; Volume 13: 181. CrossRef
Relation between Baseline Height and New Diabetes Development: A Nationwide Population-Based Study
Eun-Jung Rhee, Jung-Hwan Cho, Hyemi Kwon, Se-Eun Park, Jin-Hyung Jung, Kyung-Do Han, Yong-Gyu Park, Yang-Hyun Kim, Won-Young Lee
Diabetes & Metabolism Journal.2019; 43(6): 794. CrossRef
Issues in Measuring and Interpreting Diet and Its Contribution to Obesity
Rachael M. Taylor, Rebecca L. Haslam, Tracy L. Burrows, Kerith R. Duncanson, Lee M. Ashton, Megan E. Rollo, Vanessa A. Shrewsbury, Tracy L. Schumacher, Clare E. Collins
Current Obesity Reports.2019; 8(2): 53. CrossRef
Assessment of the validity of multiple obesity indices compared with obesity-related co-morbidities
Jaeeun Myung, Kyung Yoon Jung, Tae Hyun Kim, Euna Han
Public Health Nutrition.2019; : 1. CrossRef
Profiles of body mass index and blood pressure among young adults categorised by waist-to-height ratio cut-offs in Shandong, China
Ying-xiu Zhang, Shu-rong Wang
Annals of Human Biology.2019; 46(5): 409. CrossRef
Air Pollution Has a Significant Negative Impact on Intentional Efforts to Lose Weight: A Global Scale Analysis
Morena Ustulin, So Young Park, Sang Ouk Chin, Suk Chon, Jeong-taek Woo, Sang Youl Rhee
Diabetes & Metabolism Journal.2018; 42(4): 320. CrossRef
Being Metabolically Healthy, the Most Responsible Factor for Vascular Health
Eun-Jung Rhee
Diabetes & Metabolism Journal.2018; 42(1): 19. CrossRef
Waist-to-height ratio index for predicting incidences of hypertension: the ARIRANG study
Jung Ran Choi, Sang Baek Koh, Eunhee Choi
BMC Public Health.2018;[Epub] CrossRef
Comparison of various anthropometric indices for the identification of a predictor of incident hypertension: the ARIRANG study
J. R. Choi, S. V. Ahn, J. Y. Kim, S. B. Koh, E. H. Choi, G. Y. Lee, Y. E. Jang
Journal of Human Hypertension.2018; 32(4): 294. CrossRef
Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwe
Fang Zhang, Qin Wan, Hongyi Cao, Lizhi Tang, Daigang Li, Qingguo Lü, Zhe Yan, Jing Li, Qiu Yang, Yuwei Zhang, Nanwei Tong
BMJ Open.2018; 8(5): e019735. CrossRef
Articles inEndocrinology and Metabolismin 2016
Won-Young Lee
Endocrinology and Metabolism.2017; 32(1): 62. CrossRef
THE ASSESMENT OF RELATION BETWEEN WAIST/HEIGHT RATIO AND TYPE 2 DIABETES RISK AMONG NURSING STUDENTS
Ceren Gezer
Journal of Food and Health Science.2017; : 141. CrossRef

Thyroid
Weight Changes in Patients with Differentiated Thyroid Carcinoma during Postoperative Long-Term Follow-up under Thyroid Stimulating Hormone Suppression: Seo Young Sohn, Ji Young Joung, Yoon Young Cho, Sun Mi Park, Sang Man Jin, Jae Hoon Chung, Sun Wook Kim; Endocrinol Metab. 2015;30(3):343-351. Published online August 4, 2015; DOI: https://doi.org/10.3803/EnM.2015.30.3.343

8,363 View
72 Download
15 Web of Science
18 Crossref

Abstract PDF PubReader

Background

There are limited data about whether patients who receive initial treatment for differentiated thyroid cancer (DTC) gain or lose weight during long-term follow-up under thyroid stimulating hormone (TSH) suppression. This study was aimed to evaluate whether DTC patients under TSH suppression experience long-term weight gain after initial treatment. We also examined the impact of the radioactive iodine ablation therapy (RAIT) preparation method on changes of weight, comparing thyroid hormone withdrawal (THW) and recombinant human TSH (rhTSH).

Methods

We retrospectively reviewed 700 DTC patients who underwent a total thyroidectomy followed by either RAIT and levothyroxine (T4) replacement or T4 replacement alone. The control group included 350 age-matched patients with benign thyroid nodules followed during same period. Anthropometric data were measured at baseline, 1 to 2 years, and 3 to 4 years after thyroidectomy. Comparisons were made between weight and body mass index (BMI) at baseline and follow-up.

Results

Significant gains in weight and BMI were observed 3 to 4 years after initial treatment for female DTC but not in male patients. These gains among female DTC patients were also significant compared to age-matched control. Women in the THW group gained a significant amount of weight and BMI compared to baseline, while there was no increase in weight or BMI in the rhTSH group. There were no changes in weight and BMI in men according to RAIT preparation methods.

Conclusion

Female DTC patients showed significant gains in weight and BMI during long-term follow-up after initial treatment. These changes were seen only in patients who underwent THW for RAIT.

Citations

Citations to this article as recorded by

Effects of a low-iodine diet in post-thyroidectomy thyroid cancer patients undergoing I 131 therapy at the Vietnam National Cancer Hospital
Bach Viet Hoang, Tien Thi Hong Nguyen, Yen Thi Duong, Hoa Thi Thanh Nguyen, Thu Ha Nguyen, Thanh Thi Nguyen, Lieu Thi Thu Nguyen, Huong Thi Le
Nutrition and Health.2025; 31(2): 553. CrossRef
Exploring the Link Between Thyroid Disorders and Obesity: Mechanisms, Impacts, and Clinical Implications
Ashni Dharia, Dimpi Desai, Kaniksha Desai
Endocrine Practice.2025; 31(5): 660. CrossRef
Factors influencing the quality of life in survivors of differentiated thyroid cancer based on patient-reported outcomes: a single-center cross-sectional study
Zhizhong Dong, Xiangxiang Zhan, Wen Liu, Dewei Rao, Miao Yang, Ying Peng, Yanjun Su, Ruochuan Cheng
Frontiers in Endocrinology.2025;[Epub] CrossRef
The complexity of the relationship between thyroid disease and body weight
Jacqueline Jonklaas
Nature Reviews Endocrinology.2025;[Epub] CrossRef
The Changes of Weight, Body Composition and Metabolic Parameters According to Treatment Modality in Patients with Thyroid Cancer
Kyong Yeun Jung, Hoon Sung Choi, Sun Wook Cho, Hyun Kyung Chung, Hee Jin Kim, Young Joo Park
International Journal of Thyroidology.2025; 18(2): 171. CrossRef
Impact of a mobile health intervention based on multi-theory model of health behavior change on self-management in patients with differentiated thyroid cancer: protocol for a randomized controlled trial
Yang Jiang, Xiangju Sun, Maomin Jiang, Hewei Min, Jing Wang, Xinghua Fu, Jiale Qi, Zhenjie Yu, Xiaomei Zhu, Yibo Wu
Frontiers in Public Health.2024;[Epub] CrossRef
Thyroidectomy Effects on the Body Mass Index and Thyroid-Stimulating Hormone: A Systematic Review and Meta-Analysis
Hyder Mirghani, Ahmad M Fnjan, Abdullah F Almalki, Ali F Almadan, Omar Abdullah M Alammar, Abdulaziz S Alhwiati, Amer A Laradhi, Ahmed M Bakour, Mohamad A Aljahed, Abdulmajeed M Alzahrani
Cureus.2024;[Epub] CrossRef
Pre-surgery dietician counseling can prevent post-thyroidectomy body weight gain: results of an intervention trial
Laura Croce, Cristina Pallavicini, Noemi Busca, Benedetto Calì, Giuseppe Bellastella, Francesca Coperchini, Flavia Magri, Luca Chiovato, Hellas Cena, Mario Rotondi
Endocrine.2023; 81(2): 246. CrossRef
Determinants and mediating mechanisms of quality of life and disease-specific symptoms among thyroid cancer patients: the design of the WaTCh study
Floortje Mols, Dounya Schoormans, Romana Netea-Maier, Olga Husson, Sandra Beijer, Katrijn Van Deun, Wouter Zandee, Marleen Kars, Pleun C. M. Wouters van Poppel, Suat Simsek, Patrick van Battum, Jérôme M. H. Kisters, Jan Paul de Boer, Elske Massolt, Rachel
Thyroid Research.2023;[Epub] CrossRef
Positive effects of thyroid replacement therapy on assisted reproductive technology outcomes in women with subclinical hypothyroidism with positive thyroid peroxidase autoantibodies
Himanshu Arora, Ineabelle Collazo, Katherine L. Palmerola, Madhumita Parmar, Manish Narasimman, Nicholas Hendon, Juergen Eisermann, Maria Bustillo
F&S Reports.2022; 3(1): 32. CrossRef
Weight Gain After Thyroidectomy: A Systematic Review and Meta-Analysis
Christine N Huynh, Janina V Pearce, Le Kang, Francesco S Celi
The Journal of Clinical Endocrinology & Metabolism.2021; 106(1): 282. CrossRef
Weight change in patients with differentiated thyroid carcinoma after total thyroidectomy versus lobectomy
Hae-Ryong Cho, Ra-Yeong Song, Kyung Ho Kang
Korean Journal of Clinical Oncology.2020; 16(2): 127. CrossRef
Postthyroidectomy obesity in a Korean population: does the extent of surgery matter?
Min-Young Park, Sang Eun Nam, Kyoung Sik Park, Madhuri Saindane, Young-Bum Yoo, Jung-Hyun Yang, Ah-Leum Ahn, Jae-Kyung Choi, Won Seo Park
Annals of Surgical Treatment and Research.2019; 97(3): 119. CrossRef
Body weight change is unpredictable after total thyroidectomy
Ron Glick, Paula Chang, Peter Michail, Jonathan W. Serpell, Simon Grodski, James C. Lee
ANZ Journal of Surgery.2018; 88(3): 162. CrossRef
Weight Changes After Thyroid Surgery for Patients with Benign Thyroid Nodules and Thyroid Cancer: Population-Based Study and Systematic Review and Meta-Analysis
Naykky Singh Ospina, Ana Castaneda-Guarderas, Oksana Hamidi, Oscar J. Ponce, Wang Zhen, Larry Prokop, Victor M. Montori, Juan P. Brito
Thyroid.2018; 28(5): 639. CrossRef
Does the Risk of Metabolic Syndrome Increase in Thyroid Cancer Survivors?
Min-Hee Kim, Jin-young Huh, Dong-jun Lim, Moo-Il Kang
Thyroid.2017; 27(7): 936. CrossRef
Thyroid hormone and its metabolites in relation to quality of life in patients treated for differentiated thyroid cancer
E.T. Massolt, M. van der Windt, T.I.M. Korevaar, B.L.R. Kam, J.W. Burger, G.J.H. Franssen, I. Lehmphul, J. Köhrle, W.E. Visser, R.P. Peeters
Clinical Endocrinology.2016; 85(5): 781. CrossRef
High Serum Levels of Thyroid-Stimulating Hormone and Sustained Weight Gain in Patients with Thyroid Cancer Undergoing Radioiodine Therapy
Hyo Jung Seo, June-Key Chung, Keon Wook Kang, E. Edmund Kim, Gi Jeong Cheon, Jin Chul Paeng, Dong Soo Lee, Young Joo Park, Do Joon Park, Jae Gol Choe
International Journal of Thyroidology.2016; 9(1): 19. CrossRef

Adrenal gland
Limited Diagnostic Utility of Plasma Adrenocorticotropic Hormone for Differentiation between Adrenal Cushing Syndrome and Cushing Disease: A Ram Hong, Jung Hee Kim, Eun Shil Hong, I Kyeong Kim, Kyeong Seon Park, Chang Ho Ahn, Sang Wan Kim, Chan Soo Shin, Seong Yeon Kim; Endocrinol Metab. 2015;30(3):297-304. Published online August 4, 2015; DOI: https://doi.org/10.3803/EnM.2015.30.3.297

9,539 View
98 Download
14 Web of Science
13 Crossref

Abstract PDF PubReader

Background

Measurement of the plasma adrenocorticotropic hormone (ACTH) level has been recommended as the first diagnostic test for differentiating between ACTH-independent Cushing syndrome (CS) and ACTH-dependent CS. When plasma ACTH values are inconclusive, a differential diagnosis of CS can be made based upon measurement of the serum dehydroepiandrosterone sulfate (DHEA-S) level and results of the high-dose dexamethasone suppression test (HDST). The aim of this study was to assess the utility of plasma ACTH to differentiate adrenal CS from Cushing' disease (CD) and compare it with that of the HDST results and serum DHEA-S level.

Methods

We performed a retrospective, multicenter study from January 2000 to May 2012 involving 92 patients with endogenous CS. The levels of plasma ACTH, serum cortisol, 24-hour urine free cortisol (UFC) after the HDST, and serum DHEA-S were measured.

Results

Fifty-seven patients had adrenal CS and 35 patients had CD. The area under the curve of plasma ACTH, serum DHEA-S, percentage suppression of serum cortisol, and UFC after HDST were 0.954, 0.841, 0.950, and 0.997, respectively (all P<0.001). The cut-off values for plasma ACTH, percentage suppression of serum cortisol, and UFC after HDST were 5.3 pmol/L, 33.3%, and 61.6%, respectively. The sensitivity and specificity of plasma ACTH measurement were 84.2% and 94.3%, those of serum cortisol were 95.8% and 90.6%, and those of UFC after the HDST were 97.9% and 96.7%, respectively.

Conclusion

Significant overlap in plasma ACTH levels was seen between patients with adrenal CS and those with CD. The HDST may be useful in differentiating between these forms of the disease, especially when the plasma ACTH level alone is not conclusive.

Citations

Citations to this article as recorded by

Dehydroepiandrosterone sulfate as a potential biomarker for assessing the etiology of canine naturally occurring Cushing’s syndrome
Inês Oliveira, Patrícia Marques, Francesca Del Baldo, Mariachiara Re, Luísa Mateus, Rodolfo Oliveira Leal
Domestic Animal Endocrinology.2026; 95: 106993. CrossRef
Consensus on the diagnosis of Cushing’s disease: a collaborative statement from the Korean Endocrine Society and Japan Endocrine Society
Jeongmin Lee, Hidenori Fukuoka, Seung Shin Park, A Ram Hong, Jung Hee Kim, Sang Ouk Chin, Han-Sang Baek, Dong-Jun Lim, Kazunori Kageyama, Mitsuru Nishiyama, Shigeyuki Tahara, Ken-Ichi Oyama, Akira Sugawara, Miho Yamashita, Naoko Inoshita, Hiroshi Arima, B
Endocrine Journal.2026; 73(2): 355. CrossRef
Diagnosis of Cushing’s Disease
Henrik Elenius, Lynnette K. Nieman
Endocrinology and Metabolism Clinics of North America.2025; 54(4): 537. CrossRef
Development of diagnostic algorithm for Cushing’s syndrome: a tertiary centre experience
A. Efthymiadis, H. Loo, B. Shine, T. James, B. Keevil, J. W. Tomlinson, A. Pal, R. Pofi
Journal of Endocrinological Investigation.2024; 47(10): 2449. CrossRef
Eurasian clinical guidelines for the diagnosis and treatment of secondary (symptomatic) forms of arterial hypertension (2022)
I. E. Chazova, N. M. Chikhladze, N. V. Blinova, Zh. E. Belaya, N. M. Danilov, E. M. Elfimova, A. Yu. Litvin, L. Ya. Rozhinskaya, N. Yu. Sviridenko, M. Yu. Shvetsov, V. A. Azizov, E. A. Grigorenko, N. P. Mit’kovskaja, I. I. Mustafaev, A. G. Polupanov, A. S
Eurasian heart journal.2023; (1): 6. CrossRef
Diagnosis and Management of Pituitary Adenomas
Nicholas A. Tritos, Karen K. Miller
JAMA.2023; 329(16): 1386. CrossRef
Distinct serum steroid profiles between adrenal Cushing syndrome and Cushing disease
Chang Gao, Li Ding, Xiaona Zhang, Menghua Yuan, Shaofang Tang, Wei Li, Yuanyuan Ye, Ming Liu, Qing He
Frontiers in Endocrinology.2023;[Epub] CrossRef
The Importance of DHEA-S Levels in Cushing’s Syndrome; Is There a Cut-off Value in the Differential Diagnosis?
Sema Ciftci, Ozlem Soyluk, Alev Selek, Selvinaz Erol, Zeliha Hekimsoy, Ayse Esen, Huseyin Dursun, Serdar Sahin, Gonca Oruk, Meral Mert, Huseyin Soylu, Banu Sarer Yurekli, Melek Eda Ertorer, Tulay Omma, Mehtap Evran, Mine Adas, Seher Tanrikulu, Kadriye Ayd
Hormone and Metabolic Research.2022; 54(04): 232. CrossRef
Epidemiology and Comorbidity of Adrenal Cushing Syndrome: A Nationwide Cohort Study
Chang Ho Ahn, Jung Hee Kim, Man Young Park, Sang Wan Kim
The Journal of Clinical Endocrinology & Metabolism.2021; 106(3): e1362. CrossRef
Metabolic changes in serum steroids for diagnosing and subtyping Cushing’s syndrome
Chang Ho Ahn, Chaelin Lee, Jaeyoon Shim, Sung Hye Kong, Su-jin Kim, Yong Hwy Kim, Kyu Eun Lee, Chan Soo Shin, Jung Hee Kim, Man Ho Choi
The Journal of Steroid Biochemistry and Molecular Biology.2021; 210: 105856. CrossRef
Clinical and Molecular Characteristics of PRKACA L206R Mutant Cortisol-Producing Adenomas in Korean Patients
Insoon Jang, Su-jin Kim, Ra-Young Song, Kwangsoo Kim, Seongmin Choi, Jang-Seok Lee, Min-Kyeong Gwon, Moon Woo Seong, Kyu Eun Lee, Jung Hee Kim
Endocrinology and Metabolism.2021; 36(6): 1287. CrossRef
Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas
Daham Kim, Cheol Ryong Ku, Se Hee Park, Ju Hyung Moon, Eui Hyun Kim, Sun Ho Kim, Eun Jig Lee
World Neurosurgery.2018; 115: e464. CrossRef
Cushing's syndrome: a practical approach to diagnosis and differential diagnoses
Joseph M Pappachan, Christian Hariman, Mahamood Edavalath, Julian Waldron, Fahmy W Hanna
Journal of Clinical Pathology.2017; 70(4): 350. CrossRef

Obesity and Metabolism
Serum Concentrations of Ghrelin and Leptin according to Thyroid Hormone Condition, and Their Correlations with Insulin Resistance: Kyu-Jin Kim, Bo-Yeon Kim, Ji-Oh Mok, Chul-Hee Kim, Sung-Koo Kang, Chan-Hee Jung; Endocrinol Metab. 2015;30(3):318-325. Published online May 18, 2015; DOI: https://doi.org/10.3803/EnM.2015.30.3.318

8,269 View
59 Download
12 Web of Science
14 Crossref

Abstract PDF PubReader

Background

Thyroid hormones can influence energy metabolism and insulin sensitivity via their interaction with adipocytokines and gut hormones. The aims of this study were to evaluate differences in serum ghrelin and leptin concentrations according to thyroid hormone levels, and to investigate the correlation of insulin resistance.

Methods

A total of 154 patients (57 hyperthyroid patients, 61 euthyroid patients, and 36 hypothyroid patients; mean age, 47.9 years) were enrolled. Serum leptin, ghrelin, and insulin levels were measured and insulin resistance was calculated using the formula of the homeostasis model assessment of insulin resistance (HOMA-IR).

Results

There were no differences in mean concentrations of ghrelin or leptin among the three groups. There were no significant differences in insulin levels between the groups (P=0.06), although hyperthyroid patients had borderline statistically significantly higher levels of insulin than did euthyroid subjects by post hoc test (26.4 µIU/mL vs. 16.1 µIU/mL, P=0.057). Regarding HOMA-IR index, the mean levels were highest in the hyperthyroid group among those of the three groups (hyperthyroid vs. euthyroid vs. hypothyroid, 6.7 vs. 3.8 vs. 4.4, P=0.068). Plasma levels of ghrelin were significantly negatively correlated with age, insulin, glucose, body mass index (BMI), and HOMA-IR. Plasma levels of leptin showed significant positive correlation with BMI and triglyceride. There were no significant correlations among thyroid hormone, thyrotropin, ghrelin, leptin, or insulin.

Conclusion

The present study found that serum ghrelin, leptin, and insulin levels didn't differ according to thyroid function conditions. Further studies with larger numbers of patients are required to establish a direct relationship between plasma ghrelin, leptin, and thyroid hormone.

Citations

Citations to this article as recorded by

Thyroid Hormone Replacement Dose Is Not Associated with Anti-TPO and Anti-TG Antibody Titers in Hashimoto’s Disease
Małgorzata Szczuko, Olimpia Szmigiel, Urszula Szczuko, Leon Rudak, Karolina Wrońska, Lidia Kwiatkowska, Małgorzata Tomasik, Anhelli Syrenicz, Jakub Pobłocki
Journal of Clinical Medicine.2026; 15(3): 970. CrossRef
Relationship between ghrelin and thyroid disease: a meta-analysis
Caihong Xin, Jiayi Yao, Huijuan Li, Xin Sun, Huijuan Wang
Frontiers in Endocrinology.2025;[Epub] CrossRef
Thyroid disorders and gastrointestinal dysmotility: an old association
Guang-Meng Xu, Ming-Xin Hu, Si-Yu Li, Xuan Ran, Hao Zhang, Xiang-Fu Ding
Frontiers in Physiology.2024;[Epub] CrossRef
Insulin resistance, leptin and adiponectin in lean and hypothyroid children and adolescents with obesity
Doaa El Amrousy, Dalia El-Afify, Shaimaa Salah
BMC Pediatrics.2022;[Epub] CrossRef
Mediators of energy homeostasis in hyperthyroidism
Avinash Patil, Suresh Vaikkakara, Mani Deepthi Dasari, Sandeep Ganta, Alok Sachan, Kiranmayi S. Vinapamula
Archives of Endocrinology and Metabolism.2022;[Epub] CrossRef
STUDY OF GHRELIN LEVELS IN HYPOTHYROID PATIENTS BEFORE AND AFTER TREATMENT
Peeyush Yadav, G. G. Kaushik
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH.2021; : 52. CrossRef
Acylated Ghrelin Attenuates l-Thyroxin–induced Cardiac Damage in Rats by Antioxidant and Anti-inflammatory Effects and Downregulating Components of the Cardiac Renin–angiotensin System
Rehab Badi
Journal of Cardiovascular Pharmacology.2021; 78(3): 422. CrossRef
Experimental hypothyroidism in adult male rats: the effects of Artemisia dracunculus aqueous extract on serum thyroid hormones, lipid profile, leptin, adiponectin, and antioxidant factors
Mohammad Mohsen Mohammadi, Mahdi Saeb, Saeed Nazifi
Comparative Clinical Pathology.2020; 29(2): 485. CrossRef
Leptin, neuropeptide Y (NPY), melatonin and zinc levels in experimental hypothyroidism and hyperthyroidism: relation with melatonin and the pineal gland
Abdulkerim Kasım Baltaci, Rasim Mogulkoc
Hormone Molecular Biology and Clinical Investigation.2018;[Epub] CrossRef
Leptin, NPY, Melatonin and Zinc Levels in Experimental Hypothyroidism and Hyperthyroidism: The Relation to Zinc
Abdulkerim Kasım Baltaci, Rasim Mogulkoc
Biochemical Genetics.2017; 55(3): 223. CrossRef
Thyroid Hormone Regulation and Insulin Resistance: Insights From Animals Naturally Adapted to Fasting
Bridget Martinez, Rudy M. Ortiz
Physiology.2017; 32(2): 141. CrossRef
Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis
Antonietta Messina, Carolina De Fusco, Vincenzo Monda, Maria Esposito, Fiorenzo Moscatelli, Anna Valenzano, Marco Carotenuto, Emanuela Viggiano, Sergio Chieffi, Vincenzo De Luca, Giuseppe Cibelli, Marcellino Monda, Giovanni Messina
Frontiers in Neural Circuits.2016;[Epub] CrossRef
Serum Concentrations of Ghrelin and Leptin according to Thyroid Hormone Condition, and Their Correlations with Insulin Resistance (Endocrinol Metab2015;30:318-25, Kyu-Jin Kim et al.)
Jin Hwa Kim
Endocrinology and Metabolism.2015; 30(4): 631. CrossRef
Serum Concentrations of Ghrelin and Leptin according to Thyroid Hormone Condition, and Their Correlations with Insulin Resistance (Endocrinol Metab2015;30:318-25, Kyu-Jin Kim et al.)
Chan-Hee Jung
Endocrinology and Metabolism.2015; 30(4): 633. CrossRef

Ghrelin Inhibits Oligodendrocyte Cell Death by Attenuating Microglial Activation: Jee Youn Lee, Tae Young Yune; Endocrinol Metab. 2014;29(3):371-378. Published online September 25, 2014; DOI: https://doi.org/10.3803/EnM.2014.29.3.371

7,410 View
36 Download
32 Web of Science
31 Crossref

Abstract PDF PubReader

Background

Recently, we reported the antiapoptotic effect of ghrelin in spinal cord injury-induced apoptotic cell death of oligodendrocytes. However, how ghrelin inhibits oligodendrocytes apoptosis, is still unknown. Therefore, in the present study, we examined whether ghrelin inhibits microglia activation and thereby inhibits oligodendrocyte apoptosis.

Methods

Using total cell extracts prepared from BV-2 cells activated by lipopolysaccharide (LPS) with or without ghrelin, the levels of p-p38 phosphor-p38 mitogen-activated protein kinase (p-p38MAPK), phospho-c-Jun N-terminal kinase (pJNK), p-c-Jun, and pro-nerve growth factor (proNGF) were examined by Western blot analysis. Reactive oxygen species (ROS) production was investigated by using dichlorodihydrofluorescein diacetate. To examine the effect of ghrelin on oligodendrocyte cell death, oligodendrocytes were cocultured in transwell chambers of 24-well plates with LPS-stimulated BV-2 cells. After 48 hours incubation, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay and terminal deoxynucleotidyl transferase 2'-deoxyuridine, 5'-triphosphate nick end labeling staining were assessed.

Results

Ghrelin treatment significantly decreased levels of p-p38MAPK, p-JNK, p-c-Jun, and proNGF in LPS-stimulated BV-2 cells. ROS production increased in LPS-stimulated BV-2 cells was also significantly inhibited by ghrelin treatment. In addition, ghrelin significantly inhibited oligodendrocyte cell death when cocultured with LPS-stimulated BV-2 cells.

Conclusion

Ghrelin inhibits oligodendrocyte cell death by decreasing proNGF and ROS production as well as p38MAPK and JNK activation in activated microglia as an anti-inflammatory hormone.

Citations

Citations to this article as recorded by

Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers
Heli Jeskanen, Sami Heikkinen, Inka Kervinen, Jenni Lehtisalo, Tiia Ngandu, Roosa-Maria Willman, Jessica Rosa, Dorit Hoffmann, Ville Leinonen, Annakaisa Haapasalo, Mari Takalo, Henna Martiskainen, Mikko Hiltunen
Alzheimer's Research & Therapy.2026;[Epub] CrossRef
Ghrelin, Neuroinflammation, Oxidative Stress, and Mood Disorders: What Are the Connections?
Jessica Mingardi, Ramona Meanti, Caterina Paoli, Carlo Cifani, Antonio Torsello, Maurizio Popoli, Laura Musazzi
Current Neuropharmacology.2025; 23(2): 172. CrossRef
Potential role of ghrelin in neuroprotection and cognitive function: implications for diabetic cognitive impairment
Yuhan Zhang, Ruihua Zhang, Xin Wang, Leilei Shi, Hongzhe Zhu, Jiping Liu
PeerJ.2025; 13: e18898. CrossRef
Ghrelin-induced neuronal NPY promotes brain metastasis in lung cancer patients with low BMI
Abhishek Tyagi, Shih-Ying Wu, Jee-Won Kim, Ravindra Pramod Deshpande, Kerui Wu, Eleanor C. Smith, Giuseppe L. Banna, Kounosuke Watabe
Nature Communications.2025;[Epub] CrossRef
Pro- and Anti-Inflammatory Neuropeptides and Glia: The Balance Between Neuroprotection and Neuroinflammation
Eli J. Futran-Sheinberg, Victoria Urbina, Sofia Nava, Daniel Sanchez, Gilberto Guzmán-Valdivia, Mario A. Zetter
Neuroglia.2025; 6(3): 35. CrossRef
Ghrelin may protect against vascular endothelial injury in Acute traumatic coagulopathy by mediating the RhoA/ROCK/MLC2 pathway
Chengjian He, Xiaojing Song, Zigui Zhu, Yan Xiao, Jiacheng Chen, Hongyi Yao, Rongjun Xie
Journal of Thrombosis and Thrombolysis.2024; 58(1): 84. CrossRef
Ferroptosis in the neurovascular unit after spinal cord injury
Yushan Huang, Jinzhu Bai
Experimental Neurology.2024; 381: 114943. CrossRef
The Pathologic Roles and Therapeutic Implications of Ghrelin/GHSR System in Mental Disorders
Qianshuo Mao, Jinjia Wang, Zihan Yang, Ruidong Ding, Shuangyu Lv, Xinying Ji, Sizhi Ai
Depression and Anxiety.2024;[Epub] CrossRef
Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes
Hayan Jeong, Hyo-Jin Chong, Jangho So, Yejin Jo, Tae-Young Yune, Bong-Gun Ju
International Journal of Molecular Sciences.2022; 23(7): 3977. CrossRef
Inflammation: A Target for Treatment in Spinal Cord Injury
Ximena Freyermuth-Trujillo, Julia J. Segura-Uribe, Hermelinda Salgado-Ceballos, Carlos E. Orozco-Barrios, Angélica Coyoy-Salgado
Cells.2022; 11(17): 2692. CrossRef
The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases
Cristina Russo, Maria Stella Valle, Antonella Russo, Lucia Malaguarnera
International Journal of Molecular Sciences.2022; 23(21): 13432. CrossRef
Early low-dose ghrelin intervention via miniosmotic pumps could protect against the progressive dopaminergic neuron loss in Parkinson's disease mice
Lingling Jiao, Xixun Du, Fengju Jia, Yong Li, Dexiao Zhu, Tinging Tang, Qian Jiao, Hong Jiang
Neurobiology of Aging.2021; 101: 70. CrossRef
Ghrelin-Mediated Regeneration and Plasticity After Nervous System Injury
Irina Stoyanova, David Lutz
Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Microglial Lipid Biology in the Hypothalamic Regulation of Metabolic Homeostasis
Andrew Folick, Suneil K. Koliwad, Martin Valdearcos
Frontiers in Endocrinology.2021;[Epub] CrossRef
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Niklas Reich, Christian Hölscher
Frontiers in Neuroscience.2020;[Epub] CrossRef
Effects of Ghrelin on the Apoptosis of Rheumatoid Arthritis Fibroblast-Like Synoviocyte MH7A Cells
Junxian Ma, Xinbo Wang, Tingting Lv, Jie Liu, Ying Ren, Jinshan Zhang, Yan Zhang
Biological and Pharmaceutical Bulletin.2019; 42(2): 158. CrossRef
Direct and indirect effects of lipids on microglia function
Q. Leyrolle, S. Layé, A. Nadjar
Neuroscience Letters.2019; 708: 134348. CrossRef
Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity
Bernardo Stutz, Carole Nasrallah, Mariana Nigro, Daniel Curry, Zhong-Wu Liu, Xiao-Bing Gao, John D. Elsworth, Liat Mintz, Tamas L. Horvath
Molecular Metabolism.2019; 24: 120. CrossRef
MK-0677, a Ghrelin Agonist, Alleviates Amyloid Beta-Related Pathology in 5XFAD Mice, an Animal Model of Alzheimer’s Disease
Yu-on Jeong, Soo Jung Shin, Jun Yong Park, Bo Kyeong Ku, Ji Soo Song, Jwa-Jin Kim, Seong Gak Jeon, Sang Min Lee, Minho Moon
International Journal of Molecular Sciences.2018; 19(6): 1800. CrossRef
Involvement of Astrocytes in Mediating the Central Effects of Ghrelin
Laura Frago, Julie Chowen
International Journal of Molecular Sciences.2017; 18(3): 536. CrossRef
The neurological effects of ghrelin in brain diseases: Beyond metabolic functions
Qian Jiao, Xixun Du, Yong Li, Bing Gong, Limin Shi, Tingting Tang, Hong Jiang
Neuroscience & Biobehavioral Reviews.2017; 73: 98. CrossRef
Neuropeptides and Microglial Activation in Inflammation, Pain, and Neurodegenerative Diseases
Lila Carniglia, Delia Ramírez, Daniela Durand, Julieta Saba, Juan Turati, Carla Caruso, Teresa N. Scimonelli, Mercedes Lasaga
Mediators of Inflammation.2017; 2017: 1. CrossRef
Non-Neuronal Cells in the Hypothalamic Adaptation to Metabolic Signals
Alejandra Freire-Regatillo, Pilar Argente-Arizón, Jesús Argente, Luis Miguel García-Segura, Julie A. Chowen
Frontiers in Endocrinology.2017;[Epub] CrossRef
The Ghrelin/GOAT System Regulates Obesity-Induced Inflammation in Male Mice
Rebecca E. Harvey, Victor G. Howard, Moyra B. Lemus, Tara Jois, Zane B. Andrews, Mark W. Sleeman
Endocrinology.2017; 158(7): 2179. CrossRef
Central Modulation of Neuroinflammation by Neuropeptides and Energy-Sensing Hormones during Obesity
Roger Maldonado-Ruiz, Lizeth Fuentes-Mera, Alberto Camacho
BioMed Research International.2017; 2017: 1. CrossRef
Lifestyle Shapes the Dialogue between Environment, Microglia, and Adult Neurogenesis
Jorge Valero, Iñaki Paris, Amanda Sierra
ACS Chemical Neuroscience.2016; 7(4): 442. CrossRef
Signaling of ghrelin and its functional receptor, the growth hormone secretagogue receptor, promote tumor growth in glioblastomas
Yousuke Okada, Yasuo Sugita, Koichi Ohshima, Motohiro Morioka, Satoru Komaki, Junko Miyoshi, Hideyuki Abe
Neuropathology.2016; 36(6): 535. CrossRef
Ghrelin-AMPK Signaling Mediates the Neuroprotective Effects of Calorie Restriction in Parkinson's Disease
Jacqueline A. Bayliss, Moyra B. Lemus, Romana Stark, Vanessa V. Santos, Aiysha Thompson, Daniel J. Rees, Sandra Galic, John D. Elsworth, Bruce E. Kemp, Jeffrey S. Davies, Zane B. Andrews
The Journal of Neuroscience.2016; 36(10): 3049. CrossRef
MMP-3 secreted from endothelial cells of blood vessels after spinal cord injury activates microglia, leading to oligodendrocyte cell death
Jee Y. Lee, Hae Y. Choi, Tae Y. Yune
Neurobiology of Disease.2015; 82: 141. CrossRef
Role of Non-Neuronal Cells in Body Weight and Appetite Control
Pilar Argente-ArizÃ³n, Alejandra Freire-Regatillo, JesÃºs Argente, Julie A. Chowen
Frontiers in Endocrinology.2015;[Epub] CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef

Obesity and Metabolism
Vav3, a GEF for RhoA, Plays a Critical Role under High Glucose Conditions: Jie Sha, Jungsik Na, Jung Ok Lee, Nami Kim, Soo Kyung Lee, Ji Hae Kim, Ji Wook Moon, Su Jin Kim, Hye Jeong Lee, Jong-Il Choi, Sun Hwa Park, Hyeon Soo Kim; Endocrinol Metab. 2014;29(3):363-370. Published online September 25, 2014; DOI: https://doi.org/10.3803/EnM.2014.29.3.363

6,681 View
39 Download
9 Web of Science
8 Crossref

Abstract PDF PubReader

Background

The role of small GTPase molecules is poorly understood under high glucose conditions.

Methods

We analyzed the expression pattern of Vav3 in skeletal muscle C2C12 cells under high glucose culture condition with reverse transcription-polymerase chain reaction and Western blot analysis. We also measured glucose uptake using isotope-labelled glucose.

Results

We showed that expression of Vav3 (a guanine nucleotide exchange factor for RhoA) increased. mRNA and protein levels in skeletal muscle C2C12 cells under high glucose conditions. The AMP-activated protein kinase (AMPK) activator AMPK agonist 5-aminoimidazole-4-carboxy-amide-1-d-ribofuranoside (AICAR) suppressed high glucose-induced Vav3 induction. In addition, exposure of cells to high glucose concentration increased the phosphorylation of PAK-1, a molecule downstream of RhoA. The phosphorylation of paxillin, a downstream molecule of PAK-1, was also increased by exposure to high glucose. Phosphorylation of these molecules was not observed in the presence of AICAR, indicating that AMPK is involved in the RhoA signal pathway under high glucose conditions. Knock down of Vav3 enhances metformin-mediated glucose uptake. Inhibition of AMPK blocked the increases of Vav3 knock down-induced glucose uptake. Metformin-mediated Glut4 translocation was also increased by Vav3 knock-down, suggesting that Vav3 is involved in metformin-mediated glucose uptake.

Conclusion

These results demonstrate that Vav3 is involved in the process of metformin-mediated glucose regulation.

Citations

Citations to this article as recorded by

Vav3, a potential diagnostic and prognostic marker of diabetes, regulates glycolipid metabolism
Chenmoji Wang, Mengjuan Wei, Yu Wang, Huimin He, Chengcheng Huang, Deshan Liu, Yun Qiao
Molecular Aspects of Medicine.2026; 107: 101429. CrossRef
PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
Kai Wang, Lili Yan, Xun Qiu, Huan Chen, Fengqiang Gao, Wenwen Ge, Zhengxing Lian, Xuyong Wei, Shuai Wang, Hong He, Xiao Xu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2024; 1870(6): 167236. CrossRef
Peripheral origin exosomal microRNAs aggravate glymphatic system dysfunction in diabetic cognitive impairment
Lin Zhang, Dongna Li, Pengrong Yi, Jiangwei Shi, Mengqing Guo, Qingsheng Yin, Dingbin Liu, Pengwei Zhuang, Yanjun Zhang
Acta Pharmaceutica Sinica B.2023; 13(7): 2817. CrossRef
A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology
Robert Eckenstaler, Michael Hauke, Ralf A. Benndorf
Biochemical Pharmacology.2022; 206: 115321. CrossRef
Rho Family GTPases and Rho GEFs in Glucose Homeostasis
Polly A. Machin, Elpida Tsonou, David C. Hornigold, Heidi C. E. Welch
Cells.2021; 10(4): 915. CrossRef
Pharmacological Modulators of Small GTPases of Rho Family in Neurodegenerative Diseases
William Guiler, Addison Koehler, Christi Boykin, Qun Lu
Frontiers in Cellular Neuroscience.2021;[Epub] CrossRef
Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
Nuria Perretta-Tejedor, Javier Fernández-Mateos, Luis García-Ortiz, Manuel A. Gómez-Marcos, José I. Recio-Rodríguez, Cristina Agudo-Conde, Emiliano Rodriguez-Sánchez, Ana I. Morales, Francisco J. López-Hernández, José M. López-Novoa, Rogelio González-Sarm
Scientific Reports.2017;[Epub] CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef

Growth Hormone-Releaser Diet Attenuates Cognitive Dysfunction in Klotho Mutant Mice via Insulin-Like Growth Factor-1 Receptor Activation in a Genetic Aging Model: Seok Joo Park, Yoon Hee Chung, Jeong Hyun Lee, Duy-Khanh Dang, Yunsung Nam, Ji Hoon Jeong, Yong Sun Kim, Toshitaka Nabeshima, Eun-Joo Shin, Hyoung-Chun Kim; Endocrinol Metab. 2014;29(3):336-348. Published online September 25, 2014; DOI: https://doi.org/10.3803/EnM.2014.29.3.336

8,258 View
33 Download
14 Web of Science
15 Crossref

Abstract PDF PubReader

Background

It has been recognized that a defect in klotho gene expression accelerates the degeneration of multiple age-sensitive traits. Accumulating evidence indicates that aging is associated with declines in cognitive function and the activity of growth hormone (GH)/insulin-like growth factor-1 (IGF-1).

Methods

In this study, we examined whether a GH-releaser diet could be effective in protecting against cognitive impairment in klotho mutant mice.

Results

The GH-releaser diet significantly induced the expression of IGF-1 and IGF-1 receptors in the hippocampus of klotho mutant mice. Klotho mutant mice showed significant memory impairments as compared with wild-type mice. In addition, the klotho mutation significantly decreased the expression of cell survival/antiapoptotic factors, including phospho-Akt (p-Akt)/phospho-glycogen synthase kinase3β (p-GSK3β), phospho-extracellular signal-related kinase (p-ERK), and Bcl-2, but significantly increased those of cell death/proapoptotic factors, such as phospho-c-jun N-terminal kinase (p-JNK), Bax, and cleaved caspase-3 in the hippocampus. Treatment with GH-releaser diet significantly attenuated both decreases in the expression of cell survival/antiapoptotic factors and increases in the expression of cell death/proapoptotic factors in the hippocampus of klotho mutant mice. In addition, klotho mutation-induced oxidative stress was significantly attenuated by the GH-releaser diet. Consequently, a GH-releaser diet significantly improved memory function in the klotho mutant mice. GH-releaser diet-mediated actions were significantly reversed by JB-1, an IGF-1 receptor antagonist.

Conclusion

The results suggest that a GH-releaser diet attenuates oxidative stress, proapoptotic changes and consequent dysfunction in klotho mutant mice by promoting IGF-1 expression and IGF-1 receptor activation.

Citations

Citations to this article as recorded by

Risk Factors, Pathological Changes, and Potential Treatment of Diabetes‐Associated Cognitive Dysfunction
Xiaoyu Meng, Haiyang Du, Danpei Li, Yaming Guo, Peiqiong Luo, Limeng Pan, Ranran Kan, Peng Yu, Yuxi Xiang, Beibei Mao, Yi He, Siyi Wang, Wenjun Li, Yan Yang, Xuefeng Yu
Journal of Diabetes.2025;[Epub] CrossRef
New insights into the role of Klotho in inflammation and fibrosis: molecular and cellular mechanisms
Xinyue Zhao, Donghe Han, Chun Zhao, Fengfan Yang, Zhimei Wang, Yujiao Gao, Meihua Jin, Ran Tao
Frontiers in Immunology.2024;[Epub] CrossRef
The Interaction Between Attention Deficit and Hyperactivity Disorder and Nutrition
Enes Bahadir Kilic, Eda Koksal
Current Nutrition Reports.2024;[Epub] CrossRef
Virgin coconut oil reverses behavioral phenotypes of letrozole-model of PCOS in Wistar rats via modulation of NRF2 upregulation
Olabode O. Akintoye, Ayodeji J. Ajibare, Idowu O. Omotuyi
Journal of Taibah University Medical Sciences.2023; 18(4): 831. CrossRef
Nonlinear relationship between glycated hemoglobin and cognitive impairment after acute mild ischemic stroke
Lei Xu, Qin Xiong, Yang Du, Lu-wen Huang, Ming Yu
BMC Neurology.2023;[Epub] CrossRef
The location, physiology, pathology of hippocampus Melatonin MT2 receptor and MT2-selective modulators
Yueqin Feng, Xiaowen Jiang, Wenwu Liu, Hongyuan Lu
European Journal of Medicinal Chemistry.2023; 262: 115888. CrossRef
Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction
Thomas M. Barber, Ioannis Kyrou, Harpal S. Randeva, Martin O. Weickert
International Journal of Molecular Sciences.2021; 22(2): 546. CrossRef
A conserved klo-1-mpk-1 pathway regulates autophagy and modulates longevity in Caenorhabditis elegans
Jie Tang, Jian-Fan Zhang, Rui-Qiu Yang, Yuan-Li Chen, Baosen Ni
Biochemical and Biophysical Research Communications.2021; 562: 36. CrossRef
Melatonin Receptor as a Drug Target for Neuroprotection
Pawaris Wongprayoon, Piyarat Govitrapong
Current Molecular Pharmacology.2020; 14(2): 150. CrossRef
Theanine attenuates memory impairments induced by klotho gene depletion in mice
Bao Trong Nguyen, Naveen Sharma, Eun-Joo Shin, Ji Hoon Jeong, Sung Hoon Lee, Choon-Gon Jang, Seung-Yeol Nah, Toshitaka Nabeshima, Yukio Yoneda, Hyoung-Chun Kim
Food & Function.2019; 10(1): 325. CrossRef
Molecular and cellular aspects of age-related cognitive decline and Alzheimer’s disease
Rikki Hullinger, Luigi Puglielli
Behavioural Brain Research.2017; 322: 191. CrossRef
Secreted and Transmembrane αKlotho Isoforms Have Different Spatio-Temporal Profiles in the Brain during Aging and Alzheimer's Disease Progression
Anna Massó, Angela Sánchez, Lydia Gimenez-Llort, Jose Miguel Lizcano, Manuel Cañete, Belen García, Virginia Torres-Lista, Meritxell Puig, Assumpció Bosch, Miguel Chillon, David Blum
PLOS ONE.2015; 10(11): e0143623. CrossRef
Evaluation of individual aging degree by standard-free, label-free LC-MS/MS quantification of formaldehyde-modified peptides
Mei Zhang, Wei Xu, Ming Ke, Jianguo Xu, Yulin Deng
The Analyst.2015; 140(12): 4137. CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef
Insulin resistance and cognitive dysfunction
Lina Ma, Jieyu Wang, Yun Li
Clinica Chimica Acta.2015; 444: 18. CrossRef

Accelerated and Exacerbated Effects of High Dietary Fat on Neuronal Damage Induced by Transient Cerebral Ischemia in the Gerbil Septum: Seung Hwan Cheon, Bing Chun Yan, Bai Hui Chen, Joon Ha Park, Ji Hyeon Ahn, In Hye Kim, Jae-Chul Lee, Yoo Seok Park, Min Joung Kim, Yun Lyul Lee, Jun Hwi Cho, Moo-Ho Won; Endocrinol Metab. 2014;29(3):328-335. Published online September 25, 2014; DOI: https://doi.org/10.3803/EnM.2014.29.3.328

6,193 View
30 Download
8 Web of Science
8 Crossref

Abstract PDF PubReader

Background

Obesity induced by high-fat diet (HFD) is one of the most widespread metabolic disorders in current society. However, there has been little research regarding the effects of HFD-induced obesity in the septa of animal models of cerebral ischemia. Therefore, in the present study, we investigated septal effects of HFD on neuronal damage and gliosis induced by transient cerebral ischemia.

Methods

Body weight, blood glucose levels and serum lipid profiles levels were measured both in the normal diet (ND) and HFD-group. We also investigated the effects of ND and HFD on neuronal damage and gliosis in the septum after transient cerebral ischemia using immunohistochemistry.

Results

The levels of blood glucose, serum triglyceride, and total cholesterol were significantly increased in the HFD-fed gerbils compared with the ND-fed gerbils, although body weight was not significantly changed after HFD feeding. In the ND-fed gerbils, ischemia-induced neuronal damage was found in the septohippocampal nucleus (SHN) of the septum 7 days after ischemia. In the HFD-fed gerbils, ischemia-induced neuronal damage in the SHN was much more severe compared with that of the ND-fed gerbils 4 and 7 days after ischemia. In addition, we found that ischemia-induced glial activation including astrocytes and microglia was accelerated and exacerbated in the HFD-fed gerbils compared with that in the ND-fed gerbils.

Conclusion

These results indicate that HFD can lead to much more severe effects in ischemia-induced neuronal damage/death in the septum after ischemia-reperfusion, and that it may be associated with accelerated change in glial activation.

Citations

Citations to this article as recorded by

Ischemic stroke, obesity, and the anti‐inflammatory role of melatonin
Nuttapong Yawoot, Piyarat Govitrapong, Chainarong Tocharus, Jiraporn Tocharus
BioFactors.2021; 47(1): 41. CrossRef
Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain
Yi Qin, Qing Zhang, Yaru Liu
Brain Research Bulletin.2020; 156: 15. CrossRef
High fat diet accelerates and exacerbates microgliosis and neuronal damage/death in the somatosensory cortex after transient forebrain ischemia in gerbils
Won Joo Seo, Ji Hyeon Ahn, Tae-Kyeong Lee, Bora Kim, Jae-Chul Lee, Joon Ha Park, Yeon Ho Yoo, Myoung Cheol Shin, Jun Hwi Cho, Moo-Ho Won, Yoonsoo Park
Laboratory Animal Research.2020;[Epub] CrossRef
A 2-Min Transient Ischemia Confers Cerebral Ischemic Tolerance in Non-Obese Gerbils, but Results in Neuronal Death in Obese Gerbils by Increasing Abnormal mTOR Activation-Mediated Oxidative Stress and Neuroinflammation
Joon Ha Park, Ji Hyeon Ahn, Minah Song, Hyunjung Kim, Cheol Woo Park, Young Eun Park, Tae-Kyeong Lee, Jae-Chul Lee, Dae Won Kim, Choong-Hyun Lee, In Koo Hwang, Bing Chun Yan, Sungwoo Ryoo, Young-Myeong Kim, Il Jun Kang, Moo-Ho Won, Soo Young Choi
Cells.2019; 8(10): 1126. CrossRef
Prolonged High Fat Diet Worsens the Cellular Response to a Small, Covert-like Ischemic Stroke
Kathleen E. Fifield, Todd M. Rowe, Joanna B. Raman-Nair, Michiru Hirasawa, Jacqueline L. Vanderluit
Neuroscience.2019; 406: 637. CrossRef
Antioxidant Properties of Fucoidan Alleviate Acceleration and Exacerbation of Hippocampal Neuronal Death Following Transient Global Cerebral Ischemia in High-Fat Diet-Induced Obese Gerbils
Ji Hyeon Ahn, Myoung Cheol Shin, Dae Won Kim, Hyunjung Kim, Minah Song, Tae-Kyeong Lee, Jae-Chul Lee, Hyeyoung Kim, Jun Hwi Cho, Young-Myeong Kim, Jong-Dai Kim, Soo Young Choi, Moo-Ho Won, Joon Ha Park
International Journal of Molecular Sciences.2019; 20(3): 554. CrossRef
Obesity and stroke: Can we translate from rodents to patients?
Michael J Haley, Catherine B Lawrence
Journal of Cerebral Blood Flow & Metabolism.2016; 36(12): 2007. CrossRef
Articles in 'Endocrinology and Metabolism' in 2014
Won-Young Lee
Endocrinology and Metabolism.2015; 30(1): 47. CrossRef

Adrenal gland
Effects of Chronic Restraint Stress on Body Weight, Food Intake, and Hypothalamic Gene Expressions in Mice: Joo Yeon Jeong, Dong Hoon Lee, Sang Soo Kang; Endocrinol Metab. 2013;28(4):288-296. Published online December 12, 2013; DOI: https://doi.org/10.3803/EnM.2013.28.4.288

14,682 View
206 Download
172 Crossref

Abstract PDF PubReader

Background

Stress affects body weight and food intake, but the underlying mechanisms are not well understood.

Methods

We evaluated the changes in body weight and food intake of ICR male mice subjected to daily 2 hours restraint stress for 15 days. Hypothalamic gene expression profiling was analyzed by cDNA microarray.

Results

Daily body weight and food intake measurements revealed that both parameters decreased rapidly after initiating daily restraint stress. Body weights of stressed mice then remained significantly lower than the control body weights, even though food intake slowly recovered to 90% of the control intake at the end of the experiment. cDNA microarray analysis revealed that chronic restraint stress affects the expression of hypothalamic genes possibly related to body weight control. Since decreases of daily food intake and body weight were remarkable in days 1 to 4 of restraint, we examined the expression of food intake-related genes in the hypothalamus. During these periods, the expressions of ghrelin and pro-opiomelanocortin mRNA were significantly changed in mice undergoing restraint stress. Moreover, daily serum corticosterone levels gradually increased, while leptin levels significantly decreased.

Conclusion

The present study demonstrates that restraint stress affects body weight and food intake by initially modifying canonical food intake-related genes and then later modifying other genes involved in energy metabolism. These genetic changes appear to be mediated, at least in part, by corticosterone.

Citations

Citations to this article as recorded by

Impact of Sex, Gonadectomy, and Repeated Restraint Stress on Gut Microbiome in Mice
Chahrazed Mekadim, Jakub Mrázek, Martin Vodička, Peter Ergang, Kateřina Olša Fliegerová, Tiziana Maria Mahayri, Kallayanee Chawengsaksophak, Jiří Pácha
Molecular Neurobiology.2026;[Epub] CrossRef
Impacts of prolonged different social (equality and inequality) conditions on spatial learning and memory deficits, as well as obsessive-compulsive disorder-like behaviors in male rats
Mohammad Mazaheri, Maryam Radahmadi, Mohammad Reza Sharifi
Physiology & Behavior.2026; 305: 115177. CrossRef
Differential effects of chronic restraint stress on two active avoidance tasks in rats
Alba López-Moraga, Mirte De Ceuninck, Yana Van der Heyden, Laura Vercammen, Rupert Palme, Bram Vervliet, Tom Beckers, Laura Luyten
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2026; 144: 111586. CrossRef
Comprehensive analysis of the effects of high stocking density stress on broiler health
Dongying Bai, Caifang Guo, Penghui Ma, Ziwei Wang, Xiaodie Zhao, Xiqiang Ma, Xiaolin Xie, Yi Zhang, Fangshen Guo, Yushu Zhang, Bingkun Zhang, Cai Zhang, Wenrui Zhen, Yanbo Ma
Frontiers in Veterinary Science.2026;[Epub] CrossRef
Evaluation of the Relationship Between Orexin A, Peptide YY, AgRP, and POMC Levels and Sleep Disorders in Children with Malnutrition
Anna Carina Ergani, Mustafa Esad Tezcan, Ümmügülsüm Can, Emine Arslan Kılıçoğlu
Nutrients.2026; 18(3): 377. CrossRef
RETRACTED ARTICLE: Chronic stress-mediated dysregulations in inflammatory, immune and oxidative circuitry impairs the therapeutic response of methotrexate in experimental autoimmune disease models
Rishabh Chaudhary, Mohd Akhtar Azam, Bhavana Dowand, Alpana Singh, Mujeeba Rehman, Vipul Agarwal, Anand Kumar, Arjun Singh Kaushik, Sukriti Srivastava, Siddhi Srivastava, Vikas Mishra
Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(4): 4305. CrossRef
Sex differences in the murine HPA axis after acute and repeated restraint stress
Isabella Flor Nalepa, Vibeke Nielsen, Tanja Esther Wolf, Chadi Touma, Morten Grupe, Ayodeji A. Asuni, Cecilia Ratner
Stress.2025;[Epub] CrossRef
Cuscuta epithymum extract affects epileptic offspring behaviour and weight after applying preconception immobility stress on parents
Narjes Khavasi, Leila Ghassemifard, Hajar Ramezanikhah, Saeed Sardari, Ehsan Saboory
International Journal of Developmental Neuroscience.2025;[Epub] CrossRef
How does chronic psychosocial distress induce pain? Focus on neuroinflammation and neuroplasticity changes
Barbara Fülöp, Éva Borbély, Zsuzsanna Helyes
Brain, Behavior, & Immunity - Health.2025; 47: 100964. CrossRef
Effects of a mixture of ambient air pollution and its metabolites on depression: From epidemiology to molecular mechanisms
Hai Duc Nguyen
Journal of Environmental Sciences.2025; 158: 405. CrossRef
Pre-gestational restraint stress affects reproductive outcomes in adult rats by modulating ovarian and uterine function
Harini Raghavendhira, Divya Srinivasan, Jeyakumari Paul, Ravindran Rajan, Ravi Sankar Bhaskaran
Gene Expression Patterns.2025; 55: 119391. CrossRef
Anti-Stress Effects of Tremella fuciformis Berk. Enzymatic Extracts: A Preclinical Study
Gahye Moon, Nodir Rustamov, Junhang Park, Hanseul Park, Kumju Park, Eun Hye Choi, Yoon-Seok Roh
Nutrients.2025; 17(5): 914. CrossRef
Non-aversive handling in laboratory animals and its effects on depressive-like and anxiety-related behaviors: A scoping review
Louise Castro de Jesus, Ana Lúcia S․ Rodrigues
Physiology & Behavior.2025; 294: 114883. CrossRef
Vagal pathway activation links chronic stress to decline in intestinal stem cell function
Guoying Zhang, Yannan Lian, Qingguo Li, Shudi Zhou, Lili Zhang, Liting Chen, Junzhe Tang, Hailong Liu, Ni Li, Qiang Pan, Yongqiang Gu, Naiheng Lin, Hanling Wang, Xuege Wang, Jiacheng Guo, Wei Zhang, Zige Jin, Beitao Xu, Xiao Su, Moubin Lin, Qi Han, Jun Qi
Cell Stem Cell.2025; 32(5): 778. CrossRef
Running Reverses Chronic Stress‐Induced Changes in Serotonergic Modulation of Hippocampal Granule Cells and Altered Behavioural Responses
Carmen Soto, Lazaro P. Orihuela, Grego Apostol, Carmen Vivar
European Journal of Neuroscience.2025;[Epub] CrossRef
The ROCK Inhibitor Fasudil and Sertraline Share Morphological and Molecular Effects in the Hippocampus of Chronically Stressed Rats: Exploring Common Antidepressant Pathways by Network Pharmacology
Gonzalo García-Rojo, Ignacio Valenzuela Martínez, Felipe Aguayo, Mauricio Muñoz-Llanos, David Ramírez, Jenny L. Fiedler
ACS Pharmacology & Translational Science.2025; 8(5): 1292. CrossRef
Vitamin D alleviates chronic stress-induced testicular steroidogenesis disruption in Wistar rats
Siddhi Srivastava, Sukriti Srivastava, Vipul Agarwal, Mujeeba Rehman, Rishabh Chaudhary, Arjun Singh Kaushik, Sapana Kushwaha, Vikas Mishra
Tissue and Cell.2025; 95: 102910. CrossRef
Hippocampal CA1 neuron, a crucial regulator for chronic stress exacerbating Alzheimer’s disease progression
Qing-Lin Gao, Hai-Wei Zha, Zi-Jie Liu, Miao-Miao Wang, Yu-Qing Zhang, Jia-Rui Bi, Tian-Yang Wu, Zhen-Jiang Liu, Hui Wu, Dong Sun
Cell & Bioscience.2025;[Epub] CrossRef
Development of novel electrospun nanofibers loaded with Levosulpiride and Cannabidiol encapsulated in cyclodextrin-phospholipid inclusion complex for ameliorated treatment of anxiety and depression
Iqra Zai, Mohd Aqil, Yasmin Sultana
International Journal of Pharmaceutics.2025; 682: 125909. CrossRef
Sex and Circadian Rhythm Dependent Behavioral Effects of Chronic Stress in Mice and Modulation of Clock Genes in the Prefrontal Cortex
Jessica Mingardi, Mattia Giovenzana, Noemi Nicosia, Paulina Misztak, Alessandro Ieraci, Laura Musazzi
International Journal of Molecular Sciences.2025; 26(13): 6410. CrossRef
In-vitro experiments suggest Ixodes ricinus nymphs prefer blood with Borrelia infection and low glucocorticoid levels
Tosca Vanroy, Bram Catfolis, Elin Verbrugghe, Kris Verheyen, Luc Lens, Diederik Strubbe, Frank Pasmans, An Martel, Siska Croubels, Marc Cherlet, Lander Baeten
Experimental Parasitology.2025; 276: 108999. CrossRef
Attenuation Effect of Withania somnifera Extract on Restraint Stress-Induced Anxiety-like Behavior and Hippocampal Alterations in Mice
Kippuem Lee, Daehyeop Lee, Joo Yun Kim, Jae Jung Shim, Jae Woo Bae, Jae Hwan Lee
International Journal of Molecular Sciences.2025; 26(15): 7317. CrossRef
Protective Effects of Momordica charantia Fruit Extract on Male Sexual Dysfunction and Testicular Damage in Rats Induced by Chronic Unpredictable Stressors
Therachon Kamollerd, Suwit Uopasai, Tarinee Sawatpanich, Nongnut Uabundit, Supatcharee Arun, Nareelak Tangsrisakda, Chayakorn Taoto, Chadaporn Chaimontri, Natthapol Lapyuneyong, Wipawee Thukhammee, Sararat Innoi, Sitthichai Iamsaard
Life.2025; 15(10): 1559. CrossRef
Vitamin D supplementation stimulates germ cell proliferation in a restraint-stressed mouse
Rahul Kumar, Lalrawngbawli Annie, Guruswami Gurusubramanian, Ajit Singh, Vikas Kumar Roy
Reproductive Toxicology.2025; 138: 109077. CrossRef
Unraveling the potency of naturally derived Virgin coconut oil in modulating chronic restraint stress-induced spatial learning and memory
Rucha Dafale, Shobha U. Kamath, Gitika Bhasin, Vasanthalaxmi K., Ujjal Bose, Ramesh Babu, Dhiren Punja, Amith Bharadwaj, Manjula S. D.
Nutritional Neuroscience.2025; : 1. CrossRef
AKT/mTOR/BDNF pathway mediates the antidepressant-like effects of NAc-DBS in a mouse model of depression
Ranran Li, Xuhui Huang, Siwen Lv, Yongtao Liu, Ruijiao Li, Qianqian Li, Junyao Zhu, Wenjie Ren, Lujing Geng, Shuangping Ma, Yi Yu, Lei Wang, Wei Wang
Frontiers in Behavioral Neuroscience.2025;[Epub] CrossRef
Comparison of Various Dosages of Escitalopram on Anxiety-like Behavior and Body Weight in Male Rats under Severe Chronic Stress
Maryam Radahmadi, Zahra Farahbakhsh
Advanced Biomedical Research.2025;[Epub] CrossRef
Potential antimicrobial activity of camel milk as a traditional functional food against foodborne pathogens in vivo and in vitro
Amro Abdelazez, Sherif Melak, Heba Abdelmotaal, Garsa Alshehry, Huda Al-jumayi, Eman Algarni, Xiang-Chen Meng
Food Science and Technology International.2024; 30(3): 239. CrossRef
Effects of home‐cage elevation on behavioral tests in mice
Hiroshi Ueno, Yu Takahashi, Shinji Murakami, Kenta Wani, Yosuke Matsumoto, Motoi Okamoto, Takeshi Ishihara
Brain and Behavior.2024;[Epub] CrossRef
Anaesthesia-induced Changes in Genomic Expression Leading to Neurodegeneration
Khalid Saad Alharbi, Waleed Hassan Almalki, Sami I. Alzarea, Imran Kazmi, Fahad A. Al-Abbasi, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Mohammed Albratty, Asim Najmi, Gaurav Gupta
CNS & Neurological Disorders - Drug Targets.2024; 23(4): 411. CrossRef
Stress integration by an ascending adrenergic-melanocortin circuit
Connor Laule, Nilufer Sayar-Atasoy, Iltan Aklan, Hyojin Kim, Tayfun Ates, Debbie Davis, Deniz Atasoy
Neuropsychopharmacology.2024; 49(9): 1361. CrossRef
Stress-induced changes in cognitive function and intestinal barrier integrity can be ameliorated by venlafaxine and synbiotic supplementations
Sarawut Lapmanee, Nattapon Supkamonseni, Sakkarin Bhubhanil, Nattakan Treesaksrisakul, Chaiyos Sirithanakorn, Mattaka Khongkow, Katawut Namdee, Piyaporn Surinlert, Chittipong Tipbunjong, Prapimpun Wongchitrat
PeerJ.2024; 12: e17033. CrossRef
Effects of prenatal THC vapor exposure on body weight, glucose metabolism, and feeding behaviors in chow and high-fat diet fed rats
Catherine Hume, Samantha L. Baglot, Lucia Javorcikova, Savannah H. M. Lightfoot, Jessica Scheufen, Matthew N. Hill
International Journal of Obesity.2024; 48(7): 981. CrossRef
The inhalation effect of Osmanthus fragrans var. Aurantiacus on physiological parameters in chronically stressed rats
Moon Yeon Youn, Jin-Ju Cho, Seong Jun Hong, Seong Min Jo, Hyangyeon Jeong, Sojeong Yoon, Younglan Ban, Hyeonjin Park, Jae Kyeom Kim, Young Jun Kim, Eui-Cheol Shin
Food Chemistry: X.2024; 22: 101304. CrossRef
Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences
Soraia Silva, Joana Bicker, S. Fialho, Susana Cunha, Amílcar Falcão, Ana Fortuna
Biochemical Pharmacology.2024; 223: 116184. CrossRef
Translational models of stress and resilience: An applied neuroscience methodology review
Zeynep Seda Albayrak, Andreia Vaz, Joeri Bordes, Selen Ünlü, Milou S.C. Sep, Christiaan H. Vinkers, Luisa Pinto, Hale Yapici-Eser
Neuroscience Applied.2024; 3: 104064. CrossRef
Prenatal restraint stress affects early neurobehavioral response and oxidative stress in mice pups.
Oumaima Essaidi, Meriem Laaroussi, Hafsa Malqui, Laila Berroug, Hammou Anarghou, Hamadi Fetoui, Fatiha Chigr
Behavioural Brain Research.2024; 468: 115025. CrossRef
Cerebrovascular dysfunction and depressive symptoms in preclinical models: insights from a scoping review
Nithin J. Menon, Clara Sun, Jashnoor Chhina, Brayden D. Halvorson, Jefferson C. Frisbee, Stephanie J. Frisbee
Journal of Applied Physiology.2024; 136(6): 1352. CrossRef
Improved Memory and Lower Stress Levels in Male Mice Co-Housed with Ovariectomized Female Mice
Layung Sekar Sih Wikanthi, Johan Forsström, Birgit Ewaldsson, Vilborg Palsdottir, Therése Admyre
Animals.2024; 14(10): 1503. CrossRef
The effects of Gastrodia elata on anxiety-like behavior in mice
Lan-Qiao He, Jia-Yu Lin, Ming-Zhi Yu, Peng-Yu Fan, Cen-Jie He, Ting-Ting Zhao
All Life.2024;[Epub] CrossRef
Chronic stress intensify PTZ-induced seizures by triggering neuroinflammation and oxidative stress
Jehan Zeb Khan, Syeda Rida Zainab, Mujeeb Ur Rehman, Muhammad Abid, Muhammad Usama Mazhar, Fawad Ali Shah, Muhammad Khalid Tipu
Biochemical and Biophysical Research Communications.2024; 729: 150333. CrossRef
Subregion-specific transcriptomic profiling of rat brain reveals sex-distinct gene expression impacted by adolescent stress
Kristen N. Krolick, Jingyi Cao, Evelyn M. Gulla, Meeta Bhardwaj, Samantha J. Marshall, Ethan Y. Zhou, Andor J. Kiss, Fouad Choueiry, Jiangjiang Zhu, Haifei Shi
Neuroscience.2024; 553: 19. CrossRef
Sex-dependent astrocyte reactivity: Unveiling chronic stress-induced morphological changes across multiple brain regions
Ariel Y. Zhang, Elias Elias, Melissa T. Manners
Neurobiology of Disease.2024; 200: 106610. CrossRef
A Light-Responsive Neural Circuit Suppresses Feeding
Hailan Liu, Na Qu, Natalia Valdez Gonzalez, Marco A. Palma, Huamin Chen, Jiani Xiong, Abhinav Choubey, Yongxiang Li, Xin Li, Meng Yu, Hesong Liu, Longlong Tu, Nan Zhang, Na Yin, Kristine Marie Conde, Mengjie Wang, Jonathan Carter Bean, Junying Han, Nikola
The Journal of Neuroscience.2024; 44(30): e2192232024. CrossRef
Pharmacological inhibition of histone deacetylase alleviates chronic unpredictable stress induced atherosclerosis and endothelial dysfunction via upregulation of BDNF
Mujeeba Rehman, Vipul Agarwal, Rishabh Chaudhary, Arjun Singh Kaushik, Siddhi Srivastava, Sukriti Srivastava, Anand Kumar, Sanjay Singh, Vikas Mishra
Biochemical and Biophysical Research Communications.2024; 735: 150485. CrossRef
Plasma leptin levels are lower in females, but not males, with ketamine use disorder
Ming-Chyi Huang, Li-Jung Chiang, Wan-Hsi Chien, Tung-Hsia Liu, Chun-Hsin Chen, Yu-Li Liu
The American Journal of Drug and Alcohol Abuse.2024; 50(5): 659. CrossRef
Acyl-CoA binding protein for the experimental treatment of anorexia
Hui Chen, Stéphanie Moriceau, Adrien Joseph, Francois Mailliet, Sijing Li, Virginie Tolle, Philibert Duriez, Roland Dardennes, Sylvère Durand, Vincent Carbonnier, Gautier Stoll, Allan Sauvat, Sylvie Lachkar, Fanny Aprahamian, Carolina Alves Costa Silva, H
Science Translational Medicine.2024;[Epub] CrossRef
Feedforward inhibition of stress by brainstem neuropeptide Y neurons
Yan Zhang, Jiayi Shen, Famin Xie, Zhiwei Liu, Fangfang Yin, Mingxiu Cheng, Liang Wang, Meiting Cai, Herbert Herzog, Ping Wu, Zhi Zhang, Cheng Zhan, Tiemin Liu
Nature Communications.2024;[Epub] CrossRef
Maternal stress during pregnancy alters circulating small extracellular vesicles and enhances their targeting to the placenta and fetus
Mario Sánchez-Rubio, Lorena Abarzúa-Catalán, Ana del Valle, Maxs Méndez-Ruette, Natalia Salazar, Jacinta Sigala, Soledad Sandoval, María Inés Godoy, Alejandro Luarte, Lara J. Monteiro, Roberto Romero, Mahesh A. Choolani, Úrsula Wyneken, Sebastián E. Illan
Biological Research.2024;[Epub] CrossRef
Real-Time Imaging Assessment of Stress-Induced Vascular Inflammation Using Heartbeat-Synchronized Motion Compensation
Minseok A. Jang, Joon Woo Song, Ryeong Hyun Kim, Dong Oh Kang, Ungyo Kang, Hyun Jung Kim, Jin Hyuk Kim, Eun Jin Park, Ye Hee Park, Bo-Hyung Lee, Chi Kyung Kim, Kyeongsoon Park, Jin Won Kim, Hongki Yoo
Arteriosclerosis, Thrombosis, and Vascular Biology.2024; 44(12): 2493. CrossRef
Investigation of the Effect of Crowding Stress on Mice Oocyte Parameters and Reproductive Organs
Farzad Rajaei, Fatemeh Sabbaghziarani
Scientific Journal of Kurdistan University of Medical Sciences.2024; 29(1): 22. CrossRef
Stress exacerbates pancreatic cancer both directly and indirectly by creating an immunosuppressive environment
Takahiro Ikeda, Tomohiko Adachi, Takayuki Tanaka, Daisuke Miyamoto, Hajime Imamura, Hajime Matsushima, Kazuo Yamamoto, Masaaki Hidaka, Kengo Kanetaka, Susumu Eguchi
Journal of Hepato-Biliary-Pancreatic Sciences.2023; 30(7): 935. CrossRef
Up-regulation of BDNF/TrkB signaling by δ opioid receptor agonist SNC80 modulates depressive-like behaviors in chronic restraint-stressed mice
Shuo Wu, Kuan Ning, Yujun Wang, Lesha Zhang, Jinggen Liu
European Journal of Pharmacology.2023; 942: 175532. CrossRef
Assessment of Stress Caused by Environmental Changes for Improving the Welfare of Laboratory Beagle Dogs
Gwang-Hoon Lee, Woori Jo, Tae-Ku Kang, Taeho Oh, KilSoo Kim
Animals.2023; 13(6): 1095. CrossRef
Butein ameliorates chronic stress induced atherosclerosis via targeting anti-inflammatory, anti-fibrotic and BDNF pathways
Mujeeba Rehman, Rishabh Chaudhary, Sonu Rajput, Vipul Agarwal, Arjun Singh Kaushik, Siddhi Srivastava, Sukriti Srivastava, Rohit Singh, Irfan Aziz, Sanjay Singh, Vikas Mishra
Physiology & Behavior.2023; 267: 114207. CrossRef
Impact of exercise on brain-bone marrow interactions in chronic stress: potential mechanisms preventing stress-induced hypertension
Thu Van Nguyen, Ko Yamanaka, Keisuke Tomita, Jasenka Zubcevic, Sabine S. S. Gouraud, Hidefumi Waki
Physiological Genomics.2023; 55(5): 222. CrossRef
Effect of mobile phone radiofrequency electromagnetic radiations on oxidative stress and feeding behaviour in Sprague Dawley (SD) rats
Pravallika Pagadala, Vinutha Shankar M S, Sumathi M E
Indian Journal of Physiology and Pharmacology.2023; 67: 131. CrossRef
Mechanical loading and autophagy: A study on the BoNT-A injection-induced condylar cartilage degeneration
Siyu Hou, Sisi Peng, Hongwei Dai, Jinlin Song, Ling Xu, Jianping Zhou, Lingjie Li
Archives of Biochemistry and Biophysics.2023; 749: 109788. CrossRef
Continuous deep brain stimulation of the nucleus accumbens reduces food intake but does not affect body weight in mice fed a high-fat diet
Harold F. Hounchonou, Hui Tang, Raik Paulat, Andrea Kühn, Joachim Spranger, Christoph van Riesen, Lukas Maurer
Scientific Reports.2023;[Epub] CrossRef
Chronic stress predisposes to the aggravation of inflammation in autoimmune diseases with focus on rheumatoid arthritis and psoriasis
Rishabh Chaudhary, Ajay Prasad, Vipul Agarwal, Mujeeba Rehman, Anand Kumar, Arjun Singh Kaushik, Siddhi Srivastava, Sukriti Srivastava, Vikas Mishra
International Immunopharmacology.2023; 125: 111046. CrossRef
Venlafaxine and synbiotic attenuated learned fear-like behavior and recognition memory impairment in immobilized-stressed rats
Sarawut Lapmanee, Sakkarin Bhubhanil, Siriwan Sriwong, Mattaka Khongkow, Katawut Namdee, Prapimpun Wongchitrat, Pawin Pongkorpsakol
Physiology and Pharmacology.2023; 27(2): 171. CrossRef
Gonadotropin levels reduced in seven days immobilization stress-induced depressive-like behavior in female rats
Zafer Sahin, Alpaslan Ozkurkculer, Omer Faruk Kalkan, Funda Gulcu Bulmus, Ozgur Bulmus, Selim Kutlu
Journal of Basic and Clinical Physiology and Pharmacology.2022; 33(2): 199. CrossRef
Impact of the Sound of Magnetic Resonance Imaging Pulse Sequences in Awake Mice
Joana Almeida, Frederico Severo, Daniel Nunes
Journal of Applied Animal Welfare Science.2022; 25(1): 75. CrossRef
Virgin coconut oil abrogates depression-associated cognitive deficits by modulating hippocampal antioxidant balance, GABAergic and glutamatergic receptors in mice
Edem Ekpenyong Edem, Blessing Eghosa Ihaza, Adedamola Adediran Fafure, Azeez Olakunle Ishola, Kate Eberechukwu Nebo, Linus Anderson Enye, Elizabeth Toyin Akinluyi
Drug Metabolism and Personalized Therapy.2022; 37(2): 177. CrossRef
Characterizing the behavioral and neuroendocrine features of susceptibility and resilience to social stress
Dalia Murra, Kathryn L. Hilde, Anne Fitzpatrick, Pamela M. Maras, Stanley J. Watson, Huda Akil
Neurobiology of Stress.2022; 17: 100437. CrossRef
VTA-projecting cerebellar neurons mediate stress-dependent depression-like behaviors
Soo Ji Baek, Jin Sung Park, Jinhyun Kim, Yukio Yamamoto, Keiko Tanaka-Yamamoto
eLife.2022;[Epub] CrossRef
Repeated Restraint Stress and Binge Alcohol during Adolescence Induce Long-Term Effects on Anxiety-like Behavior and the Expression of the Endocannabinoid System in Male Rats
Laura Sánchez-Marín, María Flores-López, Ana L. Gavito, Juan Suárez, Francisco Javier Pavón-Morón, Fernando Rodríguez de Fonseca, Antonia Serrano
Biomedicines.2022; 10(3): 593. CrossRef
“Sibling” battle or harmony: crosstalk between nesfatin-1 and ghrelin
Xi Chen, Jing Dong, Qian Jiao, Xixun Du, Mingxia Bi, Hong Jiang
Cellular and Molecular Life Sciences.2022;[Epub] CrossRef
Pharmacological Enhancement of Extinction Retention in Non-stressed Adolescent Rats but Not Those Exposed to Chronic Corticosterone
Anthea A. Stylianakis, Kathryn D. Baker, Rick Richardson
Frontiers in Neuroscience.2022;[Epub] CrossRef
The effect of choline alphoscerate on non spatial memory and neuronal differentiation in a rat model of dual stress
Hyo Jeong Yu, Ye Lin Kim, Min Jung Kim, Jung Mee Park, So Young Park, Shi Nae Park, Dong Won Yang
Brain Research.2022; 1786: 147900. CrossRef
Stress and the brain transcriptome: Identifying commonalities and clusters in standardized data from published experiments
Adrian M. Stankiewicz, Aneta Jaszczyk, Joanna Goscik, Grzegorz R. Juszczak
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2022; 119: 110558. CrossRef
Repeated restraint stress modifies fatty acid and amino acid metabolism in the mouse skin
Yume KITAGAWA, Kaho HAYAKAWA, Daichi OIKAWA, Kazuki IKEDA, Maki IKEDA, Daiki HARADA, Mitsuhiro FURUSE
Journal of Veterinary Medical Science.2022; 84(4): 511. CrossRef
Antidiabetic Properties and Toxicological Assessment of Antidesma celebicum Miq: Ethanolic Leaves Extract in Sprague–Dawley Rats
Raysa Y. Pratiwi, Berna Elya, Heri Setiawan, Roshamur C. Forestrania, Rizna T. Dewi, Kim Wei Chan
Advances in Pharmacological and Pharmaceutical Sciences.2022; 2022: 1. CrossRef
Proteomic and microbiota analyses of the oral cavity during psychological stress
Durga Paudel, Yasuhiro Kuramitsu, Osamu Uehara, Tetsuro Morikawa, Koki Yoshida, Sarita Giri, Syed Taufiqul Islam, Takao Kitagawa, Tadashi Kondo, Kazuki Sasaki, Hirofumi Matsuoka, Hiroko Miura, Yoshihiro Abiko, Jon M. Jacobs
PLOS ONE.2022; 17(5): e0268155. CrossRef
Long-lasting effects of postweaning sleep deprivation on cognitive function and social behaviors in adult mice
Boya Huang, Binhuang Sun, Rui Yang, Shihao Liang, Xinrui Li, Yi Guo, Qian Meng, Yaling Fu, Wenshuya Li, Penghui Zhao, Miao Gong, Yun Shi, Li Song, Sheng Wang, Fang Yuan, Haishui Shi
Neuropharmacology.2022; 215: 109164. CrossRef
High Housing Density-Induced Chronic Stress Diminishes Ovarian Reserve via Granulosa Cell Apoptosis by Angiotensin II Overexpression in Mice
Jihyun Kim, Sooseong You
International Journal of Molecular Sciences.2022; 23(15): 8614. CrossRef
The effect of chronic stress and its preconditioning on spatial memory as well as hippocampal LRP1 and RAGE expression in a streptozotocin-induced rat model of Alzheimer’s disease
Zohreh Taghadosi, Asadollah Zarifkar, Vahid Razban, Hadi Aligholi
Metabolic Brain Disease.2022; 37(8): 2699. CrossRef
Validity of the peak velocity to detect physical training improvements in athymic mice
Maurício Beitia Kraemer, Karen Christine Silva, Camila Cunha França Kraemer, Juliana Silva Pereira, Ivan Gustavo Masseli dos Reis, Denise Gonçalves Priolli, Leonardo Henrique Dalcheco Messias
Frontiers in Physiology.2022;[Epub] CrossRef
Nicotine exposure through breastfeeding affects brain‐derived neurotrophic factor and synaptic proteins levels in the brain of stressed adult female mice
Antonio Alves Pereira Júnior, Gabriel Estevam Santos de Amorim, Raphael Caio Tamborelli Garcia, Jéssyca Milene Ribeiro, Alessandra Oliveira Silva, Carolina Aparecida de Faria Almeida, Carla Speroni Ceron, Silvia Graciela Ruginsk, José Antunes‐Rodrigues, L
International Journal of Developmental Neuroscience.2022; 82(8): 758. CrossRef
Fluoxetine treatment supports predictive validity of the three hit model of depression in male PACAP heterozygous mice and underpins the impact of early life adversity on therapeutic efficacy
Tamás Gaszner, József Farkas, Dániel Kun, Balázs Ujvári, Gergely Berta, Valér Csernus, Nóra Füredi, László Ákos Kovács, Hitoshi Hashimoto, Dóra Reglődi, Viktória Kormos, Balázs Gaszner
Frontiers in Endocrinology.2022;[Epub] CrossRef
Abnormal expression of cortical cell cycle regulators underlying anxiety and depressive-like behavior in mice exposed to chronic stress
Ana Paula Mendes-Silva, Thomas Damien Prevot, Mounira Banasr, Etienne Sibille, Breno Satler Diniz
Frontiers in Cellular Neuroscience.2022;[Epub] CrossRef
Chronic Inhibition of Aggressive Behavior Induces Behavioral Change in Mice
Hiroshi Ueno, Yu Takahashi, Shinji Murakami, Kenta Wani, Tetsuji Miyazaki, Yosuke Matsumoto, Motoi Okamoto, Takeshi Ishihara, Enzo Emanuele
Behavioural Neurology.2022; 2022: 1. CrossRef
Korean Red Ginseng reduces chronic social defeat stress-induced mood disorders via N-methyl-D-aspartate receptor modulation in mice
Bo-Ram Lee, Ju-Hyun Lee, Yong-Hyun Ko, Jee-Yeon Seo, Kwang-Hyun Hur, Young-Jung Kim, Seon-Kyung Kim, Seong-Eon Kim, Seok-Yong Lee, Choon-Gon Jang
Journal of Ginseng Research.2021; 45(2): 254. CrossRef
The Rap1 small GTPase is a critical mediator of the effects of stress on prefrontal cortical dysfunction
B. A. Kermath, A. M. Vanderplow, K. J. Bjornson, E. N. Seablom, A. M. Novak, C. R. Bernhardt, M. E. Cahill
Molecular Psychiatry.2021; 26(7): 3223. CrossRef
Anxiolytic activity of Psidium guajava in mice subjected to chronic restraint stress and effect on neurotransmitters in brain
Swati Sahoo, Prashant S. Kharkar, Niteshkumar U. Sahu, Brijesh S.
Phytotherapy Research.2021; 35(3): 1399. CrossRef
Changes in nitric oxide, carbon monoxide, hydrogen sulfide and male reproductive hormones in response to chronic restraint stress in rats
Amira Moustafa
Free Radical Biology and Medicine.2021; 162: 353. CrossRef
Behavioral and neurological improvement by Cydonia oblonga fruit extract in chronic immobilization stress rats
Fatma Z. Sakhri, Naoki Adachi, Sakina Zerizer, Yusuke Ohashi, Hideshi Ikemoto, Mana Tsukada, Zahia Kabouche, Tadashi Hisamitsu, Masataka Sunagawa
Phytotherapy Research.2021; 35(4): 2074. CrossRef
Restraint stress induces uterine microenvironment disorder in mice during early pregnancy through the β2-AR/cAMP/PKA pathway
Jiayin Lu, Guanhui Liu, Zixu Wang, Jing Cao, Yaoxing Chen, Yulan Dong
Stress.2021; 24(5): 514. CrossRef
A model of negative emotional contagion between male-female rat dyads: Effects of voluntary exercise on stress-induced behavior and BDNF-TrkB signaling
Gavin M. Meade, Lily S. Charron, Lantz W. Kilburn, Zhe Pei, Hoau-Yan Wang, Siobhan Robinson
Physiology & Behavior.2021; 234: 113286. CrossRef
Chronic stress promotes acute myeloid leukemia progression through HMGB1/NLRP3/IL-1β signaling pathway
Na Liu, Yifan Wu, Xin Wen, Peng Li, Fei Lu, Hong Shang
Journal of Molecular Medicine.2021; 99(3): 403. CrossRef
Interleukin-17 induced by cumulative mild stress promoted depression-like behaviors in young adult mice
Jinho Kim, Yoo-Hun Suh, Keun-A Chang
Molecular Brain.2021;[Epub] CrossRef
Amelioration on oxidative stress, testosterone, and cortisol levels after administration of Vitamins C and E in albino rats with chronic variable stress
Nanik Hidayatik, Agus Purnomo, Faisal Fikri, Muhammad Thohawi Elziyad Purnama
Veterinary World.2021; 14(1): 137. CrossRef
Decreased expression of AKAP4 and TyrPho proteins in testis, epididymis, and spermatozoa with low sexual performance of mice induced by modified CUMS
Pannawat Choowong‐in, Jintana Sattayasai, Chanasorn Poodendaen, Sitthichai Iamsaard
Andrologia.2021;[Epub] CrossRef
Chronic Mild Unpredictable Stress and High-Fat Diet Given during Adolescence Impact Both Cognitive and Noncognitive Behaviors in Young Adult Mice
Stephen L. P. Lippi
Brain Sciences.2021; 11(2): 260. CrossRef
Additional Assessment of Fecal Corticosterone Metabolites Improves Visual Rating in the Evaluation of Stress Responses of Laboratory Rats
Tina Kroll, Nikola Kornadt-Beck, Angela Oskamp, David Elmenhorst, Chadi Touma, Rupert Palme, Andreas Bauer
Animals.2021; 11(3): 710. CrossRef
COVID-19 Stress and Food Intake: Protective and Risk Factors for Stress-Related Palatable Food Intake in U.S. Adults
Jennifer R. Sadler, Gita Thapaliya, Elena Jansen, Anahys H. Aghababian, Kimberly R. Smith, Susan Carnell
Nutrients.2021; 13(3): 901. CrossRef
Effects of Long‐Term Exposure of Intermediate Frequency Magnetic Fields (20 kHz, 360 µT) on the Development, Pathological Findings, and Behavior of Female Mice
Alexander Lerchl, Karen Drees (née Grote), Isabel Gronau, Dirk Fischer, Julia Bauch, Axel Hoppe
Bioelectromagnetics.2021; 42(4): 309. CrossRef
Impact of whole‐body versus nose‐only inhalation exposure systems on systemic, respiratory, and cardiovascular endpoints in a 2‐month cigarette smoke exposure study in the ApoE−/− mouse model
Ulrike Kogel, Ee Tsin Wong, Justyna Szostak, Wei Teck Tan, Francesco Lucci, Patrice Leroy, Bjoern Titz, Yang Xiang, Tiffany Low, Sin Kei Wong, Emmanuel Guedj, Nikolai V. Ivanov, Walter K. Schlage, Manuel C. Peitsch, Arkadiusz Kuczaj, Patrick Vanscheeuwijc
Journal of Applied Toxicology.2021; 41(10): 1598. CrossRef
Neuroprotective Effects of Acrocomia aculeata Pulp Oil Microcapsules on Rats Subjected to Chronic Stress
Ana Cristina Jacobowski, Eduardo Benedetti Parisotto, Leonardo Recena Aydos, Roberta Serafim de Souza, Sandra Viveros, Ana Laura Colín-Gonzalez, Iandara Schettert Silva, Eliana Janet Sanjinez-Argandoña, Danilo Wilhelm Filho, Abel Santamaría-Del Angel, Mar
Journal of Medicinal Food.2021; 24(10): 1068. CrossRef
Chronic Sulfasalazine Treatment in Mice Induces System xc− - Independent Adverse Effects
Lise Verbruggen, Lindsay Sprimont, Eduard Bentea, Pauline Janssen, Azzedine Gharib, Lauren Deneyer, Laura De Pauw, Olaya Lara, Hideyo Sato, Charles Nicaise, Ann Massie
Frontiers in Pharmacology.2021;[Epub] CrossRef
Effects of Achillea tenuifolia Lam. hydro-alcoholic extract on anxiety-like behavior and reproductive parameters in rat model of chronic restraint stress
Y Bagheri, E Fathi, A Maghoul, S Moshtagh, K Mokhtari, A Abdollahpour, S Montazersaheb, A Bagheri
Human & Experimental Toxicology.2021; 40(11): 1852. CrossRef
Pain sensitivity increases with sleep disturbance under predictable chronic mild stress in mice
Junhel Dalanon, Sachiko Chikahisa, Tetsuya Shiuchi, Noriyuki Shimizu, Parimal Chavan, Yoshitaka Suzuki, Kazuo Okura, Hiroyoshi Séi, Yoshizo Matsuka
Scientific Reports.2021;[Epub] CrossRef
Stress Diminishes BDNF-stimulated TrkB Signaling, TrkB-NMDA Receptor Linkage and Neuronal Activity in the Rat Brain
Siobhan Robinson, Allison S. Mogul, Elisa M. Taylor-Yeremeeva, Amber Khan, Anthony D. Tirabassi, Hoau-Yan Wang
Neuroscience.2021; 473: 142. CrossRef
Improved Training and Semen Collection Outcomes Using the Closed Box Chair for Macaques
Lisa A. Houser, Cathy Ramsey, Fernanda M. de Carvalho, Breanna Kolwitz, Chelsey Naito, Kristine Coleman, Carol B. Hanna
Animals.2021; 11(8): 2384. CrossRef
Ethologically relevant repeated acute social stress induces maternal neglect in the lactating female mouse
Zachary J. Rosinger, Heather S. Mayer, Jacqueline I. Geyfen, Mable K. Orser, Danielle S. Stolzenberg
Developmental Psychobiology.2021;[Epub] CrossRef
Sperm epigenetic alterations contribute to inter- and transgenerational effects of paternal exposure to long-term psychological stress via evading offspring embryonic reprogramming
Xiaoguo Zheng, Zhenhua Li, Guishuan Wang, Hanshu Wang, Yuchuan Zhou, Xinzhi Zhao, C. Yan Cheng, Yunbo Qiao, Fei Sun
Cell Discovery.2021;[Epub] CrossRef
Involvement of Ghrelin Dynamics in Stress-Induced Eating Disorder: Effects of Sex and Aging
Chihiro Yamada
International Journal of Molecular Sciences.2021; 22(21): 11695. CrossRef
Voluntary wheel running behaviour as a tool to assess the severity in a mouse pancreatic cancer model
Nora Weegh, Eva Zentrich, Dietmar Zechner, Birgitta Struve, Laura Wassermann, Steven Roger Talbot, Simone Kumstel, Miriam Heider, Brigitte Vollmar, André Bleich, Christine Häger, Dragan Hrncic
PLOS ONE.2021; 16(12): e0261662. CrossRef
Chronic Restraint Stress Decreases the Excitability of Hypothalamic POMC Neuron and Increases Food Intake
Go Eun Ha, Eunji Cheong
Experimental Neurobiology.2021; 30(6): 375. CrossRef
Protective Effect of Sphaerococcus coronopifolius Crude Extract in Combination with Bacillus Calmette-Guerin on Ligature-Induced Depression in Female Wistar Rats
Fahima Fellah, Rédha Djenidi, Imen Chebout
Psychiatry Investigation.2020; 17(2): 130. CrossRef
Physical and Physiological Indicators of Welfare in Guinea Pigs (Cavia porcellus) Serving as Ambassador Animals
David M. Powell, Corinne P. Kozlowski, John Clark, Alice Seyfried, Eli Baskir, Ashley D. Franklin
Animals.2020; 10(5): 815. CrossRef
2,3,5,4′-Tetrahydroxystilbene-2-O-β-d-glucoside Restores BDNF-TrkB and FGF2-Akt Signaling Axis to Attenuate Stress-induced Depression
Xi-Xi Li, Yun Yu, Xiu-Yuan Lang, Cheng-Yong Jiang, Rongfeng Lan, Xiao-Yan Qin
Neuroscience.2020; 430: 25. CrossRef
Anxiolytic activity of Coriandrum sativum seeds aqueous extract on chronic restraint stressed mice and effect on brain neurotransmitters
Swati Sahoo, S. Brijesh
Journal of Functional Foods.2020; 68: 103884. CrossRef
Vitamin C supplementation during chronic variable stress exposure modulates contractile functions of testicular artery and sperm parameters in male Wistar rats
Shakiru Ademola Salami, Hussein Mofomosara Salahdeen, Oyinlola Toluwani Moronkola, Babatunde Adekunle Murtala, Yinusa Raji
Middle East Fertility Society Journal.2020;[Epub] CrossRef
A POMC-originated circuit regulates stress-induced hypophagia, depression, and anhedonia
Na Qu, Yanlin He, Chunmei Wang, Pingwen Xu, Yongjie Yang, Xing Cai, Hesong Liu, Kaifan Yu, Zhou Pei, Ilirjana Hyseni, Zheng Sun, Makoto Fukuda, Yi Li, Qing Tian, Yong Xu
Molecular Psychiatry.2020; 25(5): 1006. CrossRef
Mirogabalin prevents repeated restraint stress-induced dysfunction in mice
Takashi Iwai, Akinori Kikuchi, Misa Oyama, Shun Watanabe, Mitsuo Tanabe
Behavioural Brain Research.2020; 383: 112506. CrossRef
A Systematic Review of In Vitro and In Vivo Radio Frequency Exposure Methods
Jared W. Hansen, Ellen M. Swartz, Jerika D. Cleveland, Sajid M. Asif, Benjamin Brooks, Benjamin D. Braaten, Daniel L. Ewert
IEEE Reviews in Biomedical Engineering.2020; 13: 340. CrossRef
Diminished ovarian reserve induced by chronic unpredictable stress in C57BL/6 mice
Lingyun Gao, Fangui Zhao, Yang Zhang, Wenjun Wang, Qi Cao
Gynecological Endocrinology.2020; 36(1): 49. CrossRef
Stress-induced blood brain barrier disruption: Molecular mechanisms and signaling pathways
Menizibeya O. Welcome, Nikos E. Mastorakis
Pharmacological Research.2020; 157: 104769. CrossRef
Anaesthetic-dependent changes in gene expression following acute and chronic exposure in the rodent brain
Dannielle H. Upton, Kata Popovic, Roger Fulton, Michael Kassiou
Scientific Reports.2020;[Epub] CrossRef
Comparative analysis of acute and chronic stress-induced neurobehavioral alteration and liver injury in mice
Tae Woo Oh, Kwang-Youn Kim, Hyun Ju Do, Young-Woo Kim, Kwang-Il Park
Molecular & Cellular Toxicology.2020; 16(4): 367. CrossRef
The impact of chronic stress on energy metabolism
Michael A. van der Kooij
Molecular and Cellular Neuroscience.2020; 107: 103525. CrossRef
In vitro and in vivo studies of nanoparticles of chitosan-Pandanus tectorius fruit extract as new alternative treatment for hypercholesterolemia via Scavenger Receptor Class B type 1 pathway
Efriyana Oksal, Inten Pangestika, Tengku Sifzizul Tengku Muhammad, Habsah Mohamad, Hermansyah Amir, Murni Nur Islamiah Kassim, Yosie Andriani
Saudi Pharmaceutical Journal.2020; 28(10): 1263. CrossRef
Behavioral, metabolic, and renal outcomes of 1-month isolation in adolescent male Dahl salt-sensitive rats
Oksana Nikolaienko, Elena Isaeva, Vladislav Levchenko, Oleg Palygin, Alexander Staruschenko
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology.2020; 319(6): R684. CrossRef
The Good, the Bad and the Unknown Aspects of Ghrelin in Stress Coping and Stress-Related Psychiatric Disorders
Eva Maria Fritz, Nicolas Singewald, Dimitri De Bundel
Frontiers in Synaptic Neuroscience.2020;[Epub] CrossRef
Therapeutic Effects of Modified Gengnianchun Formula on Stress-Induced Diminished Ovarian Reserve Based on Experimental Approaches and Network Pharmacology

Lingyun Gao, Yang Zhang, Huangfang Xu, Fangui Zhao, Wenjun Wang
Drug Design, Development and Therapy.2020; Volume 14: 4975. CrossRef
Vitamin C protects against chronic social isolation stress-induced weight gain and depressive-like behavior in adult male rats
Alireza Najaf Dulabi, Zeinab Shakerin, Nasrin Mehranfard, Maedeh Ghasemi
Endocrine Regulations.2020; 54(4): 266. CrossRef
Intermittent restraint-induced sympathetic activation attenuates hepatic steatosis and inflammation in a high-fat diet-fed mouse model
Sung Bae Lee, Hyeong Geug Kim, Jin Seok Lee, Won Yong Kim, Myong Min Lee, Yun Hee Kim, Jung Ok Lee, Hyeon Soo Kim, Chang Gue Son
American Journal of Physiology-Gastrointestinal and Liver Physiology.2019; 317(6): G811. CrossRef
Involvement of Hepatic SHIP2 and PI3K/Akt Signalling in the Regulation of Plasma Insulin by Xiaoyaosan in Chronic Immobilization-Stressed Rats
Qiuxia Pan, Jiajia Wu, Yueyun Liu, Xiaojuan Li, Jiaxu Chen
Molecules.2019; 24(3): 480. CrossRef
miR-132/212 is induced by stress and its dysregulation triggers anxiety-related behavior
Sydney Aten, Chloe E. Page, Anisha Kalidindi, Kelin Wheaton, Anzela Niraula, Jon P. Godbout, Kari R. Hoyt, Karl Obrietan
Neuropharmacology.2019; 144: 256. CrossRef
Oxytocin involves in chronic stress-evoked melanoma metastasis via β-arrestin 2-mediated ERK signaling pathway
Haoyi Ji, Na Liu, Jing Li, Dawei Chen, Dan Luo, Qian Sun, Yingchun Yin, Yanli Liu, Bing Bu, Xiaoyang Chen, Jingxin Li
Carcinogenesis.2019; 40(11): 1395. CrossRef
Anxiolytic effects of γ-oryzanol in chronically- stressed mice are related to monoamine levels in the brain
Salina Akter, Hiroyuki Sasaki, Kazi Rasel Uddin, Yuko Ikeda, Hiroki Miyakawa, Shigenobu Shibata
Life Sciences.2019; 216: 119. CrossRef
Resveratrol and dimethyl fumarate ameliorate testicular dysfunction caused by chronic unpredictable mild stress-induced depression in rats
Atef Tadros Fahim, Amal Ahmed Abd El-Fattah, Nermin Abdel Hamid Sadik, Bassam Mohamed Ali
Archives of Biochemistry and Biophysics.2019; 665: 152. CrossRef
Centella asiaticaPrevents Increase of Hippocampal Tumor Necrosis Factor-αIndependently of Its Effect on Brain-Derived Neurotrophic Factor in Rat Model of Chronic Stress
Mawaddah Ar Rochmah, Ika Murti Harini, Dian Eurike Septyaningtrias, Dwi Cahyani Ratna Sari, Rina Susilowati
BioMed Research International.2019; 2019: 1. CrossRef
Stress-related over-enhancement of the hypothalamic-pituitary-adrenal axis causes experimental neurolathyrism in rats
Kimino Minagawa, Shin-ichi Yamada, Ayano Suzuki, Saeko Ta, Toshio Kumai, Fernand Lambein, Kuniko Kusama-Eguchi
Environmental Toxicology and Pharmacology.2019; 72: 103245. CrossRef
Chronic Stress Combined with a Fructose Diet Reduces Hypothalamic Insulin Signaling and Antioxidative Defense in Female Rats
Sanja Kovačević, Jelena Nestorov, Gordana Matić, Ivana Elaković
Neuroendocrinology.2019; 108(4): 278. CrossRef
Gut-Brain Neuroendocrine Signaling Under Conditions of Stress—Focus on Food Intake-Regulatory Mediators
Andreas Stengel, Yvette Taché
Frontiers in Endocrinology.2018;[Epub] CrossRef
Chronic unpredictable mild stress-induced depressive-like behavior and dysregulation of brain levels of biogenic amines in Drosophila melanogaster
Stífani Machado Araujo, Marcia Rósula Poetini, Vandreza Cardoso Bortolotto, Shanda de Freitas Couto, Franciane Cabral Pinheiro, Luana Barreto Meichtry, Francielli Polet de Almeida, Elize Aparecida Santos Musachio, Mariane Trindade de Paula, Marina Prigol
Behavioural Brain Research.2018; 351: 104. CrossRef
Melatonin attenuates chronic immobilization stress-induced muscle atrophy in rats: Influence on lactate-to-pyruvate ratios and Na+/K+ ATPase activity
Eman S.H. Abd Allah, Ahmed M. Mahmoud
Pathophysiology.2018; 25(4): 353. CrossRef
Chronic stress effects and their reversibility on the Fallopian tubes and uterus in rats
S. Divyashree, H. N. Yajurvedi
Reproduction, Fertility and Development.2018; 30(2): 380. CrossRef
Evidence-based severity assessment: Impact of repeated versus single open-field testing on welfare in C57BL/6J mice
Carina Bodden, Sophie Siestrup, Rupert Palme, Sylvia Kaiser, Norbert Sachser, S. Helene Richter
Behavioural Brain Research.2018; 336: 261. CrossRef
Repeated Neck Restraint Stress Bidirectionally Modulates Excitatory Transmission in the Dentate Gyrus and Performance in a Hippocampus-dependent Memory Task
Jadwiga Spyrka, Grzegorz Hess
Neuroscience.2018; 379: 32. CrossRef
Stress-induced strain and brain region-specific activation of LINE-1 transposons in adult mice
Ugo Cappucci, Giulia Torromino, Assunta Maria Casale, Jeremy Camon, Fabrizio Capitano, Maria Berloco, Andrea Mele, Sergio Pimpinelli, Arianna Rinaldi, Lucia Piacentini
Stress.2018; 21(6): 575. CrossRef
The involvement of Rhopr-CRF/DH in feeding and reproduction in the blood-gorging insect Rhodnius prolixus
Shirin Mollayeva, Ian Orchard, Angela B. Lange
General and Comparative Endocrinology.2018; 258: 79. CrossRef
Ghrelin is a persistent biomarker for chronic stress exposure in adolescent rats and humans
Muhammad I. ul Akbar Yousufzai, Elia S. Harmatz, Mohsin Shah, Muhammad O. Malik, Ki A. Goosens
Translational Psychiatry.2018;[Epub] CrossRef
Sub-Chronic Stress Exacerbates the Pro-Thrombotic Phenotype in BDNFVal/Met Mice: Gene-Environment Interaction in the Modulation of Arterial Thrombosis
Leonardo Sandrini, Alessandro Ieraci, Patrizia Amadio, Fabrizio Veglia, Maurizio Popoli, Francis S. Lee, Elena Tremoli, Silvia Stella Barbieri
International Journal of Molecular Sciences.2018; 19(10): 3235. CrossRef
Juvenile stress induces behavioral change and affects perineuronal net formation in juvenile mice
Hiroshi Ueno, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yosuke Matsumoto, Motoi Okamoto, Shozo Aoki, Takeshi Ishihara
BMC Neuroscience.2018;[Epub] CrossRef
Chronic stress induced duration dependent alterations in immune system and their reversibility in rats
H.N. Sarjan, H.N. Yajurvedi
Immunology Letters.2018; 197: 31. CrossRef
Chronic stress alters adrenal clock function in a sexually dimorphic manner
Matthew Stagl, Mary Bozsik, Christopher Karow, David Wertz, Ian Kloehn, Savin Pillai, Paul J Gasser, Marieke R Gilmartin, Jennifer A Evans
Journal of Molecular Endocrinology.2018; 60(2): 55. CrossRef
Impaired Growth Performance and Testicular Cells Apoptosis Following Restraint Stress in Adult Hypothyroid Mice
Asif Mehfooz, Quanwei Wei, Mohamed Babo Fadlalla, Farman Ali Siyal, Kuldeep Dhama, Dagan Mao, Fangxiong Shi
International Journal of Pharmacology.2017; 13(6): 541. CrossRef
Chronic stress induced disruption of the peri-infarct neurovascular unit following experimentally induced photothrombotic stroke
Zidan Zhao, Lin Kooi Ong, Sarah Johnson, Michael Nilsson, Frederick R Walker
Journal of Cerebral Blood Flow & Metabolism.2017; 37(12): 3709. CrossRef
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Leonie Stolz, Amin Derouiche, Kavi Devraj, Frank Weber, Robert Brunkhorst, Christian Foerch
Journal of Neuroinflammation.2017;[Epub] CrossRef
Maternal high-fat diet intensifies the metabolic response to stress in male rat offspring
Roxana Karbaschi, Homeira Zardooz, Fariba Khodagholi, Leila Dargahi, Mina Salimi, FatemehSadat Rashidi
Nutrition & Metabolism.2017;[Epub] CrossRef
The effect of chronic noise stress on serum levels of cortisol, gonadotropins, and sexual hormones at implantation time of mice
Alireza Shafiei, Hassan Ehteram, Hossein Akbari, Masoud Motalebi Kashani, Mandana Beigi, Javad Amini Mahabadi, Tahere Mazoochi
Comparative Clinical Pathology.2017; 26(4): 779. CrossRef
Aging rather than stress strongly influences amino acid metabolisms in the brain and genital organs of female mice
Momoko Kodaira, Mao Nagasawa, Takeshi Yamaguchi, Hiromi Ikeda, Kimie Minaminaka, Vishwajit S. Chowdhury, Shinobu Yasuo, Mitsuhiro Furuse
Mechanisms of Ageing and Development.2017; 162: 72. CrossRef
Histone deacetylase-2 is involved in stress-induced cognitive impairment via histone deacetylation and PI3K/AKT signaling pathway modification
Jie Wu, Cui Liu, Ling Zhang, Chun-Hui Qu, Xiao-Long Sui, Hua Zhu, Lan Huang, Yan-Feng Xu, Yun-Lin Han, Chuan Qin
Molecular Medicine Reports.2017; 16(2): 1846. CrossRef
High Hydrostatic Pressure Extract of Ginger Exerts Antistress Effects in Immobilization-Stressed Rats
Sohee Moon, Mak-Soon Lee, Sunyoon Jung, Bori Kang, Seog-Young Kim, Seonyoung Park, Hye-Yeon Son, Chong-Tai Kim, Young-Hee Jo, In-Hwan Kim, Young Soon Kim, Yangha Kim
Journal of Medicinal Food.2017; 20(9): 864. CrossRef
Insulin, not glutamine dipeptide, reduces lipases expression and prevents fat wasting and weight loss in Walker 256 tumor-bearing rats
Hely de Morais, Flaviane de Fatima Silva, Francemilson Goulart da Silva, Milene Ortiz Silva, Maria Fernanda Rodrigues Graciano, Maria Isabel Lovo Martins, Ângelo Rafael Carpinelli, Tânia Longo Mazucco, Roberto Barbosa Bazotte, Helenir Medri de Souza
European Journal of Pharmacology.2017; 806: 67. CrossRef
HBK-15 protects mice from stress-induced behavioral disturbances and changes in corticosterone, BDNF, and NGF levels
Karolina Pytka, Monika Głuch-Lutwin, Magdalena Kotańska, Elżbieta Żmudzka, Magdalena Jakubczyk, Anna Waszkielewicz, Paulina Janiszewska, Maria Walczak
Behavioural Brain Research.2017; 333: 54. CrossRef
The exercise-glucocorticoid paradox: How exercise is beneficial to cognition, mood, and the brain while increasing glucocorticoid levels
Chong Chen, Shin Nakagawa, Yan An, Koki Ito, Yuji Kitaichi, Ichiro Kusumi
Frontiers in Neuroendocrinology.2017; 44: 83. CrossRef
Long-term chronic stress exposure induces PCO phenotype in rat
S Divyashree, H N Yajurvedi
Reproduction.2016; 152(6): 765. CrossRef
Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation
Byung Soo Kong, Soo Jung Im, Yang Jong Lee, Yoon Hee Cho, Yu Ri Do, Jung Woo Byun, Cheol Ryong Ku, Eun Jig Lee, Maria Cristina Vinci
PLOS ONE.2016; 11(3): e0149394. CrossRef
Effects of long-term chronic stress on the lymphoid organs and blood leukocytes of the rat (Rattus norvegicus)
S. Divyashree, H.N. Sarjan, H.N. Yajurvedi
Canadian Journal of Zoology.2016; 94(2): 137. CrossRef
Physiological effects of a habituation procedure for functional MRI in awake mice using a cryogenic radiofrequency probe
Keitaro Yoshida, Yu Mimura, Ryosuke Ishihara, Hiroshi Nishida, Yuji Komaki, Tomohito Minakuchi, Tomokazu Tsurugizawa, Masaru Mimura, Hideyuki Okano, Kenji F. Tanaka, Norio Takata
Journal of Neuroscience Methods.2016; 274: 38. CrossRef
Integrated circuits and molecular components for stress and feeding: implications for eating disorders
J. A. Hardaway, N. A. Crowley, C. M. Bulik, T. L. Kash
Genes, Brain and Behavior.2015; 14(1): 85. CrossRef
The Use of Animal Models to Decipher Physiological and Neurobiological Alterations of Anorexia Nervosa Patients
Mathieu MÃ©quinion, Christophe Chauveau, Odile Viltart
Frontiers in Endocrinology.2015;[Epub] CrossRef
Kososan, but not milnacipran, elicits antidepressant‐like effects in a novel psychological stress‐induced mouse model of depression
Atsushi Hori, Naoki Ito, Tetsuro Oikawa, Toshihiko Hanawa
Traditional & Kampo Medicine.2015; 2(1): 1. CrossRef
Electroconvulsive stimulation, but not chronic restraint stress, causes structural alterations in adult rat hippocampus—A stereological study
Mikkel V. Olesen, Gitta Wörtwein, Bente Pakkenberg
Hippocampus.2015; 25(1): 72. CrossRef
Dopamine release in the lateral hypothalamus is stimulated by α-MSH in both the anticipatory and consummatory phases of feeding
Romain Legrand, Nicolas Lucas, Jonathan Breton, Pierre Déchelotte, Sergueï O. Fetissov
Psychoneuroendocrinology.2015; 56: 79. CrossRef
Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
Won-Young Lee
Endocrinology and Metabolism.2014; 29(3): 251. CrossRef
Contrasting mechanisms by which social isolation and restraint impair healing in male mice
Leah M. Pyter, Linglan Yang, Cassandra McKenzie, José M. da Rocha, C. Sue Carter, Bin Cheng, Christopher G. Engeland
Stress.2014; 17(3): 256. CrossRef
G Protein-Coupled Estrogen Receptor-1 Is Involved in the Protective Effect of Protocatechuic Aldehyde against Endothelial Dysfunction
Byung Soo Kong, Yoon Hee Cho, Eun Jig Lee, Rajesh Mohanraj
PLoS ONE.2014; 9(11): e113242. CrossRef

Obesity and Metabolism
Hemoglobin A1c Is Positively Correlated with Framingham Risk Score in Older, Apparently Healthy Nondiabetic Korean Adults: Ji Hye Shin, Ji In Kang, Yun Jung, Young Min Choi, Hyun Jung Park, Jung Hae So, Jin Hwa Kim, Sang Yong Kim, Hak Yeon Bae; Endocrinol Metab. 2013;28(2):103-109. Published online June 18, 2013; DOI: https://doi.org/10.3803/EnM.2013.28.2.103

6,710 View
35 Download
7 Web of Science
9 Crossref

Abstract PDF PubReader

Background

Several studies have suggested that elevated levels of hemoglobin A1c (HbA1c) are associated with cardiovascular disease (CVD) in nondiabetic individuals. However, it is unclear whether HbA1c levels can serve as a simple screening marker for increased CVD risk in nondiabetic individuals. Our objective was to evaluate the relationship between HbA1c levels and CVD risk using the Framingham risk score (FRS) in older, apparently healthy nondiabetic Korean adults.

Methods

We retrospectively studied 2,879 Korean adults between the ages of 40 and 79 who underwent voluntary health check-ups at the Health Promotion Center of our hospital from July 2009 to June 2011. Subjects were subdivided based on their HbA1c levels into four groups: tertiles within the HbA1c normal tolerance range and a group for subjects with an increased risk for diabetes (IRD).

Results

The mean FRS for the upper tertile (9.6±3.8) group was significantly higher than that of the middle tertile (8.4±4.0) and lower tertile (7.6±3.8) groups. In addition, FRS was highest in the IRD group (10.5±3.7). Multiple linear regression analysis demonstrated that HbA1c levels exhibited a significant positive correlation with FRS when adjusted for confounding variables in all subjects (β±standard error [SE], 0.018±0.002; R², 0.131), women (β±SE, 0.023±0.003; R², 0.170), and men (β±SE, 0.016±0.004; R², 0.109).

Conclusion

HbA1c levels were positively correlated with FRS in older, apparently healthy nondiabetic Korean adults. We propose that HbA1c levels may reflect CVD risk in nondiabetic individuals.

Citations

Citations to this article as recorded by

Correlation between cardiovascular risk and glycemic control among patients with diabetes
Naomi Niari Dalimunthe, Herwindo Ahmad, Dina Arwina Dalimunthe
MGM Journal of Medical Sciences.2024; 11(1): 44. CrossRef
Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea
Hyuk Sang Kwon, Kee Ho Song, Jae Myung Yu, Dong Sun Kim, Ho Sang Shon, Kyu Jeung Ahn, Sung Hee Choi, Seung Hyun Ko, Won Kim, Kyoung Hwa Lee, Il Seong Nam-Goong, Tae Sun Park
Journal of Obesity & Metabolic Syndrome.2021; 30(3): 261. CrossRef
Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes
Hun-Sung Kim, Hyunah Kim, Hae-Kyung Yang, Eun Young Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Hyeon Woo Yim, Bong-Yun Cha
Diabetes & Metabolism Journal.2017; 41(3): 187. CrossRef
Randomized, Open-Label, Parallel Group Study to Evaluate the Effect of Internet-Based Glucose Management System on Subjects with Diabetes in China
Hun-Sung Kim, Chenglin Sun, So Jung Yang, Lin Sun, Fei Li, In Young Choi, Jae-Hyoung Cho, Guixia Wang, Kun-Ho Yoon
Telemedicine and e-Health.2016; 22(8): 666. CrossRef
GA to HbA1C ratio, but not HbA1C is associated with cognition in Chinese nondiabetic old adults
Yuan Zhong, Jun Jin, Chan Chan Xu, Guo Xiang Fu
Aging & Mental Health.2015; 19(9): 853. CrossRef
Relationship of Glycated Hemoglobin A1c, Coronary Artery Calcification and Insulin Resistance in Males Without Diabetes
Chan-Hee Jung, Eun-Jung Rhee, Kyu-Jin Kim, Bo-Yeon Kim, Se Eun Park, Yoosoo Chang, Seungho Ryu, Cheol-Young Park, Ji-Oh Mok, Ki-Won Oh, Chul-Hee Kim, Sung-Woo Park, Sung-Koo Kang, Won-Young Lee
Archives of Medical Research.2015; 46(1): 71. CrossRef
Evaluation of Nutrient Intake and Food Variety in Korean Male Adults according to Framingham Risk Score
Mi-Kyeong Choi, Yun-Jung Bae
The Korean Journal of Food And Nutrition.2014; 27(3): 484. CrossRef
Brief Review of Articles in 'Endocrinology and Metabolism' in 2013
Won-Young Lee
Endocrinology and Metabolism.2014; 29(3): 251. CrossRef
Suicidal ideation and suicide attempts among diabetes mellitus: The Korea National Health and Nutrition Examination Survey (KNHANES IV, V) from 2007 to 2012
Jae Ho Chung, Kitae Moon, Do Hyung Kim, Joo-Won Min, Tae Ho Kim, Hee-Jin Hwang
Journal of Psychosomatic Research.2014; 77(6): 457. CrossRef

Review Articles

Neuroendocrine Regulation of Energy Metabolism.: Marcelo O Dietrich, Tamas L Horvath; Endocrinol Metab. 2012;27(4):268-273. Published online December 20, 2012; DOI: https://doi.org/10.3803/EnM.2012.27.4.268

3,722 View
32 Download
1 Crossref

Abstract PDF

Significant advancements have been made in the past century regarding the neuronal control of feeding behavior and energy expenditure. The effects and mechanisms of action of various peripheral metabolic signals on the brain have become clearer. Molecular and genetic tools for visualizing and manipulating individual components of brain homeostatic systems in combination with neuroanatomical, electrophysiological, behavioral, and pharmacological techniques have begun to elucidate the molecular and neuronal mechanisms of complex feeding behavior and energy expenditure. This review article highlights some of these advancements that have led to the current understanding of the brain's involvement in the acute and chronic regulation of energy homeostasis.

Citations

Citations to this article as recorded by

Neuronal HSF-1 coordinates the propagation of fat desaturation across tissues to enable adaptation to high temperatures in C. elegans
Laetitia Chauve, Francesca Hodge, Sharlene Murdoch, Fatemeh Masoudzadeh, Harry-Jack Mann, Andrea F. Lopez-Clavijo, Hanneke Okkenhaug, Greg West, Bebiana C. Sousa, Anne Segonds-Pichon, Cheryl Li, Steven W. Wingett, Hermine Kienberger, Karin Kleigrewe, Mari
PLOS Biology.2021; 19(11): e3001431. CrossRef

Vitamin D: A D-Lightful Vitamin for Health.: Michael F Holick; Endocrinol Metab. 2012;27(4):255-267. Published online December 20, 2012; DOI: https://doi.org/10.3803/EnM.2012.27.4.255

3,788 View
48 Download
9 Crossref

Abstract PDF

Vitamin D is a sunshine vitamin that has been produced on this earth for more than 500 million years. Because foods contain so little vitamin D most humans have always depended on sun exposure for their vitamin D requirement. Vitamin D deficiency has been defined as a serum 25-hydroxyvitamin D concentration < 20 ng/mL (50 nmol/L); vitamin D insufficiency as a serum 25-hydroxyvitamin D of 21-29 ng/mL and vitamin D sufficiency as a serum 25-hydroxyvitamin D of 30-100 ng/mL whereas toxicity is usually not seen until blood levels are above 150 ng/mL. Vitamin D deficiency is a global health problem that increases risk for metabolic bone diseases in children and adults as well as many chronic illnesses including autoimmune diseases, type 2 diabetes, cardiovascular disease, infectious disease, and cancer. The major causes of vitamin D deficiency are lack of adequate sensible exposure to sunlight, inadequate dietary intake and obesity. The United States Endocrine Society recommended that to prevent vitamin D deficiency in those at risk, children 1 year and older require 600-1,000 international unit (IU) of vitamin D daily and adults require 1,500-2,000 IU of vitamin D daily. Obese patients require 2-3 times more vitamin D to both treat and prevent vitamin D deficiency.

Citations

Citations to this article as recorded by

Higher intakes of dietary caffeine are associated with 25-hydroxyvitamin D deficiency
Qiwei Chen, Hamed Kord-Varkaneh, Heitor O. Santos, Rafael Genario, Minyan Dang
International Journal for Vitamin and Nutrition Research.2022; 92(2): 85. CrossRef
WITHDRAWN: Higher intakes of dietary caffeine are associated with 25-hydroxyvitamin D deficiency: a study from the NHANES
Fang Yang, Ning Wang
Nutrition.2021; : 111380. CrossRef
Association of metabolic syndrome and 25‐hydroxyvitamin D with cognitive impairment among elderly Koreans
Eun Young Lee, Su Jin Lee, Kyoung Min Kim, Young Mi Yun, Bo Mi Song, Jong Eun Kim, Hyeon Chang Kim, Yumie Rhee, Yoosik Youm, Chang Oh Kim
Geriatrics & Gerontology International.2017; 17(7): 1069. CrossRef
Korean Society for Bone and Mineral Research Task Force Report: Perspectives on Intermittent High-dose Vitamin D Supplementation
Han Seok Choi, Yong-Ki Min, Dong Won Byun, Myung Hoon Hahn, Kyoung Min Kim, Beom Jun Kim, Ki-Won Oh
Journal of Bone Metabolism.2017; 24(3): 141. CrossRef
Efficacy and safety of vitamin D3 B.O.N intramuscular injection in Korean adults with vitamin D deficiency
Han Seok Choi, Yoon-Sok Chung, Yong Jun Choi, Da Hea Seo, Sung-Kil Lim
Osteoporosis and Sarcopenia.2016; 2(4): 228. CrossRef
Endocrine Risk Factors for Cognitive Impairment
Jae Hoon Moon
Endocrinology and Metabolism.2016; 31(2): 185. CrossRef
The effect of thyroid stimulating hormone suppressive therapy on bone geometry in the hip area of patients with differentiated thyroid carcinoma
Jae Hoon Moon, Kyong Yeun Jung, Kyoung Min Kim, Sung Hee Choi, Soo Lim, Young Joo Park, Do Joon Park, Hak Chul Jang
Bone.2016; 83: 104. CrossRef
Serum 25‐hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging (KLoSHA)
J.H. Moon, S. Lim, J.W. Han, K.M. Kim, S.H. Choi, K.W. Kim, H.C. Jang
Clinical Endocrinology.2015; 83(1): 36. CrossRef
Vitamin D Status in Korea
Han Seok Choi
Endocrinology and Metabolism.2013; 28(1): 12. CrossRef

Original Articles

Prevalence and Characteristics of Metabolically Obese but Normal Weight and Metabolically Healthy but Obese in Middle-aged Koreans: the Chungju Metabolic Disease Cohort (CMC) Study.: Seung Hwan Lee, Hee Sung Ha, Young Jun Park, Jin Hee Lee, Hyeon Woo Yim, Kun Ho Yoon, Moo Il Kang, Won Chul Lee, Ho Young Son, Yong Moon Park, Hyuk Sang Kwon; Endocrinol Metab. 2011;26(2):133-141. Published online June 1, 2011; DOI: https://doi.org/10.3803/EnM.2011.26.2.133

3,920 View
38 Download
2 Crossref

Abstract PDF

BACKGROUND
We attempted to determine the prevalence and characteristics of metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) individuals in a large cohort of middle-aged Koreans. METHODS: 8,987 non-diabetic subjects were selected from the Chungju Metabolic disease Cohort Study performed in 2003-2006. MONW was defined as a body mass index (BMI) > or = 18.5 and < 23 kg/m2 with a homeostasis model assessment of insulin resistance (HOMA-IR) in the highest quartile. MHO was defined as BMI > or = 25 kg/m2 with HOMA-IR in the lowest quartile. RESULTS: The mean age of the subjects was 62.3 +/- 10.5 years (men 40.4%). The age-adjusted prevalence of MONW and MHO were 4.3% (5.3% men, 3.7% women) and 5.6% (3.6% men, 7.0% women), respectively. 14.2% of men and 12.9% of women were classified as MONW among the normal weight population, whereas 10.7% of men and 14.5% of women were classified as MHO among the obese subjects. The prevalence of prediabetes was significantly higher in the MONW group than in the MHO group (34.7 vs. 12.5%, P < 0.0001 in men; 23.1 vs. 8.8%, P < 0.0001 in women). The MONW group evidenced an equivalent risk of coronary heart disease (CHD) relative to the MHO group (10.77 +/- 0.68 vs. 10.22 +/- 0.90% in men; 7.02 +/- 0.34 vs. 7.26 +/- 0.26% in women, means +/- standard error [SE]). CONCLUSION: The subjects in the MONW group are characterized by a high risk of diabetes and CHD, despite their normal weights. Their substantial prevalence in the population emphasizes the importance of identifying subjects in the MONW group, and warrants more intensive risk management.

Citations

Citations to this article as recorded by

Obesity, metabolic health, and mortality in adults: a nationwide population-based study in Korea
Hae Kyung Yang, Kyungdo Han, Hyuk-Sang Kwon, Yong-Moon Park, Jae-Hyoung Cho, Kun-Ho Yoon, Moo-Il Kang, Bong-Yun Cha, Seung-Hwan Lee
Scientific Reports.2016;[Epub] CrossRef
The Definition of Metabolically Healthy Obesity
Hae Kyung Yang, Seung-Hwan Lee
The Journal of Korean Diabetes.2014; 15(1): 17. CrossRef

The Comparison of Clinical Factors according to Growth Velocity during Gonadotropin-Releasing Hormone Agonist Treatment in Central Precocious Puberty Girls.: Hyo Kyoung Nam, Jung Yeon Shin, Yeon Joung Oh, Young Jun Rhie, Young Yoo, Sang Hee Park, Kee Hyoung Lee; Endocrinol Metab. 2010;25(3):206-212. Published online September 1, 2010; DOI: https://doi.org/10.3803/EnM.2010.25.3.206

2,969 View
32 Download
1 Crossref

Abstract PDF

BACKGROUND
The aim of this study was to investigate the favorable factors for gonadotropin-releasing hormone (GnRH) agonist treatment with regard to the growth velocity and the predicted adult height (PAH) in central precocious puberty (CPP) girls. METHODS: We reviewed the clinical and auxological parameters in 46 CPP girls who were treated with GnRH agonist at the pediatric endocrinology clinic of Korea University Hospital from January 2001 to August 2007. We divided the two groups according to the growth velocity of 5 cm/yr and we assessed the related factors associated with growth velocity. We also assessed the changes in PAH for two years. RESULTS: The pretreatment chronological age and bone age were significantly younger in the high growth velocity group (> 5 cm/yr) compared to that of the low growth velocity group (7.8 +/- 0.9 year vs. 8.4 +/- 0.5 year, 9.4 +/- 1.2 year vs. 10.1 +/- 0.9 year, respectively) (P < 0.05). The PAH after treatment was significantly greater in the high growth velocity group (> 5 cm/yr)(P < 0.05). Growth velocity during treatment had negative correlation with the pretreatment chronological age and positive correlation with the PAH after one and two years of treatment (r = -0.45, P < 0.05 and r = 0.51, P < 0.01). PAH had positive correlation with the treatment duration (r = 0.31, P < 0.05). CONCLUSION: In our study, the growth velocity during GnRH agonist treatment was negatively related to age at the initiation of treatment. Therefore, earlier treatment is important to improve the outcomes and to maintain appropriate growth velocity in CPP girls.

Citations

Citations to this article as recorded by

Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
Joon-Woo Baek, Hyo-Kyoung Nam, Dahee Jin, Yeon Joung Oh, Young-Jun Rhie, Kee-Hyoung Lee
Annals of Pediatric Endocrinology & Metabolism.2014; 19(1): 27. CrossRef

Case Reports

A Case of Pseudohypoparathyroidism Worsened by Rhabdomyolysis.: Won Jun Kim, Sin Je Moon, Hye Young Kim, Chang Beom Lee; J Korean Endocr Soc. 2009;24(3):195-200. Published online September 1, 2009; DOI: https://doi.org/10.3803/jkes.2009.24.3.195

3,346 View
26 Download
1 Crossref

Abstract PDF

The term pseudohypoparathyroidism describes a rare disorder characterized by resistance to the action of immunoreactive parathyroid hormone (PTH) in peripheral tissue rather than a deficiency of PTH. Patients present with tetany, spasm, hypocalcemia, hyperphosphatemia, and Albright's hereditary osteodystrophy (AHO). We present a case of symptomatic hypocalcemia due to pseudohypoparathyroidism aggravated by rhabdomyolysis. A 21-year-old man presented with tetany, AHO phenotypes and an ankle infection. Rhabdomyolysis was confirmed by marked elevation of serum creatine phosphokinase, more than 10 times above normal. Spasm was observed and the serum value of total calcium was as low as 3.7 mg/dL and that of phosphate was as high as 7.0 mg/dL, and the peak level of PTH was at 80.4 pg/mL. Although not surveyed by Ellsworth-Howard test and molecular study, it was classified as pseudohypoparathyroidism type 1a or 1c. The clinical and laboratory abnormalities were corrected by vitamin D in addition to calcium. The patient's mother, sister, and grandmother had AHO phenotypes without clinical and biochemical manifestations. To the best of our knowledge, this is the first case by maternal inheritance that AHO phenotypes appear for three generations of a family in Korea.

Citations

Citations to this article as recorded by

A Case of Pseudohypoparathyroidism with Graves' Disease
Gil Woo Lee, Jae Hoon Kim, Kang Won Lee, Sa Il Kim, Sang Mo Hong, Dong Sun Kim, Woong Hwan Choi, You Hern Ahn, Tae Wha Kim
Endocrinology and Metabolism.2010; 25(3): 221. CrossRef

A Case of Pseudopseudohypoparathyroidism with Normal Stature.: Sae Rom Kim, Yun Jeong Doh, Hee Kyung Kim, Seong Su Moon, Ju Young Lee, Jae Han Jeon, Soo Won Kim, Bo Wan Kim, In Kyu Lee, Jung Guk Kim; J Korean Endocr Soc. 2009;24(2):138-143. Published online June 1, 2009; DOI: https://doi.org/10.3803/jkes.2009.24.2.138

3,513 View
34 Download
1 Crossref

Abstract PDF

Pseudopseudohypoparathyroidism (PPHP) is characterized by the phenotype of Albright hereditary osteodystrophy (AHO) alone without biochemical evidence of multihormone resistance, which is unlike pseudohypoparathyroidism. AHO is associated with characteristic developmental abnormalities that include a short stocky stature, a short neck, brachydactyly, a round face, central obesity, mental retardation and subcutaneous ossifications. AHO is an autosomal dominant disease that's caused by heterozygous inactivating mutations in the Gsalpha gene (GNAS1). Melanocortin-4 receptor (MC4R) is a hypothalamic Gs-coupled receptor that is thought to mediate the central effect of leptin on satiety. MC4R mutations cause morbid obesity starting in infancy, as well as an elevated leptin level. A 62 year old man with a height of 171.5 cm, a round face, a short neck, central obesity and brachydactyly had normal ranges of serum calcium, phosphorus and PTH and a normal Ellsworth-Howard test. GNAS1 gene analysis revealed substitution of alanine to cysteine in the 165 codon of exon 6 and substitution of alanine to cysteine in the 231 codon of exon 9. Two known SNPs (Cyt-1042Thy, Gua-719Ade) in the MC4R were detected in the patient. We report here on a case of PPHP and the patient had normal stature. We propose that MC4R may have contributed to the obesity & normal stature of this patient.

Citations

Citations to this article as recorded by

Polyglandular Autoimmune Syndrome Type III with Primary Hypoparathyroidism
Sang Jin Kim, Sang-Yoon Kim, Han-Byul Kim, Hyukwon Chang, Ho-Chan Cho
Endocrinology and Metabolism.2013; 28(3): 236. CrossRef

Original Articles

Effect of Weight Loss on Endothelial Function in Obese Premenopausal Women.: Se Woong Ma, Se Hwa Kim, Hyo Sung Nam, Kee Myoung Jung, Byung Hyun Yu, Yong Ju Lee, Seok O Park, Sung Kil Lim; J Korean Endocr Soc. 2006;21(6):506-514. Published online December 1, 2006; DOI: https://doi.org/10.3803/jkes.2006.21.6.506

2,567 View
19 Download

Abstract PDF: BACKGROUND
Endothelial dysfunction, a pathological feature of obesity, can predict the occurrence of cardiovascular disease. The endothelial function was compared in obese, non-obese, and type 2 diabetic women, and the effect of weight loss on endothelial function in obese premenopausal women was also investigated. METHODS: Twenty type 2 diabetes patients, 35 obese and 20 non-obese non-diabetic subjects were recruited. Both the endothelium-dependent vasodilation (EDV) and endothelium-independent vasodilation (EIV) were measured. The body composition, serum lipid, serum adiponectin and resistin were also measured. Weight loss in obese women was obtained by 6 months of calorific restriction, aerobic exercise and medication (sibutramine or orlistat). RESULTS: EDV was significantly impaired in the type 2 diabetes and obese groups compared to the control group (6.0 +/- 1.3% in diabetes group, 6.7 +/- 3.9% in obese group, 12.4 +/- 4.1% in control group, P < 0.01, respectively). The mean weight loss after 6 months was 8.5 +/- 3.2 kg (P < 0.001) in the obese group. There was a significant increase in EDV after weight loss (from 5.8 +/- 3.5% to 12.3 +/- 3.9%, P < 0.05). There was no change in EIV after weight loss. In addition, weight loss was associated with significant reductions in the levels of high-sensitivity C-reactive protein (hs-CRP) and serum triglyceride (P < 0.05, respectively). However, there were no significant changes in the serum adiponectin and resistin levels after weight loss. CONCLUSIONS: Our data demonstrated that weight loss was associated with improved endothelial function in obese premenopausal women, as assessed by brachial artery EDV and reduced hs-CRP.

The Relationship between Lumbar Spine Bone Mineral Density and Cardiovascular Risk Factors in Korean Female Adults.: Young Yul Koh, Eun Jung Rhee, Se Yeon Kim, Chan Hi Jung, Cheol Young Park, Won Young Lee, Ki Won Oh, Sung Woo Park, Sun Woo Kim; J Korean Endocr Soc. 2006;21(6):497-505. Published online December 1, 2006; DOI: https://doi.org/10.3803/jkes.2006.21.6.497

3,372 View
19 Download
4 Crossref

Abstract PDF

BACKGROUND
Recent studies suggest a possible pathogenic linkage between the osteoporosis and atherosclerosis. We investigated the relationship between cardiovascular risk factors, including high sensitivity C-reactive protein (hs-CRP), insulin resistance, lipid profiles and bone metabolism in Korean females. METHODS: Anthropometric measurements were performed on 437 women (mean age 52 yrs), and cardiovascular risk factors, including fasting blood glucose, fasting blood insulin, lipid profiles and hs-CRP, measured. An atherogenic index was calculated using the serum total cholesterol level divided by the high-density lipoprotein cholesterol (HDL-C) level. The lumbar spine bone mineral density (BMD) was measured using dual X-ray absorptiometry. RESULTS: From bivariate analyses, the lumbar spine BMD showed negative correlations with age, systolic and diastolic blood pressures, serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), triglyceride levels and atherogenic index, and a positive correlation with the HDL-C level. After adjustment for age and BMI, the atherogenic index and HDL-C showed consistent correlation with the lumbar spine BMD. The log-transformed hs-CRP showed no correlation with the lumbar spine BMD. In premenopausal women, age, BMI and atherogenic index showed significant associations with the lumbar spine BMD and the atherogenic index showed consistently significant correlation, even after adjustment for age and BMI. In postmenopausal women, only age and BMI showed significant correlations with the lumbar spine BMD. From multiple linear regression analyses of all the study subjects, age, BMI, atherogenic index and the presence of menopause were found to be determinants of the lumbar spine BMD (R2 = 0.422, p < 0.05), which was consistently significant in analysis performed on premenopausal women (R2 = 0.157, P < 0.05). In postmenopausal women, age and BMI were found to be the determinants of the lumbar spine BMD (R2 = 0.257, P < 0.05). CONCLUSIONS: The lumbar spine BMD was negatively correlated with the atherogenic index in all and in premenopausal women. The menopause seems to play an important role in the relationship of cardiovascular risk factors with BMD in Korean females.

Citations

Citations to this article as recorded by

Comparison of Relationship between Biochemical Indices and Bone Mineral Densityof Pre- and Post- Menopausal Women in Gyeongnam Area
Mi-Young Park, Sung-Hee Kim
Journal of the East Asian Society of Dietary Life.2017; 27(4): 408. CrossRef
Relationship between Plasma Lipids and Osteoporosis in Korean Postmenopausal Women
Kyung Shik Lee, Jae Hwan Cho, Chang Hae Park, Bo Seung Kim, Kyung Hwan Cho, Seung Hwan Lee, Byung Jun Ko, Do Hoon Kim
Journal of the Korean Geriatrics Society.2011; 15(2): 99. CrossRef
Relationships among Obesity, Bone Mineral Density, and Cardiovascular Risks in Post-menopausal Women
Heeyoung So, Sukhee Ahn, Rhayun Song, Hyunli Kim
Korean Journal of Women Health Nursing.2010; 16(3): 224. CrossRef
Association of the Metabolic Syndrome and Bone Mineral Density in Postmenopausal Women
Jong-Chang Park, Hyuk-Jung Kweon, Yun-Kyo Oh, Hyun-Jin Do, Seung-Won Oh, Youl-Lee Lym, Jae-Kyung Choi, Hee-Kyung Joh, Dong-Yung Cho
Korean Journal of Family Medicine.2010; 31(1): 9. CrossRef

First
Prev
Page of 2
Next
Last

Search